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ABSTRACT 
Sickle Cell Disease (SCD) is a genetic disorder which affects hemoglobin and is 
associated with high rates of neurologic and neurocognitive deficits. Recent studies have 
indicated executive functioning (EF) as a common area of impairment for children 
diagnosed with SCD; however, there is no consensus about which measures of executive 
function are best to use in clinical practice or research. The purpose of the present 
research is to assess the properties of a new executive function measure, the 
“EXAMINER” to determine its utility with the SCD population.  Thirty-two children 
with SCD and 86 demographically-matched controls completed established cognitive 
measures known to be sensitive to SCD-related neurocognitive deficits as well as 
EXAMINER tasks of executive attention, set shifting, working memory, inhibition, 
planning, and fluency. A statistical analysis compared performance on the attention, set 
shifting, inhibition, planning, and fluency measures in the EXAMINER relative to 
established measures (i.e., the verbal comprehension, processing speed, short term 
memory measures in the Woodcock Johnson Tests of Cognitive Abilities III) to compare 
reliability and validity. It was expected that the EXAMINER would show comparable 
reliability and validity to the established measures using traditional definitions of these 
constructs.  In addition, examination of cultural validity was examined due to the high 
preponderance of SCD among the African-American population.  Statistical analysis 
indicated support for internal consistency, convergent validity, cultural validity, and
 vi 
 
 
   
sensitivity of the EXAMINER, relative to traditional cognitive measures. Taken together, 
these results suggest that the EXAMINER is a useful neuropsychological test for the 
pediatric SCD population. Future research should focus on using more sophisticated scale 
development approaches, including greater ethnic and economic diversity with norming 
groups, and incorporating children in the statistical models to further establish strong 
psychometric properties. 
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CHAPTER I 
     INTRODUCTION 
 
 The identification of appropriate executive function (EF) measures for pediatric 
sickle cell disease (SCD) is pivotal in understanding disease related impacts on cognitive 
functioning. SCD is an autosomal recessive genetic blood disorder commonly found in 
individuals with African, Mediterranean, Indian, and Middle Eastern heritage. 
Approximately 1 in 11 African Americans in the United States (US) carry the sickle cell 
trait and it is estimated that 1 in 500 African-Americans have SCD in the United States 
(Charache, Lubin, & Reid, 1992).  
 SCD is a multi-systemic disease that ultimately impacts the biological integrity of 
organs, especially the brain. Decrements associated with SCD brain effects have been 
found in a wide range of cognitive areas that can be categorized as EF. EF is a broad 
construct that incorporates a collection of interconnected cognitive processes responsible 
for focused, goal oriented behavior (Gioia, Isquith, & Guy, 2001).  Even when children 
with SCD appear normal by magnetic resonance imaging (MRI) scan and on traditional 
measures of cognition, such as Intelligence Quotient (IQ), cognitive functioning has been 
found to be impaired (Steen, Fineberg-Buchner, Hankins, Weiss, Prifitera, & Mulhern, 
2005; Schatz, Finke, Kellett, & Kramer, 2002; Wang et al., 2001).  However, pediatric 
SCD treatment studies have consistently utilized neurologic imaging technologies and 
global measures of IQ to understand cognition, as opposed to modality specific 
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neuropsychological assessment (Schatz, Finke, Kellett, & Kramer, 2002). 
 Methodological issues associated with the measurement of cognitive functioning 
are important several reasons, especially in this population.  First, multi-center SCD 
randomized clinical treatment trials have been halted by The National Heart Lung and 
Blood (NHLB) for safety concerns associated with aparticipants completing 
neuroimaging exams (Lee, Piomelli, Granger, Miller, Harkness, Brambilla, Adams, 
2006).  Second, neuroimaging exams may only capture structural lesions and 
underestimate the full extent of neurocognitive deficits (Schatz, Brown,  Pascual, Hsu, 
DeBaun, 2001; Schatz, Finke, Kellett, & Kramer, 2002).  In addition, the brain health of 
children with SCD may be improved if measurement of the narrow abilities associated 
with cognition were incorporated in pediatric SCD treatment studies. Pediatric SCD 
treatment studies have excluded specific measures of cognitive ability performance from 
their outcomes, in part due to inconsistent measurement practices in the research 
literature. Deficits in children with SCD have been shown to impact general intellectual 
ability, attention, language, visual-spatial abilities, short and long term memory, and 
academic outcomes (Steen, Fineberg-Buchner, Hankins, Weiss,  Prifitera, & Mulhern, 
2005; Schatz, Finke, & Roberts, 2004; Schatz, Finke, Kellett, & Kramer, 2002). While 
this distinct cognitive profile for pediatric SCD is apparent, there is a lack of standard 
psychometric tools which evaluate these cognitive abilities across this body of literature. 
Furthermore, within this literature, there is a wide assortment of neuropsychological 
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measures which are used to investigate cognition partly due to the lack of systematic 
evaluation of the measures themselves for use with the SCD population.  
 The development of a neuropsychological assessment battery focused on 
executive functions that will meet or exceed the current established by cognitive 
batteries, such as the Wechsler Intelligence Scales for Children (WISC) and the 
Woodcock Johnson-III Tests of Cognitive Abilities (WJ-III), will help the field develop 
more accurate measurement of disease impacts for children with pediatric SCD.  The 
issue of having well validated tools to measure executive functions for clinical research is 
common across multiple neurologic conditions.  The Executive Abilities: Methods and 
Instruments for Neurobehavioral Evaluation and Research (EXAMINER) was 
constructed to address this limitation. The overall goal for the development of the 
EXAMINER was to reliably and validly assess domains of EF for clinical investigations 
and clinical trials that were adaptable across a wide range of ages and disorders. The 
purpose of the present investigation was to validate the psychometric integrity of the 
EXAMINER for use in children with SCD.   
Organization of Review 
 This study sought to integrate SCD research, SCD treatment, and EF literature to 
propose utilization of a standard psychometric battery which will impact both science as 
well as practice. The background information to set the stage for this study was 
conducted in three separate sections. The first section provided background information 
on SCD and SCD associated neurologic complications. Pediatric SCD studies examining 
cognitive functioning in relation to neurologic disease and treatment were discussed. The 
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concept of EF, construct conceptualization, and measurement in the context of clinical 
outcomes and clinical decision making was reviewed in the second section.  
The third section, of this document, assessed the current state of the science for 
cognitive tools in pediatric SCD literature and identified the minimal standards that EF 
measures should meet or exceed in order to become the new state of the art for clinical 
outcome studies in SCD. In this section, an overall description of the measures that are 
currently in use with this population is presented. Additionally, the psychometrics of 
specific tests utilized with pediatric SCD are reviewed.  Strengths and weaknesses 
associated with the cognitive measures, used to-date, with the SCD population are also 
described. Finally, general comments are offered about the current state of EF measures 
within these existing studies.  
Section I: Sickle Cell Disease 
Nearly  50,000 Americans in the United States (US) have SCD and the majority of 
these individuals are of African, Mediterranean, Indian, and Middle Eastern descent 
(Edwards et al., 2005; McCrae & Lumley, 1998).  It has been estimated that 1 out of 500 
African Americans have a genetic variation of sickle cell disease (Charache, Lubin, & 
Reid, 1992).  SCD refers to a category of inherited blood disorders (McCrae and Lumley, 
1998). SCD occurs when an individual inherits an S-type hemoglobin (sickle type 
hemoglobin) gene along with another hemoglobin gene that does not code for A-type 
hemoblobin (the most common form of hemoglobin).  Hebbel, Mohandas, Embury, & 
Hebbel (1994) describe four major genotypes of SCD: hemoglobin SS (HbSS), 
hemoglobin SC, (HbSC), HbS-beta-zero-thalassemia (HBSβ0), and HbS-beta-plus 
thalassemia (HBSβ+). Sickle Cell Anemia, hemoglobin SS, is the most severe form of the 
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disease and affects 65% to 75% of people diagnosed with SCD in the US (Platt, Orkin, 
Dover, Beardsley, Miller, Nathan, 1984).  
 Individuals with SCD produce abnormal hemoglobin, which is influenced by the 
genetic genotype of the disease. When oxygen saturation in the blood drops below a 
critical threshold the red blood cells (RBCs) outer membrane change from typical disk-
like, “donut” shape to a curved, elongated, “banana” or “sickle” shape. Rigid “sickled” 
cells often lead to common complications associated with the disease, due to these cells 
having reduced lifespan and poorer oxygen carrying capacity (Serjeant, 1997). Chronic 
symptoms include unpredictable pain from vessel occlusion, anemia, increased fatigue, 
splenic sequestration, lung functioning impairment, priapism, enuresis, growth delays, 
increased risk of infection, tissue infarction, cerebral vascular disease (CVD), and acute 
chest syndrome (Sickle Cell Disease Guideline Panel, 1993). 
 Chronic symptoms related to SCD have been found to directly and indirectly 
impact cognitive ability through brain function. In particular, CVD and neurologic 
dysfunctions related to blood vessel function have been found to increase the probability 
of neurologic complication (Hillery & Panepinto, 2004). This damage is thought to occur 
because “sickled” cells reduce oxygen delivery to the brain and also damage small and 
large vessels in the brain (Huttenlocher, Mohr, Johns, et al. 1994). Silent stroke can be 
evidenced on clinical MRI exams in areas such as the arteriole-capillary-venule beds, 
such as found in white matter regions at the distal parts of the major cerebral arteries 
(Adams, McKie, Hsu, Files, Vichinsky, et al., 1998). Overt stroke, which is evidenced 
with clinical MRI exams and an observable neurologic event, can be present from the 
internal carotids to the circle of Willis (DeBaun, Derdeyn, McKinstry, 2006). In children 
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with SCD and overt stroke, decreased verbal intelligence quotient (VIQ), full-scale 
intelligence quotient (FIQ), and narrower abilities such as freedom from distractibility, 
attention, and other location-specific functions (e.g., motor skills contralateral to the 
injury) have been demonstrated (Craft, Schatz, Glauser, Lee, DeBaun, 1993; Steen, 
Emudianughe, Hankins, Wynn, et al., 2003). Less severe neurocognitive deficits, in 
similar areas of cognitive ability as overt stroke, have been associated with silent stroke 
in children with SCD (Armstrong, Thompson, Wang, Zimmerman, Pegelow, Miller, et 
al., 1996; Bernaudin, Verlhac, Freard, Roudot-Thoraval, Benkerrou, et al., 2000). 
Furthermore, deficits associated with FIQ, general cognitive ability, and attention-related 
skills (e.g., short term memory and processing speed) have been shown for those with 
SCD without identifiable brain injury on clinical MRI (Schatz et al., 2004). These deficits 
have been demonstrated to not be related to general disease severity (e.g., hospitalization 
rates, pain severity, anemia severity) and are above and beyond social risk factors for 
poorer cognitive test scores (for review, see Schatz et al., 2002). In terms of functional 
behavior, the broad and narrow cognitive processes affected by SCD are important as 
inter-related processes which are responsible for purposeful, goal-directed behavior. This 
is one of the definitions of EF (Gioia, Isquith, Guy, and Kenworthy, 2000).  
 SCD neurologic injury has been a focal point of treatment studies; however 
assessing EF from a psychological perspective is uncommon in pediatric SCD treatment 
studies. Many of these studies have not included cognitive measures due to contextual 
and methodological considerations in the research associated with pediatric SCD and 
cognition. Many pediatric hematology centers have limited access to psychology 
resources. The use of cognitive tools has been inconsistent across clinical studies.  
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Methodologically, in contrast to tools such as clinical/structural MRI exams for 
identifying cerebral infarcts, there is not a gold standard assessment battery 
recommended to measure cognitive deficits in this population. This limitation reduces the 
use of cognitive abilities as a primary measure of treatment outcomes. The absence of 
established, standard neuropsychological tests may also influence the results obtained for 
children with SCD. The cognitive performance of children with SCD has often been 
measured with tools idiosyncratic to each study, and many of which have varying 
psychometric quality. Additionally, research studies which evaluate cognition in pediatric 
SCD generally have small samples sizes, thus restraining the generalizability of findings 
(Nikhar et al., 2011).  Furthermore, pediatric SCD research methodology is varied in 
nature which creates challenges in comparing findings across studies (e.g., different 
control groups, different approaches to sampling, etc.). Although there are limitations 
associated with pediatric SCD neuropsychological research, neuropsychological 
assessment is generally viewed as valid and reliable with validity measures equaling or 
exceeding those of medical tests, including neuroimaging (Matarazzo, 1990; Meyer, 
Finn, Eyde, et al., 2001). Therefore, the inclusion of cognitive measures is important for 
improved understanding of disease related mechanisms and treatments.  
Overview of neurocognitive relationships in SCD 
 An examination of the existing literature on the cognitive effects of pediatric SCD 
is essential for the understanding how to best select neuropsychological measures to 
include in treatment studies. Stroke, silent infarct, and general disease status differentially 
affect the severity of cognitive deficits.  Additionally, the cognitive performance of 
children has been shown to be impacted by location, size, and volume of neurologic 
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tissue damaged by SCD morbidity (Watkins, Hewes, Connelly, Kendall, Kingsley, 
Evans, Gadian, Vargha-Khadem, Kirkham, 1998).  Compared to healthy children, stroke 
risk has been shown to increase by 221-fold in pediatric SCD (King, Herron, McKinstry, 
Bacak, Armstrong, White, and DeBaun, 2006). Overall, stroke has been shown to 
negatively impact language ability, attention, working memory, processing speed, and 
executive functioning on various neuropsychological tests (Steen et al., 2005; Schatz, 
Finke, & Roberts, 2004; Schatz, Finke, Kellett, & Kramer, 2002; Noll et al., 2001; Schatz 
et al., 2001). In addition, the SCD-related risk of silent cerebral infarct is 410-fold higher 
versus peers without SCD (King, Herron, McKinstry, Bacak, Armstrong, White, and 
DeBaun, 2006). Children diagnosed with SCD and silent cerebral infarcts generally 
perform poorer in FIQ, VIQ, performance intelligence quotient (PIQ), language, memory, 
academic achievement, attention, processing speed and motor coordination than children 
with SCD and no MRI abnormality (Bernaudin et al., 2000; Schatz et al. 2001;  Schatz & 
Buzan, 2006; Steen et al. 2005). Furthermore, cognitive decrements have also been 
demonstrated in children with SCD who have no history of brain abnormalities evidenced 
on MRI (Schatz et al., 2002; Steen 2003; 2005). Overall, a wide range of psychological 
domains such as general intellectual ability, attention, language, visual-spatial abilities, 
short and long term memory, executive functioning, and academic outcomes have been 
shown to be reduced in children diagnosed with SCD when compared to healthy peers 
(Steen et al., 2005; Schatz, Finke, & Roberts, 2004; Schatz, Finke, Kellett, & Kramer, 
2002).  
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SCD Treatment Studies 
Most pediatric SCD treatment studies provide a limited view of cognitive effects 
associated with neurologic change from treatment therapies.  Treatment studies 
traditionally seek to alleviate complications associated with pediatric SCD by relieving 
pain and managing overall disease related complications (Puffer, Schatz, Roberts, 2007). 
Additionally, the primary focus of this body of literature is the prevention of secondary 
neurologic injury after an initial brain insult has occurred, due to SCD complications 
(Adams, Ohene-Frempong, Wang, 2001).  Many pediatric SCD treatment studies which 
utilize neuropsychological measures simply assess global IQ scores due to long-standing 
data on the relationships between IQ and functional outcomes, such as the likelihood of 
educational and vocational success. This methodology is flawed because measurement of 
specific executive processes is more informative than broad cognitive performance to 
understand SCD brain effects (Steen et al., 2003; Armstrong et al., 1996; Boni, Brown, 
Davis, Hsu, & Hopkins, 2001; Knight, Singhal, Thomas, & Serjeant, 1995). Treatment 
therapies also typically focus on the use of bone marrow transplantation (BMT), chronic 
transfusion therapy (CTT), and Hydroxyurea (HU) to treat symptoms associated with 
pediatric SCD.  
 At the present time, BMT is the only known curative therapy for SCD (Miller et 
al., 2000; Walters et al., 1996). The therapy consists of destroying SCD bone marrow and 
transplanting healthy bone marrow from a genetically-matched donor (Mehta, Afenyi-
Annan, Byrns, & Lottenberg, 2006) Healthy bone marrow then produces normal 
hemoglobin. Shenoy (2011) reports that BMT procedures are under-utilized in the SCD 
population, referring to data that reveals that less than five hundred bone marrow 
  
10 
 
  
 
   
 
 
transplantation procedures were reported in the Center for International Blood and 
Marrow Transplant Research database. Although BMT is effective in curing SCD, the 
Seattle collaborative study found no change in neurologic complications of patients with 
SCD after BMT (Walters et al., 1997).  This study investigated the effects of BMT in 22 
children with a mean age of 9 year 9 months who had symptomatic SCD.  MRI/MRA 
findings suggested that 2 children evidenced new neurologic damage after BMT and 
there was no change in the neurologic status for the remaining individuals in the sample. 
The lack of effectiveness of BMT for neurologic outcomes may well be due to the timing 
of BMT, which often occurs after extensive artery damage has already occurred.  
Furthermore, we do not yet know the long term effects of BMT in pediatric SCD 
(Walters et al., 2000). The gap in this literature suggests the importance of conducting 
more comprehensive neurological assessment before and after BMT treatment. Including 
neuropsychological measurement in treatment studies could provide more sensitive 
assessment of neurologic status after treatment, that is not evident by brain imaging or IQ 
scores alone. 
CTT has been shown to be the most effective treatment in the prevention of 
recurring vasoocclusive episodes for children with SCD (Piomelli et al., 1985; Pegelow et 
al., 1995). These episodes occur when the circulation of blood vessels is obstructed by 
“sickled” red blood cells, causing neurologic injuries. CTT prevents these episodes by 
increasing brain oxygenation levels, suppressing HbS synthesis, and reducing hemolysis 
(Raj et al., 2004). The Stroke Prevention Trial in Sickle Cell Anemia (STOP) was pivotal 
in demonstrating the benefits of CTT for stroke risk in children with SCD. Findings 
indicated that children who were screened with TCD and subsequently received CTT 
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demonstrated less recurrence of overt stroke. This intervention also prevented first 
episodes of stroke for children with abnormal cerebral blood flow (Adams, McKie, Hsu, 
et al.1998). Likewise, Wilimas and associates (1980) used routine neuropsychologic 
testing along with radiologic and electrophysiologic studies to evaluate children with 
SCD and previous stroke who were treated with CTT for a 3 year period.  Results 
revealed that their WISC -Revised mean FIQ increased from 63.7 to 67.2 with use of 
CCT. Presently, The Silent Infarct Multicenter Transfusion Trial is evaluating global IQ 
in those receiving blood transfusion compared to a comparison group of participants 
(study in progress). As noted by Schatz and associates (2002), use of broad scale IQ is 
limiting when compared to information obtained from specific measurement of cognitive 
functioning. More information about the treatment of CTT and cognitive effects could be 
understood if studies of this nature included measurements of narrow cognitive ability 
within the study design. Currently the literature lacks the data describing CTT and narrow 
range cognitive abilities due to the omission of neuropsychological measurement for 
these specific abilities. Without this information, treatment trials for SCD may miss 
important information about selective effects of treatment (e.g., benefits to specific 
cognitive abilities and associated neural systems) which could further inform brain 
imaging variables to study. The inclusion of modality specific cognitive measures within 
these studies could help to determine if the brain health benefits are global or specific 
with CTT.  
HU (hydroxycarbamide), is a novel and effective treatment which increases fetal 
hemoglobin in patients with SCD, which inhibits the sickling of S-type hemoglobin. It 
increases the amount of oxygen distributed in the body and thereby decreases the chances 
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of vasoocclusion (Puffer, Schatz, Roberts, 2007). In a randomized control trial, HU was 
shown to reduce the number of hospitalizations and make pain crises milder by 
decreasing vasoocclusive complications and pulmonary tissue damage from acute chest 
syndromes (Charache et al., 1995) Subsequent studies have further supported the health 
benefits of HU therapy for the SCD population (Strouse et al., 2008; Lankron et al 2008). 
To date there is only one study that investigates the effects of HU on cognition in SCD 
(Puffer, Schatz, Roberts, 2007). This study examined 15 children with SCD on HU 
therapy compared to 50 healthy peers, statistically controlling for social/demographic 
factors in a retrospective, correlational design. Results indicated that children with SCD 
on HU performed better on verbal comprehension, fluid reasoning, and general cognitive 
ability tasks than control subjects. The findings from this study provide support for the 
cognitive benefits of HU therapy in pediatric SCD. Additional prospective investigations 
of HU and cognition should be conducted for more thorough understanding of treatment 
effects. 
Summary 
 SCD refers to a category of inherited blood disorders which affect an estimated 1 
out of 500 African Americans in the US (Charache, Lubin, & Reid, 1992). SCD 
complications can influence the neuropsychological functioning of the child. The cellular 
dysfunction associated with SCD can lead to a wide range of insults to the brain 
(Huttenlocher et al., 1984). This is evidenced by findings which suggest that the 
neurologic risk of stroke for children with SCD is more than 200 times the general 
population of healthy peers and the risk doubles for silent cerebral infarct (Early et al., 
1998). Findings indicate overt stroke and SCD result in decreased cognitive ability 
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greater than silent stroke or SCD status (Steen et al., 2005; Schatz, Finke, & Roberts, 
2004; Schatz, Finke, Kellett, & Kramer, 2002; Noll et al., 2001; Schatz et al., 2001). 
Along with decreased cognitive functioning in patients with SCD and stroke, children 
with SCD and silent cerebral infarcts show decrements in cognitive ability greater than 
SCD status but less than SCD and overt stroke (Bernaudin, Verlhac, Freard, Roudot-
Thoraval, Benkerrou, et al., 2000; Schatz et al., 2001; Schatz & Buzan, 2006; Steen et al., 
2005). Unfortunately cognitive deficits have also been found for children with SCD who 
have no history of brain abnormalities evidenced on MRI (Schatz et al., 2002; Steen 
2003; 2005). Further understanding these cognitive dysfunctions are important for 
children with SCD because knowledge can help to identify disease related impacts as 
well as to inform treatment intervention research.  
 Treatment therapies such as BMT, CTT, and HU therapies have all been shown to 
significantly improve disease related effects of SCD (Walters et al., 1996; Adams et al., 
1998; Charache et al., 1995). Although some treatment studies have utilized brain 
imaging to recognize neurologic treatment effects, only the Puffer and colleagues (2007) 
study, to date, has included neuropsychological assessment measures which assess 
narrow cognitive abilities. It is essential to add comprehensive neuropsychological 
measures to these studies so that the impact of treatment therapies on specific EF is 
understood.  It is possible that treatments for SCD may differentially affect cognitive 
processes such that there is improvement in some areas yet greater deficit in other 
domains of EF. Furthermore, the absence of this information may cause treatment 
interventions to lack necessary focus to target specific cognitive systems. 
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Section II: Executive Function (EF) 
 Cognitive abilities such as those impacted in SCD are often described as EF. EF 
has been described in many different manners throughout its evolution and currently has 
no formal, broadly agreed upon definition. Historically, the EF concept largely grew out 
of awareness that IQ tests failed to capture important, higher-level cognitive abilities for 
everyday problem solving that could be seen in some individuals with neurologic disease.  
These cases often involved injury to regions of the prefrontal cortex.  The concept of EF 
has often been used synonymously with the functions of prefrontal brain regions.  More 
recently, scientists have begun defining executive function as also including important 
emotional processing and motivational/reward functions that influence judgment and 
decision making (sometimes called “hot” EF); however, classically EF has focused on 
“cold” cognitive processes involved in dealing with complex cognitive tasks.  For this 
review we will focus on “cold” EF.   
 Rabbitt (1997) described EF as a portrayal of a group of cognitive actions such as:  
dealing with novelty, planning and implementing strategies for performance, monitoring 
performance, using feedback to adjust future responding, vigilance, and inhibiting task-
irrelevant information. EF has also been defined as the cognitive processes which control 
and integrate component neurologic activities in support of adaptive behavior (Woodruff-
Pak, 1997). Similarly, Zelazo and colleagues (1997) conceptualize EF as a 
macrostructure with executive sub functions which work together to accomplish the 
higher-order function of solving problems. For the purposes of this investigation, the EF 
definition developed by Gioia, Isquith, and Guy (2001) will be used to describe these 
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broad and narrow cognitive processes. Their definition describes EF as an umbrella 
expression that incorporates a compilation of inter-related processes which are 
responsible for purposeful, goal-directed behavior.  
 Theoretical models of EF are complex and have evolved greatly over the past 30 
years. The following overview is meant to provide a sampling of the range of EF 
theories, rather than an exhaustive account, which is beyond the scope of the current 
review.  In the early 1970s the EF concept emerged in the literature when Broadbent 
developed one of the first theories invoking the concept of EF. He reported that there are 
two separate mental processes, automatic and controlled (Shiffrin & Schneider, 1977). 
Similarly, Baddeley proposed a working memory model which contained the term 
"central executive" component of cognition (Baddeley & Hitch, 1974). After that, Posner 
further elucidated on the EF concept using the term "cognitive control" and created the 
foundation for much recent EF research (Posner & Synder, 1975). Posner theorized that 
focused attention on specific aspects of the environment is controlled by a distinct 
"executive" branch of the attentional system (Posner & Petersen, 1990). Additionally, 
Lezak (1983) developed an EF definition by explaining EF as the dimension of human 
behavior that deals with “how” behavior is expressed. It is also believed that the 
prefrontal cortex of the brain may mediate many component EF abilities; however the 
tasks controlled by these brain regions are numerous (Stuss et al., 2002). Stuss and 
colleagues (2002) has elaborated on critical EF functions mediated by the prefontral 
regions such as working memory, preparatory set, and inhibitory control, which he argues 
sub-erve the goal of integrating behavior over time (e.g., maintaining goals over time, 
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anticipating events). These classic theories led to the development of the current working 
models of EF. 
 More recent theories of EF include the Top-Down Inhibitory Control Model, 
Brown’s EF Model, Miyake’s “unity and diversity” theory, and the Anderson EF Model. 
The Top-Down Inhibitory Control Model focuses on the inhibitory control mechanisms 
involved in response control, memory, selective attention, theory of mind, and emotion 
regulation as the central mechanism to EF (Anderson & Green, 2001; Tipper, 2001; 
Stone & Gerrans, 2006). However, one of the main criticisms of this hypothesis is that it 
excludes the possible impacts of bottom up inhibition (Aron, 2007).  Brown’s model 
focuses on distinct component areas of EF.  The six clusters of cognitive function in the 
Brown EF model includes activation, focus, effort, emotion, memory, and action are 
explained as dynamic and shifting functions (Brown, 2005). These models also 
emphasize domains of EF that often do not account well for EF, in an ecological sense. 
Most everyday tasks involving EF require the use of several of these domains. Miyake’s 
theory identifies three main component areas for EF (inhibition, working memory, set 
shifting). However, Miyake theorizes that in tasks with functional significance all three 
areas are required to work in concert; thus, EF measures should tap into all three of these 
domains to be relevant to everyday behavior.  Anderson’s model focused more on 
integrating information from developmental and clinical literatures and identifies four 
main areas of EF with component skills that make up each area. Each domain is believed 
to be somewhat distinct (e.g., domains may be dissociated across different clinical 
conditions), yet contains component skills that could be measured in isolation. 
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Consequently, Anderson’s theory falls somewhere between Brown and Miyake’s models 
in terms of emphasizing the unity versus the diversity of cognitive skills in EF.   
Summary  
 The EF field has progressed in both definition and theory in the past three 
decades. Currently there is not a standard definition of EF. However, the Gioia, Isquith, 
and Guy (2001) description of EF was utilized for this review. This definition was used 
because it allows for the study of component processes, which may inform us about the 
function of component neural systems. In addition, this definition upholds the notion that 
EF is critically important because of its role in adaptive behavior.  Varied definitions of 
EF and evolving theories have negatively impacted the creation of measurement tools. 
Due to the wide ranging definitions and theories, EF tasks vary greatly in their format, 
content, and measurement strategy.  It has often been the case that any task sensitive to 
prefrontal cortex injury will be described as an EF measure.  A more detailed discussion 
of EF tools will be presented next. 
EF Measurement  
 The lack of a recognized definition of EF makes the accurate assessment of 
cognitive abilities challenging. First, when invoking the EF construct, it is important to 
state the conceptual approach one is using.  Such definitional statements are often lacking 
the literature.  Many historically important measures of EF, such as the Wisconsin Card 
Sorting Test and the Category Test involved complex, cognitively heterogeneous, novel 
tasks. Although these measures are sensitive to brain dysfunction, these instruments often 
do not do a good job of identifying distinct neural systems that are affected nor do they 
perform well at identifying specific cognitive processes are affected by brain dysfunction.  
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 Specific EF abilities have been shown to be related to specific neural systems.  
For example, the Wager and Smith (2003) meta-analysis found results indicated that that 
different EF processes are associated with specific cerebral areas. For instance, they 
found results which showed that the right inferior prefrontal cortex is frequently activated 
when it is necessary to manipulate information to perform a dual task (i.e., divided 
attention or shifting mental sets across tasks). Additionally, it was demonstrated that the 
superior frontal cortex shows activation once information is presented that has to be 
constantly restructured and when it is necessary that memory for temporal order is 
sustained (i.e., working memory). Due to neurologic associations such as these, many 
current approaches to identify EF capacities and processes use a task-based assessment of 
specific processes that have distinct neural associates (Hughes & Graham, 2002). 
Conceptually, this is consistent with the “diversity” approach of considering distinct, 
component EF processes.   
Contemporary EF Measurement  
 The present day EF measurement approach involves an analysis of test 
psychometrics prior to administration, just as with any other psychological construct. 
This allows for a more thorough understanding of examinee performance. Although this 
may seem obvious to psychologists today, many neuropsychological tasks of EF were 
developed from behavioral neurology assessment tasks that lacked strong psychometric 
evaluation.  Appropriate psychometric analysis includes an examination of considerations 
of the task requirements (content coverage, practicality of the methods), reliability, 
validity, and suitability of the standardized sample chosen to assess an individual (Groth-
Marnat, 2003). These considerations are of particular importance for the SCD population 
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due to the uniqueness of disease related morbidity. Knowledge of test psychometrics aids 
in the appropriate interpretation of performance, given the characteristics of the SCD 
population and possible limitations of the measures.  
 Practicality of administration is an important assessment factor to examine prior 
to test administration. Recognition of how the measure approaches the EF construct is 
meaningful because the test may not be measuring one of the aspects of EF which are of 
interest for this population (Haynes, Richard, & Kubany, 1995). In addition, the context 
and manner in which the test is given is of particular importance. Differential ethnic 
group status between the examiner and examinee has been shown to impact the 
intellectual performance of children (Groth-Marnat, 1997; Sattler, 1992). Similarly 
Terrell, Terrell, & Taylor, (1980) found results which suggest that African American 
children obtained significantly higher scores on the WISC-R when administered the 
measure by an examiner of a similar race. Performance can be affected by educational 
attainment, as well. If the reading level of the test is higher than the subject’s ability, 
scores may be adversely impacted. 
 Children with SCD often have poor education attainment and academic 
achievement due to school absences which result in poorer reading scores than healthy 
peers (Schatz et al., 2001; King et al., 2006). Additionally, test length may negatively 
impact performance on neuropsychological measures due to examinee fatigue or 
frustration, which may not be the constructs of interest (Groth-Marnat, 2003). Many 
neuropsychological test batteries are extensive and require sustained attention over long 
periods of time. The performance of children with SCD on these measures may be 
especially impacted by test length because disease related deficits have been shown to 
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impact sustained attention (White, Moinuddin, McKinstry, Noetzel, Armstrong, & 
DeBaun, 2006; Schatz et al., 2001).  
   Another psychometric issue especially related to pediatric SCD is the adequacy of 
the norm referenced comparative sample. Norm referenced developmental samples have 
become the typical evaluation method for the performance of individuals on 
neuropsychological measures (Sparrow et al., 2000). Norms in psychological assessment 
are described as the mean and standard deviation score among a category of individuals 
(McIntire & Miller, 2007). Individual test results are evaluated relative to psychometric 
norms. Standardized norm-referenced measures with dissimilar demographics from SCD 
characteristics may not adequately reflect performance in the pediatric SCD population. 
Generally, the composition of normative groups is stratified by age and/or education level 
(Cicchetti, 1994). Children with SCD may not meet usual age range expectations due to 
disease related morbidity (Stevens et al., 1986; Zemel et al., 2007). Furthermore, most EF 
tasks have restricted age/ability ranges in contrast to SCD treatment studies (Gaston et 
al., 1986; Ballas et al., 2000). These studies often use broad age range convenience 
samples, the implications of this dissonance are possible increases in errors related to 
interpretation.  Additionally, measurement precision is often not the same across different 
ability levels (McIntire & Miller, 2007). Finally, test generalizability is limited to the 
characteristics of the norm sample. Characteristics of the norm sample should be 
investigated when compared to the examinee, particularly in the SCD population in part 
because health status has been shown to affect test psychometric scores (Johnson, 2006). 
The performance of SCD children should be interpreted with caution if the characteristics 
of the SCD sample are extremely divergent from demographics of the normative sample. 
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Methods of Isolating Specific EF Processes 
 Modern day neuropsychological measures are founded on traditional 
psychometric theory. The traditional model often compares an overall raw score of an 
individual on a cognitive task to norm referenced scores of the standardized sample 
(McGrew & Flanagan, 1998). This comparison is hypothesized to allow inference 
regarding individual performance to a control group. Ideally, this approach provides a fair 
assessment of current cognitive function (Lezak, Howieson, Loring, Hannay, & Fischer, 
2004). As noted previously, similarities between the norm group and the individual may 
influence performance on a measure (Johnson, 2006).  Most commonly, cognitive 
performance evidenced by classic cognitive tests such as the WISC are evaluated using 
this method.  This has sometimes been described as an “achievement” approach to test 
evaluation because it reflects the person’s capability (or lack of capability), but often 
provides little information about why or how the person achieved a particular score. 
 A theoretical alternative to the traditional model for identifying 
neuropsychological ability is the subtractive factors method. Donders (1868/1869) 
developed a reaction time methodological paradigm to evaluate the time involved in a set 
of specific sequences between the presentation of a stimulus event and the initiation of 
response (Schweickert, 1978). The subtractive factors approach hypothesizes that the 
time it takes to complete a particular process can be estimated by adding that process to a 
task and taking the difference in reaction time between the two tasks (Donders, 1969). 
This method has three components and has been used for recognition, discrimination, and 
response selection measurement (Gottsdanker & Shragg, 1985). Critics of this theory 
challenged the central underlying assumption that one mental process can be added to a 
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task without affecting the time to complete other mental processes (Ulrich, Mattes, & 
Miller, 1999). Currently the empirical research of Cattell support this criticism, 
nevertheless Cattell did not analyze this hypothesis within Donder’s formal model 
(Cattell, 1886; 1888; 1947). Thus, although the subtractive factors approach may not 
work with all cognitive tasks, it represents a potentially powerful method to assess 
component skills that make up a more complex task.  This approach may be well suited 
to the measurement of EF, as we may be interested in both overall performance level as 
well as measuring discrete cognitive skills.  Subtractive factors methods have recently 
been applied to norm referenced cognitive ability measures such as Delis–Kaplan 
Executive Function System (D–KEFS), NEPSY - Second Edition (NEPSY–II), 
California Verbal Learning Test (CVLT–II) and Wide Range Assessment of. Memory 
and Learning - Second Edition (WRAML).  
 Another alternative is the additive factors approach.  The additive factors method 
is an additional psychometric approach for the isolation of cognitive processes 
(Sternberg, 1969). Sternberg further developed Donder’s theoretical paradigm to create 
this model. Sternberg’s additive factors logic interpretation of reaction time pattern does 
not require the assumption of discrete stages, like subtractive factors, as long as it is 
assumed that the final output of a stage does not vary as a function of the manipulations. 
The central assumption of the additive factors method is the processing sequence between 
stimulus and response that consists in a series of discrete stages.  It has been shown to be 
a powerful tool for studying reading process models (Raake, 2006; Massaro, 1975). 
However, the additive factors approach is currently not used in any norm-referenced 
tests. This is likely because the method requires a thorough measurement of at least two 
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factors over multiple levels of those factors, including their interaction.  Thus, an additive 
factors approach would add to the length and burden of many tasks.  It is therefore best 
suited to narrow assessment of a few discrete areas cognitive ability as opposed to the 
broader assessment strategy used in most clinical contexts.   
EF Psychometrics 
 There are several different types of test validity and reliability essential to the 
psychometric properties of psychological tests. Assessment tools designed to report the 
objective performance of an individual’s neuropsychological functioning have 
traditionally been more useful to treatment research than subjective observations and 
interviews due to their greater sensitivity to change (Groth-Marnat, 1999). Once a test has 
been shown to maintain similar performance between testing sessions, additional 
psychometric qualities such as reliability and validity should be evaluated.  
 Reliability assesses the extent to which a construct is consistently measured 
within individuals (Loevinger, 1957; Clark & Watson, 1995). There are several common 
classes of reliability which include inter-rater, intra-rater, test-retest, and internal 
consistency (Groth-Marnat, 1990). For the purposes of this review, test retest and internal 
consistency reliabilities will be described for EF measures utilized in pediatric SCD 
literature. Test retest reliability is determined by administrating the test and then 
repeating test administration during another testing session. The second testing session 
must occur soon enough that changes in the underlying construct would not be expected 
(Meeker and Escobar, 1998). The test retest coefficient is calculated by a correlation of 
two different scores, on two different occasions, by the same individual (Cortina, 1993; 
Iacobucci & Duhachek, 2003). When the purpose of the measure is to make predictions 
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and ensure that stable constructs do not fluctuate highly, the evaluation of test retest 
reliability is recommended (Groth-Marnet, 1990). If test retest reliability is not known 
prior to administration of the measure, unreliable results could be obtained and false 
inferences could be made when the measure is administered before and after treatment of 
SCD.  
 Alternatively, internal consistency assesses the uniformity of test items across the 
measure and is the correlation between different items on the same test (Cortina, 1993). 
The identification of internal consistency is valuable on measures with longer formats 
and various subtests or sub scales (Groth-Marnet, 1990). These forms of reliability were 
chosen because they are the best forms of reliability to understand both the nature of the 
EF and to inform treatment evaluation.  Internal consistency is essential to the analysis of 
measures in the pediatric SCD population because brief measures may be chosen due to 
neurologic effects of the disease (e.g. decreased sustained attention). However, the 
shorter format may not adequately represent the EF construct of interest. 
 Validity is one of the most critical factors in psychometric test construction. 
Validity refers to the amount of which psychological tools assess the construct that they 
purport to measure (Guion, 1980). Content, criterion, and construct validity are the broad 
categories of test validity.  
 Content validity requires a degree of agreement to define a particular construct. 
The meaning used to assess performance can affect the inferences that may be drawn 
from the obtained data (Groth-Marnet, 1990). Depending on the definition utilized, it 
may over or under represent, omit facets, or reflect factors on the periphery of the EF 
construct (Haynes et al., 1995).  
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 The criterion validity of EF measures used in the pediatric SCD population was 
evaluated for this review. This factor was chosen because EF is a complex multi-
dimensional construct and opinions about its characterization and evaluation are often 
subjective and divergent. Criterion validity is the degree to which a test performs as 
expected based on an external standard (or criterion).  In many instances researchers use 
another established assessment test which shares a similar theoretical orientation as a 
criterion measure (similar to convergent validity).  This psychometric was chosen as an 
appropriate representation of validity for measures used in this population. The simplest 
way to understand criterion validity is to compare a psychological measure it to a gold 
standard test which measures the same construct. Sensitivity and specificity for clinical 
outcomes also inform whether a measure is highly validated or not and is sometimes used 
as an external criterion measure (White et al., 2006). In this context, sensitivity illustrates 
the accurate identification of children with known neurologic disease or suspected to be 
at high risk for neurologic disease within the SCD population. In contrast, specificity 
demonstrates the accuracy involved in correctly identifying children without neurologic 
disease.  
 Construct validity is based on the extent to which the measure correlates 
(positively or negatively) with other measures as expected from one’s theoretical model 
or known empirical relationships. Thus, a measure of working memory should correlate 
with other measures of working memory, other tasks known to be associated with 
working memory ability, but not with unrelated constructs (e.g., positive affect). In 
batteries of tasks, the correlation coefficient is calculated for each measure and sub 
scales. Inter-correlations are then determined and compared to estimate the degree to 
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which the two measures relate to each other.  Comparisons among neuropsychological 
tests, which measure EF, are informative to the evaluation of cognitive performance 
across measures. These comparisons are also used in the identification of the most 
appropriate measures to use for individuals diagnosed with pediatric SCD.  Another 
approach to construct validity is to use factor analytic methods to determine how well the 
measure conforms to the theory or framework used to develop the measure. Traditionally, 
construct validity has received the most attention in the development of norm referenced 
measures and test developers can demonstrate at least moderate to high construct validity.  
Thus, though construct validity is critical, criterion validity is the more neglected type of 
validity and the type of validity that maps on better to clinical decision making. 
Summary  
 Quality procedures for the selection of psychometric measures should be 
conducted in general, however they should be especially considered when administering 
these measures to a chronically ill pediatric population. Method of test interpretation, 
normative sample quality, reliability, and validity all influence the appropriateness of 
cognitive measures selected for use in pediatric SCD. The educational level, manner in 
which the test is administered, social-interactional context, and length of assessment have 
all been shown to impact the performance of individuals on a measure (Groth-Marnet, 
1990). Psychometricians should demonstrate culturally sensitive behaviors, during test 
administration, towards the reduction of possible contextual effects. Additionally, brief 
tests with lower reading levels given in a standardized manner are well suited for this 
population given their neurologic considerations.  
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 Similarity between the norm group and the individual may also affect the choice 
of assessment test. Dissimilarity between norm group and examinee has been shown to 
impact the examinee’s performance reported by a neuropsychological measure (Johnson, 
2006).  The norm sample used in a neuropsychological assessment for the purposes of 
comparing children with SCD should include a stratified sample. This sample should 
contain a census or over representation of African Americans children with varied 
general health status. Additionally, the subtractive factors approach to isolating specific 
abilities may be best suited for use with pediatric SCD. This approach may be superior 
due to the within subject methodology versus drawing inferences for the comparison of a 
dissimilar normative group (Gottsdanker & Shragg, 1985).  Furthermore, the reliability 
and validity of a neuropsychological measure should be evaluated prior to use (Groth-
Marnet, 2000). In particular the level of test retest reliability, internal consistency, and 
criterion validity should be evaluated and well understood when used with children 
diagnosed with SCD.  
Criticisms of Cognitive Measurement 
 There are several different criticisms for the use of EF measures in specialized 
populations. One criticism to utilizing these measures in treatment outcomes is the lack of 
information published regarding practice effects (Filskov & Boll, 1981). Practice effects 
take place when a child performs a task and then performs it again on another occasion. 
They are recognized to exist for neuropsychological tests, but the magnitude of these 
effects is not well known for specific measures (Strauss, Sherman, & Spreen, 2006). In 
treatment studies with pre-post only designs, this can pose problems for data 
interpretation. Difficulties can occur such as the child’s scores during the second 
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administration improve due to previous exposure to the test, not to the treatment therapy.  
Although the magnitude of practice effects are not well understood; thoughtful review of 
the type of measure, test retest reliability, age range, and characteristics of the subjects 
can greatly reduce the error variability associated with cognitive measurement (Dikmen 
et al., 2000).  
 Another critique for the use of neuropsychological measures in treatment studies 
is the association between cognitive measures and actual daily functioning. A strong 
correlation between the test scores and functioning is preferred because it validates the 
use of the test as a predictor of behavior.  Hairman (1991) found results that indicate a 
modest degree of association between cognitive effects and functional effects in children 
with SCD and stroke. However, the Hairman (1991) study included only children with 
stroke and may have suffered of a restriction of range for functional behavioral outcomes.  
Data has demonstrated, more with adults than children, that cognitive performance on 
neuropsychological measures is moderate in relation to measures of activities of daily 
living (Farias, Harrell, Neumann, & Houtz, 2003; Carter, Oliviera, Duponte, & Lynch, 
1988). In contrast, cognitive measures have shown large effect sizes for academic 
achievement and educational attainment in the pediatric SCD literature (Schatz 2004, 
Schatz et al., 2001; Nettles, 1994). 
 There are also critiques of neuropsychological assessment which relate directly to 
the multifaceted risk factors often found in SCD. Criticisms include the lack of cognitive 
score interpretation in light of broader psychosocial factors (Strauss, Sherman, & Spreen, 
2006). In particular, factors such as parent-family factors, educational experiences, and 
motivational factors for test performance may all be relevant to test outcomes (Thompson 
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et al., 2004). In terms of social and family factors, Thompson and colleagues (2004) 
found results that indicate one fourth of the parents of a child with SCD experienced 
clinically significant levels of psychological distress and poorer parent adjustment 
evidenced high levels of daily stress, less knowledge about child development, and lower 
expectations of efficacy. In addition they found results which indicated that poorer 
cognitive functioning was associated with the learned-helplessness attributional style for 
parents of children with SCD. This psychosocial interaction may pose a problem for 
isolating disease-specific effects or treatment-specific effects (Hertzog & Nesselroade, 
2003). Interpretation of cognitive scores in view of the psychosocial factors is best 
practices for psychological assessment and should be utilized with the pediatric SCD 
population (Sue et al., 1985).  
 Specific issues in the selection of measures for the SCD population also include 
test fairness for African Americans and lower SES children (Schatz et al., 2004). The 
SCD population is the US contains an overrepresentation of African Americans (Wang et 
al., 2001). The ethnic minority composition of the SCD population should be considered 
prior to test selection. Examination of the cognitive performance for African Americans 
has been conducted extensively and recommendations have been suggested which 
promote fairness in neuropsychological testing (Unversagt, et al., 1996; Diehr, Heaton, 
Miller, & Grant, 1998; Gladsjo et al., 1999). An example of recommendations that have 
been made for the construction of culturally fair neuropsychological test are is 
examination of “cultural contamination” prior to making predictive conclusions about the 
examinee (Helms, 2002; Darlington, 1971). Helms (2002) describe cultural 
contamination as a significant correlation between a test score and a total score on a 
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racial identity questionnaire after controlling for the criterion variable. Relatively few 
neuropsychological measures utilize this recommendation, and there are no measures 
identified in the pediatric SCD literature which follow this guideline.  
 To address concerns regarding minority performance on psychological measures, 
the Standards for Educational and Psychological Testing, published jointly by the 
American Educational Research Association, the American Psychological Association, 
and the National Council on Measurement in Education (AERA & APA) in1999 
recommend evaluating neuropsychological measures in terms of fairness. Fairness is 
estimated by four principal methods which include instrument bias, equitable treatment, 
measurement equivalence, and diagnostic validity (AERA & APA, 1999). To date only 
one measure, D–KEFS, has been found to adhere to fairness standards in the pediatric 
neuropsychological SCD literature. Selection of neuropsychological measures which 
have been evaluated by the fairness guidelines may help to ensure psychological 
measurement equity across culture for African American children which are diagnosed 
with SCD.   
 Understanding the multifaceted nature of SCD is vital to the selection of 
neuropsychological tests that are most appropriate for this population. SCD affects the 
general health as well as the neurologic condition of children with SCD. Issues such as 
such as fatigue from anemia, CVA, silent cerebral infarct, increased blood flow velocities 
may pose a significant confound for test score interpretation (Palermo, Schwartz, Drotar, 
& McGowan, 2002). When evaluating measurement tools for use with the pediatric SCD 
population, health effects may impact performance unrelated to the cognitive instrument. 
For example, children with SCD are often in pain related to vasoocculsive crisis that do 
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not require hospitalization (Platt, Thorington, Brambilla, et al. 1991; Vichinsky, Johnson, 
Lubin, 1982; Shapiro, Dinges, Carota-Orne, Ohene-Frempong, Orne, 1990). An examiner 
unfamiliar to the effects of pediatric SCD may not inquire as to the child’s current pain 
level. The absence of the information may lead to inaccurate results which are associated 
with pain instead of cognition. Therefore, administering a neuropsychological test to a 
child suffering from an unreported low level pain crisis may increase measurement error 
in the cognitive score. It is important to comprehend all of the properties related to a 
psychological measure that are not the target of study, but nonetheless result in group 
differences in test scores. Individual conditions such as health status may impact the 
fairness of administration (Van de Vijver and Poortinga, 2005).   
Summary 
 The advantages associated with the administration of neuropsychological 
assessments for children with SCD are noteworthy. Strengths associated with cognitive 
measurement for pediatric SCD include the identification of specific cognitive abilities in 
SCD treatment studies. Likewise, a more thorough understanding of brain mechanisms 
which affect cognitive processes can be discovered for individuals with pediatric SCD. 
The addition of neuropsychological measures to the existing body of literature will help 
to propel SCD treatment to a greater comprehensive knowledge base regarding both 
treatment and disease related effects.  
 Disadvantages related to using cognitive measures with this population are 
various. Practice effects are an instance of one such difficulty. The magnitude of practice 
effect for specific measures is unknown (Strauss, Sherman, Spreen, 2006). Additionally, 
the degree of association between cognition and functional living, primarily with adults, 
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has also been a critique of including cognitive measures to treatment studies (Hairman, 
1991). Furthermore, psychosocial factors which influence disease-specific or treatment-
specific effects may impact performance on neuropsychological measures (Hertzog & 
Nesselroade, 2003). Generally neuropsychological measures have been criticized for their 
fairness and disparate impact on African Americans which is salient due to the 
composition of the SCD community (Wang et al., 2001). Finally, the health related 
morbidity for children with SCD may impact performance unrelated to cognitive scores 
(Platt, Thorington, Brambilla, et al. 1991).  Given the appropriate considerations, each of 
these potential confounds can be mitigated thereby allowing for the correct interpretation 
of EF performance. 
Section III: Existing Literature on Cognition in Pediatric SCD  
 A review of the pediatric SCD literature revealed a total of 40 studies which 
contained cognitive measures to assess neuropsychological functioning, see Table 1.1. 
This table demonstrates the wide variation of neuropsychology measures that are used 
across the pediatric SCD literature. This lack in consistency has contributed to the 
complexities associated with understanding the cognitive profile of children with SCD. 
Additionally, this disparity in the literature has indirectly promoted the lack of narrow EF 
measurement in the treatment literature. These tests were selected by researchers to 
identify cognitive abilities in the pediatric SCD literature. The measurement batteries 
include six versions of the Wechsler Intelligence, three editions of the Woodcock 
Johnson Cognitive tests, DAS, Kaufman Assessment Battery for Children (KABC), D–
KEFS, Denver Developmental Screening Test, Developmental Neuropsychological 
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Assessment, Luria-Nebraska Neuropsychological Battery, Stanford-Binet, and the 
Behavior Rating Inventory of Executive Function (BRIEF). 
 Among the 18 neuropsychological batteries utilized; the Wechsler, Woodcock 
Johnson, and the DAS scales emerged as the most commonly administered in the 
pediatric SCD population. Many of these studies analyzed various facets of cognitive 
ability with the Wechsler Scales. Although this measure is commonly used in the 
literature, Wechsler (1991) reports that these scales measure only a few factors of 
cognition among the numerous that have been proposed within the Cattell-Horn-Carroll 
(CHC) theory. The CHC theory identifies 10 broad and over 70 narrow abilities to inform 
a distinct EF profile (Flanagan & Harrison, 2005). The use of this scale may therefore 
reveal an incomplete picture of cognition for this population. In contrast to the Wechsler 
scales, the WJ-III is reported to measure a multitude of factors within the CHC 
framework and was selected for use in 12 pediatric SCD studies (Woodcock, McGrew, & 
Mather, 2001). The DAS was also used, in six studies, to further understand EF in this 
population. This cognitive battery was not developed from any single theory of cognitive 
ability but instead derives from sophisticated statistical procedures. Additionally, various 
neuropsychological measures designed to specifically evaluate narrow aspects of EF were 
also used to comprehend the nature of cognition in children diagnosed with SCD. Table 
1.1 reveals the administration of 58 different cognitive tests for an analysis of EF to the 
pediatric SCD population. These cognitive measures are assorted for 2 primary reasons: 
(1) the multifaceted definition of EF and (2) the lack of standard assessment guidelines 
for this population. 
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General descriptive information for the selected studies was also examined, see 
Table 1.2. The average number of participants within the 30 studies included in this 
review was 163.8 (SD = 423.9) participants with a mean age of 10.6 (SD = 2.4) years. 
However, this statistic is misleading because 84% of the studies had samples less than 
100. By excluding Steen and colleagues (2005), which had an outlier sample of 2254, the 
mean participant pool was 82.5 (SD = 71.9) with a mean age of 10.8 (SD = 2.3). Sickle 
Cell Anemia (HbSS) was the predominant subtype of SCD in most studies. Moreover, 
this table clearly reveals the varied age range (1 year 8 months – 16 years nine months) 
and dissimilar methodological considerations in the pediatric SCD literature. An 
illustration of this these practices is evidenced when analyzing the use of the Wide Range 
Achievement Test (WRAT) in pediatric SCD studies. The WRAT was used in 3 research 
studies (Cohen et al., 1994; Wasserman et al., 1991; Fowler & Whitt, 1988). Although 
this measure was used to investigate academic achievement in children with SCD, only 2 
of the 3 studies were similar to one another in age and sample group characteristics. 
Children, mean age 9 years and 9 months, with SCD were grouped according to left 
versus right silent cerebral infarct in the Cohen and colleagues (1994) article. In contrast, 
Wasserman and colleagues (1991) compared children, with a mean age 11 years 5 
months, with SCD and no stroke to siblings. Likewise, Fowler & Whitt (1998) also 
investigated children with SCD and no stroke compared to healthy peers, mean age 12 
and 11 months. Comparing children of different age ranges, across the literature, may be 
problematic as this assumes any cognitive deficits are constant across different ages.  
There are also potential issues with cohort effects as the quality of medical care has 
changed over time.   
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 It is also unmistakable that norm referenced assessment practices are varied 
across pediatric SCD studies. The psychometric norm characteristics for each 
neuropsychological measure in this literature were either compared to a standard or local 
normative group of children. As shown in Table 1.2, an estimated forty percent of 
pediatric SCD studies selected a combination of measures which include both local and 
standard norms to assess EF. Stewart and Kaminski (2002) suggested that local norms 
provide an increased advantage of providing meaningful information regarding 
performance for a particular demographic on psychological measures. These authors also 
report that local norms decrease the likelihood of bias because a child’s test performance 
is compared to other children whose demographic factors are similar. Furthermore, they 
also demonstrate that local norms are useful in facilitating the identification of strengths 
and weaknesses. The majority of studies within pediatric SCD did not utilize measures 
which included local norms. However contrasting the cognitive results of individual 
children with SCD tested within these research studies to one another or similar group of 
children with SCD seems more informative than to a healthy group of nationally-
representative children. Increased use of measures which include a normative sample 
more appropriate for children with SCD can help to reveal a more accurate picture of 
cognition is pediatric SCD.  
 The psychometric properties of 30 identified neuropsychological measures and 
relevant subtests; when reported in the pediatric SCD literature, was reviewed. Age range 
and method of test interpretation were included as an evaluation technique to understand 
the psychometric properties of each measure. Additionally, test retest and internal 
consistency were analyzed to understand the psychometric reliability of each measure. 
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Also, convergent validity was examined to assess psychometric validity across 
neuropsychological measures. The quality of the normative sample was reviewed with 
seven different criteria (see Table 1.4). The selected psychometric factors were reviewed 
to inform the appropriateness of test selection for children with SCD.   
 Neuropsychological measures administered for this population encompass several 
different age ranges. Overall, the age ranges of neuropsychological measures were 
appropriate chosen for the study samples. However the Wechsler Memory Scales (WMS) 
were utilized outside of the intended psychometric age range by Watkins and colleagues 
(1989). The WMS suggested for use with individuals age 16-89, nevertheless the authors 
utilized this measure to understand memory functions in a sample of children with SCD 
mean age 10 years 6 months. Results reported that are associated with this measure 
should be interpreted with caution due to the age range guidelines suggested with this 
instrument. 
 The method of test interpretation within neuropsychological measures for 
pediatric SCD is limited to the traditional and subtractive factors measurement 
approaches.  As described earlier, subtractive factors may be the more potent method of 
test interpretation for children with SCD due to within subject comparison. However, it 
appears that only eight cognitive measures utilize this method of interpreting examinee 
performance among pediatric SCD studies (see Table 1.3). Specifically, use of these 
measures is generally accepted in research contexts; however due to their “experimental” 
nature, most data regarding psychometric properties is not published. It is clear that 
measures which utilize the traditional “achievement” approach of understanding 
cognition have dominated the pediatric SCD literature.   
  
37 
 
  
 
   
 
 
 There was extreme variability in reliabilities evaluated within and across the 30 
measures selected for use with the pediatric SCD population. Several works were 
consulted to describe statistically adequate measurement practices. Ultimately reliability 
evidence was determined by recommendations by Strauss and colleagues (2006). Test 
retest reliability coefficients were determined as: “Very High (≥.90), High (.80-.89), 
Adequate (.70-.79), Marginal (.60-.69), Low (.50-.59), Extremely Low (≤.49).’’ 
Additionally, internal consistency reliabilities were set as: Excellent (α ≥ .9), Good (.9 > 
α ≥ .8), Acceptable (.8 > α ≥ .7), Questionable (.7 > α ≥ .6), Unacceptable (.5 > α). In 
general reliability coefficients ranged within measures from extremely low to high, 
depending on the subscale of interest. For instance, The Self Ordered Pointing Test 
reliability associated with test retest was adequate, whereas the internal consistency was 
high. Additionally the CVLT–II, long delay recall subtest has marginal test retest 
reliability but excellent internal consistency. On average, when reported, test retest 
reliability for the selected measures across the studies is adequate and internal 
consistency is high. However, it should be noted, data was missing for many of the 
subscales utilized to asses cognitive functioning. An example of this missingness is 
evident in the Detroit Test Learning Aptitude 2nd ed. Reported test retest reliability varied 
from adequate to very high and internal consistency from acceptable to excellent on this 
instrument. However, specific subtest reliability coefficients for the measures shown to 
be sensitive to SCD could not be obtained. Ideally, reporting of reliabilities would be 
readily available and consistent with one another, such as in the case of the Decision 
Speed subtest of the WJ-III. The test retest reliability is high and the internal consistency 
is excellent.  
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 Overall measures in this literature demonstrated a strong relationship to other 
cognitive measures which measure the same features of EF (see Table 1.3).  The 
following convergent validity correlations established by Strauss et al. 2006 were utilized 
for this review: Strong (.50 to 1.0), Moderate (.30 to .49), Low (.10 to .29). A few 
neuropsychological measures diverge from the overall prevalence strong associations in 
the research literature. For instance, measures such as CVLT–II, Gordon Continuous 
Performance Task, Kagan Matching Familiar Figures Test, and Self Ordered Pointing 
Test indicated moderate associated with similar tests of cognition (see Table 1.3). These 
modest relationships are not surprising due to the nature of EF and measurement 
practices. Additionally, the Tower of Hanoi and Wisconsin Card Sorting Test have low 
associations, at best, with other measures of cognition.  
 Normative sample characteristics were evaluated by several factors to develop a 
general set of quality guidelines (see Table 1.4). The guidelines created for this review 
originated from recommendations for normative samples by Mitrushina and associates 
(2005). The 10 criteria chosen describe the degree of support for the normative samples 
utilized by each neuropsychological measure.  Additionally, these guidelines include 
cultural considerations indicated by Suzuki and Ponterotto (2008) relevant to the SCD 
populations. Notably, evaluation of the quality criteria requires an extent of subjectivity 
in judging psychometric standards. Norm quality consists of an analysis of: sample size, 
representativeness of United States (US) census data, stratification, etlhnicity by 
stratification, geographic diversity, African American cultural effects, health condition, 
special education inclusion, and exclusion/inclusion criteria. An analysis of these factors 
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resulted in a categorization of deficits on the following continuum “excellent ≥ 8 factors, 
adequate ≥ 6 factors, good ≥ 4 factors, and poor ≤  3.”  
 Normative samples from 13 of the 30 articles analyzed were reviewed to be of 
“poor” quality (see Table 1.3). This status was the result of a combination of factors such 
as small sample size, no representativeness from US census data, no stratification, limited 
geographic diversity, strong African American cultural effects, etc. An example of a 
neuropsychological measure with a designation of “poor” for the normative sample is the 
Connors’s Continuous Performance Test. The clinical sample was comprised of 670 
individuals who were stratified by eight age bands. This sample was not representative of 
the US census and subjects were only selected from five US states and a province in 
Southern Ontario. The general health condition of the sample was not indicated and 
children receiving special education were excluded from the sample. However, the 
mental health status of the sample was reported and no ethnic/racial effects were reported 
as well. This sample lacks the necessary properties to appropriately compare the 
performance of children with SCD. A more appropriate measure, with a description of 
“excellent” for the test norms is the WJ-III. The sample size is large, consisting of 5972 
children stratified by both individual and community socioeconomic variables. 
Additionally, the validation sample is geographically diverse, with individuals selected 
from over 100 geographic regions within 27 US states. Similarly, comparable scores have 
been evidenced for African American children when compared to their Caucasian peers. 
Albeit, it is significant to mention the general health conditions of the sample were not 
reported, the only exclusion criteria were less than one year of fluent English speaking. 
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Despite this, the test norms represent an acceptable comparative sample for children with 
SCD, which provide a more accurate representation of cognitive performance.  
Norms, Measurement Approach, and Reliability of Cognitive Measures Used to Date 
 The psychometric properties of 30 identified neuropsychological measures and 
relevant subtests, when reported, in the pediatric SCD literature indicate many measures 
used to date have been lacking in one or more key dimensions. Age range was included 
in this range because it is desirable for many clinical studies to be able to include a wide 
range of ages.  Method of test interpretation were included as an evaluation technique to 
understand the whether the measure allows for more fine-grained analysis of cognitive 
skills. Additionally, test retest and internal consistency were analyzed to understand the 
psychometric reliability of each measure. Convergent validity was examined to assess 
psychometric validity across neuropsychological measures. The quality of the normative 
sample was reviewed with ten different criteria. The selected psychometric factors were 
reviewed to inform the appropriateness of test selection for children with SCD (see Table 
1.4). 
 Neuropsychological measures administered for this population encompass several 
different age ranges. Overall, the age ranges of neuropsychological measures were 
appropriate chosen for the study samples. However the WMS were utilized outside of the 
intended psychometric age range by Watkins and colleagues (1989). The WMS suggested 
for use with individuals age 16-89, nevertheless the authors utilized this measure to 
understand memory functions in a sample of children with SCD mean age 10 years 6 
months. Results reported that are associated with this measure should be interpreted with 
caution due to the age range guidelines suggested with this instrument. 
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 The method of test interpretation within neuropsychological measures for 
pediatric SCD is limited to the traditional and subtractive factors measurement 
approaches.  As described earlier, subtractive factors may be the more ideal method of 
test interpretation for children with SCD due to within subject comparison to isolate 
specific skills. However, it appears that only eight cognitive measures utilize this method 
of interpreting examinee performance among pediatric SCD studies (see Table 1.4). For 
some of these measures using subtractive factors were “experimental” (not norm-
referenced measures designed for individual-level interpretation in clinical contexts). 
Specifically, use of these measures is accepted in the study contexts; however due to their 
“experimental” nature most data regarding psychometric properties is not published. On 
the contrary, it is clear that measures which utilize the traditional “achievement” 
approach of understanding cognition have dominated the pediatric SCD literature.   
 There was extreme variability in reliabilities evaluated within and across the 30 
measures selected for use with the pediatric SCD population. Several works were 
consulted to describe statistically adequate measurement practices. Ultimately reliability 
evidence was determined by recommendations by Strauss and colleagues (2006). Test 
retest reliability coefficients were determined as: “Very High (≥.90), High (.80-.89), 
Adequate (.70-.79), Marginal (.60-.69), Low (.50-.59), Extremely Low (≤.49).’’ 
Additionally, internal consistency reliabilities were set as: Excellent (α ≥ .9), Good (.9 > 
α ≥ .8), Acceptable (.8 > α ≥ .7), Questionable (.7 > α ≥ .6), Unacceptable (.5 > α). In 
general reliability coefficients ranged within measures from extremely low to high, 
depending on the subscale of interest. For instance, The Self Ordered Pointing Test 
reliability associated with test retest was adequate, whereas the internal consistency was 
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high. Additionally the CVLT–II, long delay recall subtest has marginal test retest 
reliability but excellent internal consistency. On average, when reported, test retest 
reliability for the selected measures across the studies is adequate and internal 
consistency is high. However, it should be noted, data was missing for many of the 
subscales utilized to asses cognitive functioning. An example of this missingness is 
evident in the Detroit Test Learning Aptitude 2nd ed. Reported test retest reliability varied 
from adequate to very high and internal consistency from acceptable to excellent on this 
instrument. However, specific subtest reliability coefficients for the measures shown to 
be sensitive to SCD could not be obtained. Ideally, reporting of reliabilities would be 
readily available and consistent with one another, such as in the case of the Decision 
Speed subtest of the WJ-III. The test retest reliability is high and the internal consistency 
is excellent.  
 Overall measures in this literature demonstrated a strong relationship to other 
cognitive measures which measure the same features of EF (see Table 1.3).  The 
following convergent validity correlations established by Strauss et al. 2006 were utilized 
for this review: Strong (.50 to 1.0), Moderate (.30 to .49), Low (.10 to .29). A few 
neuropsychological measures diverge from the overall prevalence strong associations in 
the research literature. For instance, measures such as CVLT–II, Gordon Continuous 
Performance Task, Kagan Matching Familiar Figures Test, and Self Ordered Pointing 
Test indicated moderate associated with similar tests of cognition. These modest 
relationships are not surprising due to the nature of EF and measurement practices. 
Additionally, the Tower of Hanoi and Wisconsin Card Sorting Test have low 
associations, at best, with other measures of cognition. This finding is also not surprising 
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given the concurrent and complex cognitive functions that are necessary to complete 
these tasks. 
 Normative sample characteristics were evaluated by several factors to develop a 
general set of quality guidelines (see Table 1.4). The guidelines created for this review 
originated from recommendations for normative samples by Mitrushina and associates 
(2005). The 10 criteria chosen describe the degree of support for the normative samples 
utilized by each neuropsychological measure.  Additionally, these guidelines include 
cultural considerations indicated by Suzuki and Ponterotto (2008) relevant to the SCD 
populations. Notably, evaluation of the quality criteria requires an extent of subjectivity 
in judging psychometric standards. Norm quality consists of an analysis of: sample size, 
representativeness of United States (US) census data, stratification, ethnicity by 
stratification, geographic diversity, African American cultural effects, health condition, 
special education inclusion, and exclusion/inclusion criteria. An analysis of these factors 
resulted in a categorization of deficits on the following continuum “excellent ≥ 8 factors, 
good ≥ 6 factors, adequate ≥ 4 factors, and poor ≤ 3.”  
 Normative samples from 13 of 25 test analyzed were reviewed to be of “poor” 
quality (see Table 1.4). This status was the result of a combination of factors such as 
small sample size, no representativeness from US census data, no stratification, limited 
geographic diversity, strong African American cultural effects, etc. An example of a 
neuropsychological measure with a designation of “poor” for the normative sample is the 
Connors’s Continuous Performance Test. The clinical sample was comprised of 670 
individuals who were stratified by eight age bands. This sample was not representative of 
the US census and subjects were only selected from five US states and a province in 
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Southern Ontario. The general health condition of the sample was not indicated and 
children receiving special education were excluded from the sample. However, the 
mental health status of the sample was reported and no ethnic/racial effects were reported 
as well. This sample lacks the necessary properties to appropriately compare the 
performance of children with SCD. A more appropriate measure, with a description of 
“excellent” for the test norms is the WJ-III. The sample size is large, consisting of 5972 
children stratified by both individual and community socioeconomic variables. 
Additionally, the validation sample is geographically diverse, with individuals selected 
from over 100 geographic regions within 27 US states. Similarly, comparable scores have 
been evidenced for African American children when compared to their Caucasian peers. 
Albeit, it is significant to mention the general health conditions of the sample were not 
reported, the only exclusion criteria were less than one year of fluent English speaking. 
Despite this, the test norms represent an acceptable comparative sample for children with 
SCD, which provide a more accurate representation of cognitive performance.  
Cognitive Measures and SCD Morbidity (Criterion Validity) 
            Neurologic damage caused from SCD related mechanisms often result in stroke, 
silent infarcts, and cerebral blood flow abnormalities. In addition, general disease severity 
factors such as anemia may also be related to brain health. Data were reviewed to identify 
neuropsychological test sensitivity associated with different types of SCD disease effects. 
            The Stroke Prevention Trial in Sickle Cell Anemia identified the importance of 
TCD intervention for children identified at high stroke risk. Three research studies have 
been identified that address neuropsychological sensitivity for elevated TCD velocities 
and performance on the Wechsler scales (Bernaudin et al., 2000; Kral et al., 2003; Kral & 
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Brown, 2004). Bernaudin and collegues (2000) conducted an investigation which 
examined the first study evidencing an effect of thrombocytosis and revealing that silent 
stroke alone is not a factor of cognitive deficit when not associated with low hematocrit 
or thrombocytosis. Results indicated cognitive deficits were observed in SCD patients 
with a history of overt stroke and that cognitive deficits are apparent for children with 
SCD and silent stroke evidenced by infarcts on MRI, severe chronic anemia, and elevated 
TCD values. Another research team found that children diagnosed with SCD and 
abnormal TCD values evidenced greater executive dysfunction than children with SCD 
and conditional TCD values (Kral et al., 2003). It also appears that children with 
abnormal TCD values and SCD performed differentially worse than children with 
conditional and normal TCD values (Kral & Brown, 2004). Results from these studies 
suggest that Wechsler scales are sensitive to cognitive deficits in children with SCD and 
elevated TCD values.  
Similarly, SCD researchers have begun to investigate the utility of the BRIEF in 
evaluating cognitive functioning behaviors and SCD related neural mechanisms in the 
pediatric SCD population. An early investigation of pediatric SCD and TCD revealed that 
children diagnosed with SCD with normal TCD findings demonstrated better executive 
functioning than children with SCD and conditional or abnormal TCD values (Kral, 
Brown, Nietert, Abboud, Jackson, and Hynd, 2003). Kral and colleagues (2004) also 
found that teacher ratings of children with SCD and abnormal TCD demonstrate poorer 
cognitive functioning than children with SCD and conditional or normal TCD values. 
More recently, Berg (2012) published findings which suggest that children with SCD 
scored significantly lower than matched controls on the Metacognitive Index and Global 
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Executive Composite scales of the BRIEF. Due to the low number of studies revealing 
findings associated with neurologic test sensitivity and SCD morbidity, more research is 
needed to understand the utility of the BRIEF in assessing pediatric SCD morbidity.   
Six research studies indicated that the Wechsler Intelligence Scales, Woodcock 
Johnson Cognitive Abilities, and D–KEFS were sensitive to the effects of pediatric SCD 
severity.  This was demonstrated by the measures showing decreased performance 
associated with disease severity in comparison to healthy peers (Bernaudin, Verlhac, 
Freard, Roudot-Thoraval, Benkerrou, et al., 2000, Schatz, 2004; Schatz et al., 2004; 
Schatz et al, 2007; Kral, Brown, Nietert, Abboud, Jackson, MD*; and Hynd, 2003; Berg, 
Edwards, and King, 2012). Among this small group of measures the WJ-III were shown 
to have the strongest psychometric properties related to pediatric SCD, as reviewed above 
(see Table 1.4).  
 It was also shown that the D–KEFS and WJ-III indicated decreased cognitive 
performance associated with SCD status alone in five research studies (Goonan et al., 
1994; Puffer, Schatz, Roberts, 2007; 2010; Schatz et al., 2005).  These findings are 
believed to reflect disease-related neurologic problems that do not reveal themselves with 
current clinical neuroimaging methods.  As the D–KEFS is the only measure within this 
body of literature to reflect the fairness guidelines for test practices, it is notable that 
results converge for both the WJ-III and this measure. Additionally, the Wechsler Scales, 
WJ-III, CVLT–II, and Wisconsin Card Sorting Test demonstrated test sensitivity for 
children with SCD and evidence of CVA within 13 research studies. Children with SCD 
and CVA evidenced greater deficits than healthy peers and children with SCD and silent 
infarct on these measures. However, as demonstrated by table 1.4 and 1.5, the Wisconsin 
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Card Sorting Task psychometrics was found to be low as well as the norm sample “poor.” 
Consequently test use for SCD and CVA is not recommended for this measure.  
 Approximately a third of the research articles (n = 10) provided results which 
indicate children with SCD and silent infarct demonstrated cognitive performance which 
was sensitive to detection on the Wechsler Scales, WJ-III, CVLT–II, and the Children’s 
Memory Scale. Children with SCD and silent infarct performed poorer than age-matched 
peers and better than children with SCD and stroke on these neuropsychological 
measures. Evaluation of the psychometrics and norm quality revealed that use of these 
tests is supported for all three of these measures however; the WJ-III might be preferred 
due to a better quality normative sample.  
 Additionally, across 19 studies, children with SCD and no abnormalities on MRI 
revealed cognitive dysfunction which could be demonstrated on the following scales: 
Wechsler Scales, WJ-III, Test, CVLT–II, Wisconsin Card Sorting Test, Trail Making 
Test, KABC, D–KEFS, and the Children’s Memory Scales. With the exception of the 
Trail Making Test, each of these measures is supported for use with children diagnosed 
with SCD and cognitive deficits having normal MRI results. The exclusion of this 
measure is based on the psychometric properties for the Trail Making Test. They were 
revealed as adequate, but the normative sample was categorized as “poor” (see Table 
1.4). 
 Neuropsychological measurement in pediatric SCD has limitations and strengths 
associated with the potential use of particular measures. Limitations such as those 
associated with utilizing tests such as Wisconsin Card Sorting and Trail Making Test 
with this population are based on limitations in the test development, such as norm 
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quality.  The norm group for both measures is “poor,” which suggests that comparisons 
made to these groups could result in inaccurate measurement of cognitive performance, 
particularly for clinical decision making at the individual level. Additionally, the 
psychometric properties reviewed only reached a threshold of adequate for these 
measures. Acceptable reliability and validity does not promote recommendation for use 
in the population when measures that achieved higher levels of reliability and validity are 
available.   
 Across studies which address morbidity associated with pediatric SCD the WJ-III 
and Wechsler Scales demonstrate the most consistent measurement sensitivity. However, 
the psychometric and normative sample quality of the WJ-III surpasses the Wechsler 
Scales for use with the pediatric SCD population (see Tables 4 and 5).  Additionally, 
when selected for use, the D–KEFS was found to detect SCD related morbidity at the 
same rate as the WJ-III; however, the WJ-III is appropriate for a wider age range of 
children (preschool through older adults) whereas the Delis Kaplan Executive Function 
System is normed beginning at age eight years. The overall implication of this review of 
psychometrics is that among measures used to date, the WJ-III excels in all areas except 
in its use of a traditional, achievement approach to ability measurement.      
Summary 
 The cognitive measurement practices for pediatric SCD studies and the 
examination of psychometric properties for these cognitive measures associated with 
pediatric SCD was identified. The purpose of these goals was to inform recommendations 
for neuropsychological assessment batteries to use in future SCD research and treatment 
studies. An examination of psychometric properties provided strong support for the 
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assertion that the WJ-III was the most appropriate of the current cognitive assessment 
batteries for use with pediatric SCD.  
 The most prominent theme demonstrated was the considerable inconsistencies in 
tests use for neuropsychological assessment of children with SCD. Use of varied 
cognitive measurement instruments has impacted the assessment of EF within both 
research and treatment methodological designs. Table 1.1 revealed that 57 different 
psychological measures have been used to better understand cognition in this special 
population. Due to the wide range of instruments in the pediatric SCD research literature, 
treatment research has been uninformed regarding the most appropriate cognitive 
construct to focus on and which instruments should be used to measure the construct. The 
use of many of these neuropsychological instruments in making clinical decisions would 
be substandard scientific practices. Review of any psychometric tool prior to 
administration is best practices for test administration (Groth-Marnat, 2003).  It is 
imperative that future research related to this body of literature utilize standard 
instruments with more regularity to assess cognitive functioning the for pediatric SCD 
population. This uniformity will promote a better understanding of cognition in pediatric 
SCD. 
 It is also essential that treatment studies diverge from the common practice of 
utilizing global IQ scores to assess cognitive performance in pediatric SCD. Future SCD 
research efforts should take steps towards formulating a more comprehensive 
understanding of both the broad and narrow abilities associated with EF. This transition is 
important because children with SCD may demonstrate equivalent full scale IQ scores 
pre/post treatment yet still have deficits in narrow abilities (Schatz et al., 2002). Left un-
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rehabilitated neurologic complications associated with pediatric SCD, have been shown 
to impact educational attainment (King et al., 2006). Additionally, use of measurement 
tools which assess a more complete picture of EF may further understanding of the 
cognitive profile for these children.  
 Among the identified measures within the pediatric SCD literature, three 
cognitive measurement batteries were utilized most often to evaluate neuropsychological 
ability: The Wechsler scales, WJ-III, and the Differential Ability Scales (DAS) 
assessment tools were shown to measure different components of cognition. These 
neuropsychological tools focus on different factors related to cognitive theory and diverse 
statistical practices to assess cognition. The WJ-III however, was the only theoretically 
driven assessment tool which was designed to measures discrete cognitive abilities. The 
other tools were largely developed to measure overall IQ with later delineation of narrow 
abilities that might be assessed with the subtests.  Therefore, the theoretical orientation 
and capacity to measure various cognitive domains makes it a superior measurement 
battery in comparison to the Wechsler Scales and the DAS. Furthermore, the WJ-III is a 
good neuropsychological test to measure cognitive outcomes in treatment-focused 
pediatric SCD studies. The WJ-III recommendation is due to relatively easy 
administration procedures, better norms, and psychometrics for use with children who are 
ethnic minority or from lower income backgrounds (two demographic factors 
overrepresented in the SCD population).  Thus, this cognitive battery should be utilized 
as the standard of comparison for neuropsychological measurement in the pediatric SCD 
field. 
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 Future directions for neuropsychological measurement in pediatric SCD field 
include improvement in four areas. The first suggestion is that WJ-III should be 
administered as the best available measure to assess cognition in pediatric SCD research 
and treatment studies. Given the superior psychometric properties and excellent norm 
sample quality, this measure could further understanding of cognition in pediatric SCD.  
Secondly, measurement of narrow cognitive abilities should be included as outcomes for 
research and treatment studies instead of broad level IQ scores. This shift from global to 
specific measurement of cognition might help clinicians to glean a greater understanding 
of cognition for children with pediatric SCD and may better delineate treatment benefits. 
Finally, more sophisticated neuropsychological measurement tools should be developed 
to assess cognition for children with SCD. For example, a limitation of the WJ-III is that 
the underlying theory does not incorporate current knowledge of neuroscience and the 
constructs used may not map well onto populations with neurologic deficits and therefore 
may not be well suited to measuring specific changes in brain function (e.g., in treatment 
studies).  A useful approach may be to compare the WJ-III to experimental measures of 
EF that have well known neural correlates. Comparative analysis of experimental 
measures to this “standard” will help the field develop more accurate measurement for 
children with pediatric SCD.  The purpose of the present research study is to address 
afore mentioned suggestions.  
 An experimental EF assessment tool, the “EXAMINER” will be utilized to 
compare sensitivity and specificity relative to the WJ-III, measure cognitive narrow 
abilities, and asses its appropriateness for use with the pediatric SCD population. More 
specifically, this new EF battery will be psychometrically evaluated, assessment of its 
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differential sensitivity compared with the WJ-III, and the cultural validity of this 
instrument will be investigated for the measurement of cognitive deficits associated with 
pediatric SCD.   
 
  
53 
 
  
 
   
 
 
Table 1.1 
Overview of Executive Function Measures Included in Sickle Cell Disease Literature 
Reference Neuropsychological Test Acronyms EF Domain 
Thompson et al., 2002 Bayley Scales of Infant 
Development III 
BSID-II Mental, Motor, and Behavioral 
Development 
Puffer et al., 2010 
Brown et al., 2000 
Cohen et al., 1994 
Brown et al., 1993 
Swift et al., 1989 
Beery-Buktenica Developmental 
Test of Visual-Motor Integration 
B-VMI Visual-Motor Deficits 
Schatz et al., 2004
i
 
Schatz et al., 2001 
Schatz et al., 1999 
DeBaun et al., 1998 
Benton Judgment of Line 
Orientation 
BJLO Visuospatial Judgment 
Craft et al., 1993 Benton Visual Retention Test BVRT Visual Perception, Visual 
Memory, Visuoconstructive 
Abilities 
Craft et al., 1993 Benton Word Fluency Test BWF Speed and Ease of Verbal 
Production 
Brown et al., 2000 
Schatz et al., 2001 
Cohen et al., 1994 
Boston Naming Test BNT Word Retrieval Performance 
Berg et al., 2012 
Kral et al., 2003 
Kral et al., 2004 
Behavior Rating Inventory of 
Executive Function 
 
 
BRIEF-
Parent Form 
 
 
Parent Observation of Executive 
Function Behaviors 
White et al., 2006 
Brandling-Bennett et 
al., 2003 
Schatz et al., 2001 
Schatz et al., 1999 
DeBaun et al., 1998 
California Verbal Learning Test – 
Children 
 
CVLT-C Verbal Learning and Memory 
Schatz et al., 2001 
Brown et al., 2000 
Cancellation of A’s Task CAT Visuospatial Function and 
Attention 
Schatz et al., 1999 
Craft et al., 1993 
Children’s Auditory Verbal 
Learning Test 
CAVLT Verbal Learning and Memory 
Berg et al., 2012 
 
Children’s Kitchen Task 
Assessment 
 
CKTA 
 
Executive Functioning 
 
Kral et al., 2003 
White et al., 2006 
Brandling-Bennett et 
al., 2003 
Children’s Memory Scale CMS Learning and Memory 
Brown et al., 1993 Conner’s Continuous 
Performance Task 
CPT Attention and Impulsivity 
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Reference Neuropsychological Test Acronyms EF Domain 
Kral et al., 2003 Conner’s Continuous 
Performance Task II 
CPT-II Attention and Impulsivity 
Craft et al., 1994 Covert Orienting Task COT Sustained Visual Task 
Schatz et al., 2007 Delayed Response Task DRT Spatial Working Memory and 
Inhibition Processes 
Berg et al., 2012 
Puffer et al., 2007 
Schatz et al., 2006 
Schatz et al., 2005 
Schatz et al., 2004
ii
 
Schatz, 2004 
Delis-Kaplan Executive Function 
System 
DKFS Higher Level Cognitive Functions 
Cohen et al., 1994 
Swift et al., 1989 
Detroit Test of Learning 
Aptitude II 
DTLA-II Specific Mental Abilities 
Schatz et al., 2007 Denver Developmental 
Screening Test II 
DDST-II Cognitive and Behavioral 
Problems 
Tarazi et al., 2007 Developmental 
NeuroPsychological Assessment 
NEPSY Neuropsychological 
Development 
Steen et al., 2002 Developing Skills Checklist DSC Wide Range of Skills 
Tarazi et al., 2007 
Schatz et al., 2004
a
 
Schatz et al., 2002 
Schatz et al., 2001 
Schatz et al., 1999 
DeBaun et al., 1998 
Differential Ability Scales DAS Variety of Cognitive Abilities 
Schatz et al., 2004
a
 Divided Hierarchical Attention 
Task 
DHAT Divided Attention 
Brown et al., 1993 Expressive One Word 
Vocabulary Test 
EVT Oral Language 
Cohen et al., 1994 
Craft et al., 1993 
Finger Tapping FT Motor Speed 
Cohen et al., 1994 Finger Tip Number Writing FTNW Complex Tactile Perception and 
Concentration 
Cohen et al., 1994 Gray Oral Reading Test – 
Revised 
GORT=R Oral Reading Growth and 
Difficulties 
Brown et al., 1993 
Fowler et al., 1988 
Kagan Matching Familiar Figures 
Test 
MFFT Attention and Impulse Control 
(Cognitive Tempo) 
Goonan et al., 1994 Gordon’s Continuous 
Performance Task 
GCPT Selective Attention and 
Impulsivity 
Puffer et al., 2010 
Brown et al., 2000 
Cohen et al., 1994 
Brown et al., 1993 
Swift et al., 1989 
Kaufman Assessment Battery for 
Children 2
nd
 ed. 
KABC-II Cognitive Development 
Schatz et al., 2004
 a
 Koenig, Reiss, and Kosslyn’s 
Categorical and Coordinate 
Spatial Judgment Task 
KRKCSI Categorical and Coordinate 
Spatial Judgment 
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Reference Neuropsychological Test Acronyms EF Domain 
Bernaudin et al., 2000 l’Alourette French Reading Test LFMT Reading Achievement 
Wasserman et al., 
1991 
Luria-Nebraska 
Neuropsychological Battery 
LNNB Neuropsychological Impairment 
Schatz et al., 2007 MacArthur Communication 
Development Inventory 
CDI Language and Communication 
Skills 
White et al., 2000 Memory Span MS Short Term Memory 
Craft et al., 1993 Mini Mental Status Examination MMSE Mental Impairment 
Schatz et al., 2004
 a
 
Schatz et al., 2001 
Brown et al., 1993 
Schatz et al., 1999 
DeBaun et al., 1998 
Brown et al., 1993 
Peabody Picture Vocabulary 
Test Revised 
PPVT-R Receptive Language 
Tarazi et al., 2007 
Bernaudin et al., 2000 
Brown et al., 2000 
Armstrong et al., 1996 
Cohen et al., 1994 
Purdue Pegboard Test PPT Fine and Gross Motor Dexterity 
and Coordination 
Schatz et al., 2001 
Brown et al., 2000 
Rapid Automatized Naming RAN Ability to Read, Phonological 
Awareness, and Verbal IQ, 
Schatz et al., 2006 
Schatz et al., 2005 
Self-Ordered Pointing Test SOPT Behavior  by Using Plans and 
Strategies 
Schatz et al., 2004
 a
 
DeBaun et al., 1998 
Simple Reaction Time SRT Motor Skills 
Brown et al., 1993 Stanford Binet IV SB-IV Cognitive Ability 
Schatz et al., 2001 
Schatz et al., 1999 
DeBaun et al., 1998 
Test of Variables of Attention  
TOVA 
 
Attention Disorders 
Cohen et al., 1994 Test of Visual Perceptual Skills TVPS Visual Perceptual Strengths and 
Weaknesses 
Puffer et al., 2010 Test of Language Development – 
Primary Version, 3
rd
  ed. 
TOLD III Language Development 
Cohen et al., 1994 Test of Visual-Perceptual Skills TVPS Visual Perceptual Strengths and 
Weaknesses 
Schatz et al., 1999 Tower of Hanoi TOH Problem Solving, Executive 
Function Deficits 
Kral et al., 2003 Trail Making Test TMT Visual Attention and Task 
Switching 
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Reference Neuropsychological Test Acronyms EF Domain 
Puffer et al., 2007 
Schatz et al., 2006 
Steen et al., 2005 
Schatz et al., 2005 
Schatz, 2004 
Schatz et al., 2004
b
 
Steen et al., 2003 
Boni et al., 2001 
Schatz et al., 2001 
Wang et al., 2001 
Bernaudin et al., 2000 
Brown et al., 2000 
Steen et al., 1999 
Steen et al., 1998 
Watkins et al., 1998 
Wechsler Intelligence Scale for 
Children 3
rd
 ed. 
 
WISC-III Cognitive Ability 
Berg et al., 2012 Wechsler Intelligence Scale for 
Children 4
th
 ed. 
WISC-IV Cognitive Ability 
Steen et al., 2003 
Wang et al., 2001 
Steen et al., 1998 
Armstrong  et al., 1996 
Knight et al., 1995 
Cohen et al., 1994 
Craft et al., 1993 
Wasserman et al., 
1991 
Swift et al., 1989 
Wechsler Intelligence Scale for 
Children Revised 
WISC-R Cognitive Ability 
Watkins et al., 1998 Wechsler Memory Scale WMS Memory Functions 
Watkins et al., 1998 Wechsler Preschool and Primary 
Scale of Intelligence Revised 
WPPSI-R Cognitive Ability 
Tarazi et al., 2007 Wechsler Preschool and Primary 
Scale of Intelligence 3
rd
 ed. 
WPPSI-III Cognitive Ability 
Kral et al., 2003 
Kral et al.,2004 
White et al., 2006 
Schatz et al., 2002 
Knight et al., 1995 
Wechsler Abbreviated Scale of 
Intelligence 
WAIS Cognitive Ability 
White et al., 2006 Wechsler Individual 
Achievement Test 
WIAT Academic Strengths and 
Weaknesses 
Cohen et al., 1994 Wepman Auditory 
Discrimination Test 
WADT Auditory Discrimination 
Schatz et al., 2004
b
 
 
Woodcock-Johnson 
Psychoeducational Test Battery 
WJ Cognitive Abilities, Scholastic 
Aptitude, and Academic 
Achievement 
Puffer et al., 2010 
 
   Woodcock-Johnson 
Psychoeducational Test 
   Battery III 
WJ-III Cognitive Abilities, Scholastic 
Aptitude, and Academic 
Achievement 
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Cognitive tests utilized for analysis of Executive Functioning across pediatric SCD literature. 
 
 
 
Reference Neuropsychological Test Acronyms EF Domain 
Kral et al., 2003 
Puffer  et al., 2007 
Schatz et al., 2005 
Schatz, 2004 
Schatz et al., 2004
 a
 
Wang et al., 2001 
Schatz et al., 2001 
Brown et al., 2000 
Schatz et al., 1999 
DeBaun et al., 1998 
Armstrong et al., 1996 
Craft et al., 1993 
Swift et al., 1989 
Woodcock-Johnson 
Psychoeducational Test Battery 
Revised 
 
 
 
 
 
 
 
WJR Cognitive Abilities, Scholastic 
Aptitude, and Academic 
Achievement 
Cohen et al., 1994 
Wasserman et al., 
1991 
Fowler et al., 1988 
Wide Range Achievement Test 
Revised 
WRAT-R Achievement Test 
Schatz et al., 2001 Wide Range Assessment of 
Memory and Learning 
WRAML Memory Functions 
Schatz et al., 2001 
Schatz et al., 1999 
DeBaun et al., 1998 
Wisconsin Card Sorting Test WCST Ability to Display Flexibility in 
the Face of Changing Schedules 
of Reinforcement 
Berg et al., 2012  Children's Kitchen Task 
Assessment 
CKTA Initiation, Sequencing, Safety 
Judgment, Organization, 
Working Memory 
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Table 1.2. 
Descriptive Table of Pediatric Sickle Cell Disease Studies with Executive Function 
Measures 
 
Reference Measure 
Norms: Participant 
Group 
Characteristics 
Age 
SCD 
(mean) 
n 
SCD 
n 
Control
s 
Armstrong 
et al., 1996 
Purdue Pegboard Test 
Wechsler Intelligence Scale for Children 
Revised  
Woodcock Johnson Revised 
Std Norms: SCD – 
Normal MRI vs. 
Silent Infarct vs. 
CVA 
6.1 n = 
194 
n/a 
 
Berg et. al., 
2012 
 
Delis-Kaplan Executive Function System 
Wechsler Intelligence Scale for Children 
IV 
Behavior Rating Inventory of Executive 
Function 
Children’s Kitchen Task Assessment 
144: French Memory Scale 
Local/Std Norms: 
SCD – Normal  
 
 
 
10.2 n = 
22 
n = 22 
Bernaudin 
et al., 2000 
Batterie d'Efficience Mnesique  
l’Alourette French Reading Test 
Purdue Pegboard Test  
Wechsler Intelligence Scale for Children 
III 
Local/Std Norms: 
SCD –  
Abnormal MRI vs. 
Abnormal TCD vs. 
Low Hematocrit 
vs. Siblings 
10.2 n = 
173 
n = 76 
Boni et al., 
2001 
Wechsler Intelligence Scale for Children 
III 
Std Norms: SCD – 
CVA and HbSS vs. 
Normal MRI and 
HbSS vs. Normal 
MRI and HbSC 
11.4 n = 
52 
n/a 
Brandling-
Bennett et 
al., 2003 
California Verbal Learning Test for 
Children – Children’s Version  
Children’s Memory Scale 
Std Norms: SCD - 
Abnormal MRI vs. 
Normal MRI 
12.9 n = 
83 
n/a 
Brown  et 
al., 2000 
Cancellation A’s Task  
Trails Making Test (B) 
Wechsler Intelligence Scale for Children 
III  
Woodcock Johnson Revised 
Local/ Std Norms: 
SCD - CVA vs. 
Silent stroke vs. 
Normal MRI 
9.8 n = 
63 
n/a 
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Reference Measure 
Norms: Participant 
Group 
Characteristics 
Age 
SCD 
(mean) 
n 
SCD 
n 
Control
s 
Brown  et 
al., 1993 
 
Beery-Buktenica Developmental Test of 
Visual-Motor Integration 
Continuous Performance Task   
Expressive One Word Vocabulary Test 
Kagan Matching Familiar Figures Test 
Kaufman Assessment Battery for 
Children 2
nd
 ed. 
Peabody Picture Vocabulary Test 
Revised  
Picture Vocabulary Test  
Stanford Binet IV 
Local/ Std Norms: 
SCD vs. Siblings 
10.4 n = 
88 
n/a 
Cohen et 
al., 1994 
Beery-Buktenica Developmental Test of 
Visual-Motor Integration 
Boston Naming Test 
Finger Tapping 
Finger Tip Number Writing 
Kaufman Assessment Battery for 
Children 2
nd
 ed 
Purdue Pegboard Test 
Test of Visual-Perceptual Skills 
Wechsler Intelligence Scale for Children 
Revised 
Wepman Auditory Discrimination Test 
Wide Range Achievement Test Revised 
Local/ Std Norms: 
SCD - Left  
Cerebral Infarct vs. 
Right Cerebral 
Infarct 
9.96 
years 
n = 
10 
n/a 
Craft et al., 
1994 
Covert Orienting Task Local: SCD - no 
CVA vs. Bifrontal 
Lesions vs. Diffuse 
Lesions vs. Siblings 
10.7 n = 
29 
n = 20 
Craft et al., 
1993 
Benton Verbal Fluency Test  
Benton Visual Retention Test 
Children’s Auditory Verbal Learning Test  
Finger Tapping 
Mini Mental Status Examination  
Wechsler Intelligence Scale for Children 
Revised 
Woodcock Johnson Revised 
Local/Std Norms: 
SCD – CVA with 
Anterior Lesions 
vs. CVA with 
Diffuse Lesions vs. 
CVA with Normal 
MRI vs. Siblings 
7.51 n = 
39 
n = 20 
DeBaun et 
al., 1998 
Benton Judgment of Line Orientation 
Benton Visual Form 
California Verbal Learning Test – 
Children  
Choice Reaction Time Task 
Differential Ability Scales 
Multilingual Aphasia Examination   
Peabody Picture Vocabulary Test 
Revised 
Simple Reaction Time 
Test of Variables of Attention  
Wisconsin Card Sorting Test 
Woodcock Johnson Revised 
Discrimination  
Local/Std Norms: 
SCD – Silent Stroke 
vs. Overt Stroke vs. 
Siblings 
11.5 n = 
28 
n = 17 
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Reference Measure 
Norms: Participant 
Group 
Characteristics 
Age 
SCD 
(mean) 
n 
SCD 
n 
Control
s 
Fowler et 
al., 1988 
Beery-Buktenica Developmental Test of 
Visual-Motor Integration 
Kagan Matching Familiar Figures Test 
Wechsler Intelligence Scale for Children 
Revised 
Wide Range Achievement Test  
Std Norms: SCD – 
No Stroke vs. 
Healthy Peers 
12.8 n = 
28 
n = 28 
Goonan et 
al., 1994 
Gordon’s Continuous Performance Task 
Kagan Matching Familiar Figures Test 
Local/ Std Norms: 
SCD – No CVA vs. 
Sibling 
11.5 n = 
24 
n = 11 
Knight et 
al., 1995 
Wechsler Intelligence Scale for Children 
Revised  
Wechsler Abbreviated Scale of 
Intelligence 
Std Norms: SCD vs. 
Healthy Peers 
16.85 n = 
60 
n = 60 
  Kral et al., 
2003 
 
 
 
 
 
 
Kral et al., 
2004 
 
 
 
 
Behavior Rating Inventory of Executive 
Function 
Children's Memory Scale 
Conners’s Continuous Performance Test 
II 
Trail Making Test 
Wechsler Abbreviated Scale of 
Intelligence 
Wechsler Intelligence Scale for Children 
III 
Woodcock-Johnson Psychoeducational 
Test Battery Revised 
Behavior Rating Inventory of Executive 
Function: Parent/Teacher 
Wechsler Abbreviated Scale of 
Intelligence 
 
Std Norms: SCD vs. 
Normal 
 
 
 
 
 
 
Std Norms: SCD – 
TCD status Normal 
vs. Conditional vs. 
Abnormal 
 
10.6 
 
 
 
 
 
 
10.1 
 
n = 
25 
 
 
 
 
 
 
n = 
62 
 
n = 35 
 
 
 
 
 
 
n = 0 
Puffer et 
al., 2010 
Beery-Buktenica Developmental Test of 
Visual-Motor Integration 
Kaufman Assessment Battery for 
Children 2
nd
 ed. 
Test of Language Development, 3
rd
. ed. 
Woodcock-Johnson Psycho-educational 
Test Battery III 
Std Norms: SCD – 
SCD vs. Healthy 
Peers 
6.5 n = 
64 
n = 81 
Puffer et 
al., 2007 
Delis-Kaplan Executive Function System 
Wechsler Intelligence Scale for Children 
III  
Woodcock Johnson Revised 
Std Norms: SCD - 
Hydroxyurea 
Therapy vs. 
Without 
13.2 n = 
65 
n/a 
Schatz, 
2004 
Delis-Kaplan Executive Function System 
Woodcock Johnson Revised 
Std Norms: SCD vs. 
Healthy Peers 
11.6 n = 
50 
n = 36 
Schatz et 
al., 2006 
Delis-Kaplan Executive Function System 
Self-Ordered Pointing Test   
Wechsler Intelligence Scale for Children 
III  
Local/ Std Norms: 
SCD - No Lesion vs. 
Silent Infarct vs. 
Overt Stroke vs. 
Healthy Peers 
12.8 n = 
28 
n = 16 
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Reference Measure 
Norms: Participant 
Group 
Characteristics 
Age 
SCD 
(mean) 
n 
SCD 
n 
Control
s 
Schatz et 
al., 2001 
Benton Judgment of Line Orientation 
Boston Naming Test  
California Verbal Learning Test for 
Children – Children’s Version 
Test of Variables of Attention  Wisconsin 
Card Sorting Test 
Cancellation A’s Task  
Differential Ability Scales  Peabody 
Picture Vocabulary Test Revised 
Rapid Automatized Naming  Trail Making 
Test  
Wechsler Intelligence Scale for Children 
III  
Woodcock-Johnson Psychoeducational 
Test Battery Revised 
Local/Std Norms: 
SCD – Silent 
Cerebral Infarcts 
vs. Without Infarct 
vs. Siblings 
10.8 n = 
64 
n = 16 
 
Schatz et 
al., 2004
iii
 
Benton Judgment of Line Orientation 
Differential Ability Scales   
Simple Reaction Time  
Woodcock-Johnson Psychoeducational 
Test Battery Revised 
Peabody Picture Vocabulary Test 
Revised  
Treisman and Gelade (1980) Parallel and 
Serial Visual Search Task  
Koenig, Reiss, and Kosslyn’s Categorical 
and Coordinate Spatial Judgment Task 
Local/ Std Norms: 
SCD -  Unilateral 
Left Brain Injury vs.  
Unilateral Right 
Brain Injury vs.  
Bilateral  Brain 
Injury vs. Siblings 
12.8 n = 
42 
 
n = 43 
Schatz et 
al., 1999 
Benton Judgment of Line Orientation 
California Verbal Learning Test – 
Children  
Differential Ability Scales 
Peabody Picture Vocabulary Test 
Revised  
Test of Variables of Attention  Tower of 
Hanoi 
Wisconsin Card Sorting Test    
Woodcock-Johnson Psychoeducational 
Test Battery Revised 
Local/Std Norms: 
SCD – Anterior 
Cerebral Infarct vs. 
Diffuse Cerebral 
Infarct vs. Siblings 
12.7 n = 
28 
n = 17 
Schatz et 
al., 2004
iv
 
Delis-Kaplan Executive Function System  
Wechsler Intelligence Scale for Children 
III 
Woodcock-Johnson Psychoeducational 
Test Battery Revised 
Std Norms: SCD vs. 
Healthy Peers 
11.6 n = 
50 
n = 36 
Schatz et 
al., 2005 
Delis-Kaplan Executive Function System 
Self-Ordered Pointing Test   
Wechsler Intelligence Scale for Children 
III  
Woodcock-Johnson Psychoeducational 
Test Battery Revised 
Local/ Std Norms: 
SCD vs. Healthy 
Peers 
11.4 n = 
25 
n = 25 
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Reference Measure 
Norms: Participant 
Group 
Characteristics 
Age 
SCD 
(mean) 
n 
SCD 
n 
Control
s 
Schatz et 
al., 2007 
Delayed Response Task 
Denver Developmental Screening Test II  
MacArthur Communication 
Development Inventory 
Local/ Std Norms: 
SCD - High 
Neurologic Risk vs. 
Low  Neurologic 
Risk 
2.2 n = 
61 
n/a 
Schatz et 
al., 2002 
Differential Ability Scales  
Wechsler Abbreviated Scale of 
Intelligence 
Std Norms: SCD - 
Silent Infarct Cases 
vs. No Infarct 
Cases 
12 n = 
25 
n/a 
Steen et 
al., 2005 
Wechsler Intelligence Scale for Children 
Revised  
Wechsler Intelligence Scale for Children 
III 
Std Norms: SCD vs. 
Healthy Peers 
10.9 n = 
54 
n = 
2200 
Steen et 
al., 2002 
Developing Skills Checklist Std Norms: SCD vs. 
Healthy Peers 
5.6 n = 
34 
n = 68 
Steen et 
al., 2003 
Wechsler Intelligence Scale for Children 
III 
Wechsler Intelligence Scale for Children 
Revised  
Std Norms: SCD - 
Abnormal MRI vs. 
Normal MRI 
9.5 n = 
49 
n/a 
Steen et 
al., 1998 
Wechsler Intelligence Scale for Children 
III 
Wechsler Intelligence Scale for Children 
Revised 
Std Norms: SCD – 
No MRI 
Abnormalities vs. 
Abnormal MRI vs. 
Healthy Peers  
8.4 n = 
30 
n = 24 
Steen et 
al., 1999 
Wechsler Intelligence Scale for Children 
III 
Std Norms: SCD vs. 
Healthy Peers 
10.6 n = 
50 
n = 52 
Swift et al., 
1989 
Wechsler Intelligence Scale for Children 
Revised  
Woodcock-Johnson Psychoeducational 
Test Battery Revised 
Kaufman Assessment Battery for 
Children 2
nd
 ed. 
Detroit Test of Learning Aptitude II  
Beery-Buktenica Developmental Test of 
Visual-Motor Integration 
Std Norms: SCD 
with no CVA vs. 
Siblings 
11.5 n = 
21 
n = 21 
Tarazi et 
al., 2007 
Differential Ability Scales  Wechsler 
Preschool and Primary Scale of 
Intelligence Revised PPT 
Developmental NeuroPsychological 
Assessment 
Std Norms: SCD – 
No History of 
Stroke 
4.3 n = 
28 
n/a 
Thompson 
et al., 2002 
Bayley Scales of Infant Development III  Std Norms: SCD – 
HbSS vs. 
HbSC/Other 
1.8 n = 
89 
n/a 
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Descriptive information for the selected studies utilized in the literature review. 
 
Reference Measure 
Norms: Participant 
Group 
Characteristics 
Age 
SCD 
(mean) 
n 
SCD 
n 
Control
s 
Wang et 
al., 2001 
Wechsler Intelligence Scale for Children 
III  
Wechsler Intelligence Scale for Children 
Revised  
Woodcock-Johnson Psychoeducational 
Test Battery Revised 
Std Norms: SCD - 
Abnormal MRI vs. 
Normal MRI 
8.1 n = 
373 
n/a 
Wasserma
n et al., 
1991 
Luria-Nebraska Neuropsychological 
Battery 
Wechsler Intelligence Scale for Children 
Revised  
Wide Range Achievement Test Revised 
Std Norms: SCD vs. 
Siblings 
11.5 n = 
43 
n = 30 
Watkins et 
al., 1998 
Wechsler Intelligence Scale for Children 
III  
Wechsler Memory Scale 
Wechsler Preschool and Primary Scale of 
Intelligence Revised 
Wisconsin Card Sorting Test 
Std Norms: SCD – 
CVA vs. No CVA 
and Silent Infarct 
vs. No CVA and 
Normal MRI vs. 
Siblings 
10.62 n = 
41 
n = 15 
White et 
al., 2006 
Wechsler Abbreviated Scale of 
Intelligence  
Wechsler Individual Achievement Test  
California Verbal Learning Test – 
Children  
Children’s Memory Scale 
Std Norms: SCD -  
Abnormal MRI vs. 
Normal MRI 
11.95 n = 
65 
n/a 
White et 
al., 2000 
Memory Span Local: SCD: 
History of Stroke 
vs. No History) 
11.7 n = 
31 
n/a 
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Table 1.3. 
Review of the Prominent Executive Function Psychometrics 
 
Measure & Subtest Type of Test Age Range 
Test-Retest 
Reliability 
Internal 
Consistency 
Convergent 
Validity 
Norm Quality Reference 
Behavior Rating 
Inventory of 
Executive Function 
California Verbal 
Learning Test – 
Children 
Traditional 
 
 
 
Traditional 
 
5-18 years 
 
 
 
5-16 years 
Good 
 
 
 
Marginal 
Good Child Behavior 
Checklist 
 
 
California Verbal 
Learning Test:  
Moderate 
Adequate 
 
 
 
Adequate 
Gioia, et al. 2000 
 
 
 
Diller, 1974 
-Long Delay Free 
Recall 
   
 
Excellent   Van der Elst et al., 2005 
 
Cancellation A’s 
Task 
Subtractive 
Factors 
DATA NOT REPORTED  
Children’s Auditory 
Verbal Learning Test 
 
Traditional 7-17 years Good Good CVLT: Strong Good Kennepohl et al., 2004 
Schmidt, 1996 
Tally, 1990 
Children’s Memory 
Scale 
Traditional 5-16 years   Wechsler Memory Scale 
III: Strong 
Adequate Cash, 2009 
Cohen, 1997 
Strauss et al., 2006 
-Backwards Digit 
Span 
  High High    
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Measure & Subtest Type of Test Age Range 
Test-Retest 
Reliability 
Internal 
Consistency 
Convergent 
Validity 
Norm Quality Reference 
Children’s Kitchen 
Task Assessment 
Choice Reaction 
Time Task 
Traditional             
 
 
Subtractive 
Factors 
8-12 years              Moderate                 High             BRIEF: Parent                                      Poor                      
 
 
DATA NOT REPORTED 
Rocke et al., 2008 
 
 
Canavan et al., 1974 
Conner’s Continuous 
Performance Task 
Subtractive 
Factors 
6-55+ years Adequate Not 
Reported     
Posner Visual Orienting 
Task: Strong 
Poor Conners, 1994 
 
-II                                Subtractive 
Factors 
6-55+ years              Moderate Modest Beery Test of Visual 
Perception: Acceptable 
Poor Strauss, Sherman, & Spreen, 
2006 
Memory Span Traditional DATA NOT REPORTED Gihooly et al., 1980 
Mental Status 
Examination – 
Auditory Vigilance 
Interview DATA NOT REPORTED Strub et al., 1977 
Multilingual Aphasia 
Examination 
Traditional 6-12 and  
16-97 years 
DATA NOT REPORTED Boston Naming Test 
and Wechsler 
Abbreviated Scale of 
Intelligence Revised 
– Verbal subtests: 
High 
Poor Schum et al., 1989 
Odd Man Out Traditional 22-79 DATA NOT REPORTED Cattell Culture Fair 
Intelligence 
Quotient: Strong 
Poor Pomati  et al., 1996 
Diascro et al., 1994 
Frearson et al., 1986 
Self-Ordered Pointing  
 
Subtractive 
Factors 
5-11 years Adequate High Go-No-Go: 
Moderate 
Poor Strauss et al., 2006 
Archibald  et al., 1999 
Petrides et al., 1982 
 
 
Stanford Binet IV 
 
 
Traditional 
 
 
2-23 years 
 
 
 
  
 
Kaufman 
Assessment Battery 
for Children: Strong 
 
 
Good 
Green et al. 1990 
Thorndike et al., 1986 
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Measure & Subtest Type of Test Age Range 
Test-Retest 
Reliability 
Internal 
Consistency 
Convergent 
Validity 
Norm Quality Reference 
Test of Variable of 
Attention 
Traditional 4-19 years  
 
 
Moderate to 
High 
Criteria for ADHD in 
the Diagnostic and 
Statistical Manual of 
Mental Disorders 
4
th
: Strong 
              Poor Riccio et al., 2001 
Dupuy Cenedela, 2000 
McCarney et al., 1990 
-Reaction Time   Very High     
Tower of Hanoi Puzzle 7+ Low Unacceptable Tower of London: 
Low 
Not Reported Bishop et al., 2001 
Welsh et al., 2000 
Klahr et al., 1981 
Trail Making Test Subtractive 
Factors 
9-14 and 
15-89 years 
 
 
 
Moderate to 
High 
Digit Modality Test: 
Moderate  
 
             Poor Strauss et al., 2006 
Lucas et al., 2005 
Kennepohl et al., 2004 
Lee et al., 2000 
-B 
 
 
 
 
 
Wechsler Abbreviated 
Scale of Intelligence 
 
 
 
 
 
 
Traditional 
 
 
 
 
 
 
6-89 years 
Adequate 
 
 
 
 
 
Good 
Acceptable 
 
 
 
 
 
Good 
Wisconsin Card 
Sorting Test and 
Visual Search and 
Attention and Test: 
Strong 
Kaufman Brief 
Intelligence Test: 
Strong 
 
 
 
 
 
 
             Adequate 
 
 
 
 
 
 
Wechsler, 1999 
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Measure & Subtest Type of Test Age Range 
Test-Retest 
Reliability 
Internal 
Consistency 
Convergent 
Validity 
Norm Quality Reference 
Wechsler Intelligence 
Scale for Children 3
rd
 
ed. 
Traditional 6-16 years  
 
 
 WPPSI-R, WISC-R, 
WAIS-R, Differential 
Ability Scales: Very 
Strong  
              Adequate Canivez et al., 1999 
Wechsler, 1997 
-Digit Span Backwards 
 
-Coding 
 
-Picture Arrangement 
 
-Symbol Search 
 
-Freedom from 
Distractibility 
 
 
 
 
 
 
High 
 
Adequate 
 
Adequate 
 
 
Adequate 
 
Adequate 
Acceptable 
 
Excellent 
 
Questionable 
 
 
Moderate 
 
Adequate 
 
 
 
  
-Processing Speed 
 
-4
th
 edition 
-Digit Span Backwards 
-Digit Span Forwards 
 
 
Traditional 
 
 
 
 
 
Traditional 
 
 
6-16 
 
 
 
 
 
3-80 years 
Adequate 
 
Adequate 
 
Adequate 
 
Good 
Adequate 
 
Good 
 
Good 
 
Good 
 
 
WPPSI-III, WISC-III, 
WAIS-III,: Very Strong 
 
 
 
 
 
Stanford-Binet: 
Moderate 
 
 
 
Good 
 
 
 
 
 
 
Poor 
 
 
 
 
 
Wechsler, 2003 
 
 
 
 
 
 
Woodcock, et al., 1977 
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Measure & Subtest Type of Test Age Range 
Test-Retest 
Reliability 
Internal 
Consistency 
Convergent 
Validity 
Norm Quality Reference 
Woodcock Johnson 
Psycho-Educational 
Battery 
       
 
-Visual Matching 
 
 
-Spatial Relations 
 
-Category Fluency 
 
-Digit Span 
 
 
 
 
 
 
 
Adequate 
 
 
High 
 
Adequate 
 
Marginal 
 
Moderate 
 
 
Moderate 
 
Moderate 
 
Moderate 
 
Wechsler Intelligence 
Scale for Children  
Revised: Strong 
 
 
  
Test: 
Woodcock Johnson 
Psycho-Educational 
Battery III 
 
 
Traditional 
 
2-90 years 
 
 
 
  
Standford Binet IV & 
Kaufman Adolescent 
and Adult Intelligence 
Test: Strong  
 
 
Excellent 
 
Woodcock, et al., 2001 
-Decision Speed 
 
-Memory for Words 
 
 
 
 
 
 
High 
 
Adequate 
Excellent 
 
Good 
 
 
  
Woodcock Johnson 
Psycho-Educational 
Battery Revised 
Traditional 2-90 years  
 
 
 Assessment Battery 
and Wide Range 
Achievement Test: 
Strong 
 
 
 
 
 
Woodcock, et al., 1989 
Sub-Tests: 
-Visual Matching 
 
-Processing Speed 
 
-Spatial Relations 
 
 
 
 
 
 
 
Adequate 
 
Adequate 
 
High 
 
Excellent 
 
Excellent 
 
Good 
 
 
  
Test: 
Wisconsin Card 
Sorting Test 
 
Traditional 
 
5-89 years 
 
Low to 
Marginal 
 
DATA NOT 
REPORTED 
 
Trails Making Test B: 
Marginal 
 
Poor 
 
Boone, 1999 
Ariffa et al., 1998 
Boone et al., 1993 
Axelrod et al., 1992 
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Notes: Test Retest Reliability Coefficients: Very High (≥.90), High (.80-.89), Adequate (.70-.79), Marginal (.60-.69), Low (.50-.59), Extremely Low (≤.49) 
Internal Consistency: Excellent (α ≥ .9), Good (.9 > α ≥ .8), Acceptable (.8 > α ≥ .7), Questionable (.7 > α ≥ .6), Unacceptable (.5 > α) 
Convergent Validity Correlations: Strong (.50 to 1.0), Moderate (.30 to .49), Low (.10 to .29) 
Norm Quality: Sample descriptive:  number, age, geographic location, gender, race/ethnicity, education (parental), inclusion criteria (special education, gifted): high, adequate, 
poor 
 
Psychometric properties of neuropsychological measures included in literature review.
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Table 1.4. 
Complete Normative Sample Psychometric Considerations 
 
Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Behavior 
Rating 
Inventory of 
Executive 
Function 
 
Gioia, et al., 
2000 
 
California 
Verbal 
Learning 
Test – 
Children 
 
Delis et al., 
1994 
n = 1,419  
 
 
 
 
 
 
 
n = 920 
Yes 
 
 
 
 
 
 
 
 
Yes 
Age 
Bands 
 
 
 
 
 
 
 
Random  
Age, 
Location, 
Parent 
Educatio
n, 
Gender, 
Race/ 
Ethnicity 
No 
 
 
 
 
 
 
 
 
No 
Males 
generally 
higher 
ratings for 
Inhibition  
 
 
 
 
Minimal, 
overall 
females 
outperform 
males 
 
Maryland 
public and 
private 
schools  
26.5% 
urban, 59% 
suburban, 
14.5% rural 
Public and 
Private 
Schools in 
Western, 
North, 
Central, 
Northeast, 
Southern US 
Unknown 
 
 
 
 
 
 
 
 
Unknown 
Yes 
 
 
 
 
 
 
 
 
No 
No 
 
 
 
 
 
 
 
 
Yes 
Exclusion: Special 
Education or 
Psychotropic 
Medication 
 
 
 
 
 
 
Exclusion: English 
Fluency 
Cancellation 
A’s Task 
 
Diller, 1974 
DATA NOT REPORTED 
  
 
 
 
 
 
 
 
Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Children’s 
Auditory 
Verbal 
Learning 
Test 
 
Van der 
Elst et al., 
2005 
Meta-
Norms: 
Children  
n = 80-
900 
Yes Age 
Bands 
    No A female 
Advantage 
has been 
Shown in 
Recall and 
Recognition 
Trials 
International Lower Levels 
of 
Acculturation 
are Linked to 
Lower Scores 
Yes No Exclusion: 
Learning 
Disabilities, 
Attention 
Disorders, 
Special 
Academic 
Assistance, Very 
High or Low 
Academic 
Performance 
Children’s 
Memory 
Scale 
 
Strauss et 
al., 2006 
 
 
 
 
n = 1000 Yes Age 
Bands 
No Not Reported National Minimal if 
Parent 
Education is  
Controlled 
No No Exclusion: 
Below grade 
level reading, 
grade 
repetition, 
special 
education, 
neurologic 
disorder, and 
head injury 
Choice 
Reaction 
Time Task 
 
Canavan  
et al., 1974 
DATA NOT REPORTED 
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Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Conner’s 
Continuous 
Performan
ce Task 
 
Conners , 
1994 
n = 
1190 
 
Note: 
Clinical 
- 
n = 670 
 
No 8 Age 
Bands 
 
No Not 
Reported 
5 states and 
Southern 
Ontario 
Not Reported No No Exclusion: 
“Outliers” on 
Attentional 
Diagnoses and 
those Taking 
Psychotropic 
Medication 
Controlled 
Oral Word 
Association 
Test 
 
Anderson 
et al., 1997 
n = 422 No Age 
Bands 
 
Note: Age 
Bands 14 
and 15 
contain 
less than 
20 
children 
No Overall 
Females 
Shown to 
Out-
perform 
Males 
Melbourne 
Australia 
Scores shown 
to be less than 
Caucasian 
Peers 
No No Exclusion: 
English as 
Second 
Language, 
History of 
Neurological, 
Sensory, 
Developmental 
Disorders 
Delayed 
Response 
DATA NOT REPORTED 
Delis-
Kaplan 
Executive 
Function 
System 
 
Delis et al., 
2001 
n = 750 Yes Random 
Age, 
Gender, 
Race/ 
Ethnicity, 
Education 
Level 
No Not 
Reported 
38 States Not Reported No No Sensory 
Limitations, 
Substance 
Abuse, Medical, 
Psychiatric, or 
Motor 
Condition 
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Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Detroit Test 
of Learning 
Aptitude 2
nd
 
Edition 
 
Hammill et 
al., 1985 
n = 
1532 
No Missing 
Information 
for Sample 
Ethnicity, 
Age,  
Education of 
parents 
No No 30 states Unknown:Black 
and White 
Ethnicity is 
Reported 
Together as 
“Other” (92% 
of sample) 
Not 
Reported 
 
No Not Reported 
Divided 
Hierarchical 
Attention 
Task 
Robertson et 
al., 1993 
DATA NOT REPORTED 
Gordon’s 
Continuous 
Performance 
Task 
 
Gordon et 
al., 1988 
n = 
1300 
Not Reported Age 
Bands 
Not 
Reported 
Not Found Syracuse, New 
York 
Charlottesville 
Virginia 
Not 
Reported 
No 
 
No Exclusion: ADD 
or ADD/H, 
Special 
Classroom 
Placement, 
Learning 
disability, IQ < 
70, 
Major 
Neurological 
Impairment, 
Psychotropic 
Medication, 
Psychotherapy, 
Grade 
Retention, 
Emotional 
Disturbance 
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Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Kaufman 
Assessment 
Battery for 
Children, 2
nd
 
ed. 
Kaufman et 
al., 2004 
n = 
3025 
 
Yes Random 
Age, 
Gender, 
Ethnicity, 
Parental 
Education, 
Geographic 
Region 
Yes Not Found 39 States and 
DC 
Scores 
shown to be 
less than 
Caucasian 
Peers 
 
 
No Yes Inclusion: 
Learning 
Disability, 
Speech 
Language 
Impairment, 
Mental 
Retardation, 
Emotional/Beha
vioral 
Disturbance, 
ADHD, Gifted 
Kagan 
Matching 
Familiar 
Figures Test 
 
Salkind, et 
al., 1978 
n = 
5000 
 
Note: 
2,676 
Ameri
can 
 
 
No Age Bands No Female 
Scores 
Correlated 
with Verbal 
Intelligence 
International Not 
Reported 
No No Inclusion: 
Normal 
Intelligence, 
Middle-Class 
SES 
 
Memory 
Span 
 
Gilhooly et 
al., 1980 
DATA NOT REPORTED 
Mental 
Status 
Examination 
Strub et al., 
1977 
DATA NOT REPORTED 
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Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Multilingual 
Aphasia 
Examination 
 
Schum et al., 
1989 
n = 
229 
 
Yes Age Bands 
 
No Not 
Found 
Iowa Black, Urban, 
Inner City 
Culture and 
Lower Levels 
Acculturation 
have been 
Linked to 
Lower Scores 
No No Inclusion: 
Children with 
Scores of 80-
120 on the 
Peabody 
Picture 
Vocabulary 
Test -Revised 
included 
Self-Ordered 
Pointing Test 
 
Petrides et 
al., 1982 
n = 89 Yes Age Bands No 
 
Not Found 
 
Greater 
Victoria 
School 
District in 
Canada 
 
Not Reported 
 
Note: Race/ 
Ethnicity Not 
Reported 
No 
 
 
No 
 
Exclusion: 
Significant 
Neurological, 
Psychiatric, 
Developmental 
Difficulties 
Stanford 
Binet IV 
Thorndike et 
al., 1986 
Greene et 
al., 1990 
n = 
5013 
Yes 
 
Random 
Geographic 
Region, 
Community 
Size, Ethnic 
Group, Age, 
Gender, 
Socio-
economic 
Status 
No Not 
Reported 
 
National Found to be 
Valid for 
Exceptional 
Black Male 
Students but 
not Learning 
Disabled 
No Yes Exclusion: 
Severe Medical 
Conditions, 
Communication 
Deficits, Severe 
Behavior/ 
Emotional 
Disturbances 
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Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Test of 
Variables of 
Attention 
 
Riccio et al., 
2001 
Dupuy  
Cenedela , 
2000 
n = 2551 No Age and 
Sex 
No Males have 
been 
evidenced 
to have 
Faster 
Reaction 
Times and 
Errors in 
Scores for 
Subtests 
Minneapolis 
Minnesota 
Not 
Reported 
 
Note: 
Race/ 
Ethnicity of 
Sample: 99% 
Caucasian, 
1% Other 
No 
 
No Exclusion: 
Significant 
Neurological, 
Psychiatric, 
Developmental, 
or Learning 
Difficulties 
 
Tower of 
Hanoi 
 
Welsh, 2000 
Anderson, et 
al., 1996 
Klahr et al., 
1981 
n = 200-
300 
 
Note: 
Individual 
Research 
Studies 
 
Varied 
 
Age 
Bands 
 
No Males 
Shown to 
Complete 
Task 
Quicker 
than 
Females 
Varied Not Reported No 
 
 
No Exclusion: 
Varied 
Trail Making 
Test 
 
Strauss et 
al., 2006 
Lucas et al., 
2005 
Kennepohl 
et al., 2004 
n = 100-
392 
 
Note: 
Meta-
norms 
Yes Age 
Bands 
No Females 
Shown to 
have 
Minimal 
Advantage 
Internation
al 
Lower Overall 
Scores are 
Associated 
with Black 
English 
Speakers 
No Yes Exclusion: 
Neurological, 
Developmental, 
or Psychiatric 
Disorders 
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Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Wechsler 
Abbreviated 
Intelligence 
Scale ADD 
INFO 
 
Wechsler 
Intelligence 
Scale for 
Children 3
rd
 
Edition 
 
 
 
 
 
 
n = 2200 
 
 
 
 
 
 
 
Yes 
 
 
 
 
 
 
Random 
Gender, 
Age, 
Parent 
Education 
 
 
 
 
 
 
 
No 
 
 
 
 
 
 
 
Female scores 
higher for Full 
Scale, Verbal, 
Performance 
 
 
 
 
 
 
31 states 
 
 
 
 
 
 
Black 
Scores 
shown to 
be less 
than 
Caucasian 
Peers 
 
 
 
 
 
 
No 
 
 
 
 
 
 
 
 
 
 
No 
 
 
 
Exclusion: 
(Special Group) 
Gifted, and 
Mental 
Retardation, 
Reading  
Canivez et 
al., 1999 
Wechsler , 
1997 
 
Wechsler 
Intelligence 
Scale for 
Children 4
rd
 
Edition 
 
 
Kaufman, et 
al., (2006) 
 
 
 
 
 
n = 2,200  
 
 
 
 
 
Yes 
 
 
 
 
 
Random, 
Stratified 
 
 
 
 
 
Yes 
FSIQ, 
Processing 
Speed 
 
 
Females 
scored higher 
on Coding  
 
Males   
Scored higher 
on 
Information 
and 
Arithmetic 
 
No significant 
differences in 
FSIQ 
 
 
 
 
 
4 
geographical 
areas 
covering 
United States 
and Hawaii 
 
 
 
 
 
Black 
Scores 
shown to 
be less 
than 
Caucasian 
Peers 
 
 
 
 
 
No 
 
 
 
 
 
No 
 
 
 
 
 
Disability, 
Reading and 
Written 
Expression 
Disorder, 
Learning 
Disorder, ADD, 
ADHD, 
Expressive 
Language 
Disorder,  Head 
Injury, Autistic 
Disorder, Motor 
Impairment: 
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Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Wechsler 
Memory 
Scale 
 
Wechsler, 
1945 
n = 200 
(adults) 
No Age Bands No Not Found Bellevue 
Hospital, NY 
 
Not 
Reported 
 
No No Inclusion: 
“Normal” Adults 
Woodcock 
Johnson 
Psycho-
Educational 
Battery 
 
Woodcock 
et al., 1977 
n = 3935 Yes Age Bands No Females Out 
Preformed 
Males on 
Subtests 
Related to 
Verbal 
Performance 
National 
 
Note: Rural N. 
Easterners 
and 
Southerners 
Under-
represented 
Scores 
shown to 
be less 
than 
Caucasian 
Peers 
 
No No Exclusion: Not 
Reported 
Woodcock 
Johnson 
Psycho-
Educational 
Battery III 
 
Woodcock 
et al., 2001 
n = 5972 Yes Random 
Community, 
and Individual 
Variables 
 
Note: Variables 
-Census 
Region, 
Community 
size, Sex, Race, 
Hispanic, Type 
of school, 
Adult 
Education, 
Occupation  & 
Status 
No 
 
 
 
Not Reported 100 
Geographic 
Regions in 27 
States 
Scores 
have been 
Shown to 
have 
Comparab
le 
meaning 
for African 
American 
and 
Caucasian 
groups 
No No Exclusion:  Less 
than One Year 
Experience 
English Speaking 
Classes 
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Measure 
& 
Reference 
Pediatric 
Sample 
Size 
Sample 
Representative 
of US Census 
Sample 
Stratified 
Ethnicity 
Stratified 
by SES 
Gender 
Effects 
Sample 
Geographic 
Diversity 
African 
American 
Cultural 
Effects 
Sample 
General 
Health 
Condition 
Reported 
Children 
Receiving 
Special 
Education 
Included 
 
Sample Criteria 
Woodcock 
Johnson 
Psycho 
Educational 
Battery 
Revised 
Woodcock 
et al., 1989 
n = 4359 Yes Age, Gender, 
Region, 
Community 
Size, and Race 
No Not Reported Communities 
Selected by 
Socio-
economic 
Variables in 
US 
Not Found No Yes Inclusion:  
Mainstreamed, 
Special 
Education, 
Handicapped 
Wisconsin 
Card Sorting 
Test 
 
Heaton et 
al., 1993 
n = 459 
 
 
No Age Bands No Not Reported 
 
Note: Larger 
Number of 
Males (58%) 
National Not 
Reported 
No No Exclusion: 
Neurological 
Dysfunction, 
Learning 
Disability, 
Emotional and, 
Attention 
Disorders 
Criteria used to evaluate the quality of the normative sample for executive function measure used to measure cognition in Pediatric SCD literature.
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Table 1.5. 
Studies by Type of SCD Morbidity  
 
Study 
Authors 
SCD Morbidity  
 Disease 
Severity 
 
Normal 
MRI 
SCD 
Status 
Silent 
Infarcts 
Cerebral 
Vascular 
Accident 
Abnormal 
TCD 
Results 
Berg et 
al.,2012 
 
  
X X X 
 
Children with SCD earned lower 
scores in the domains of 
metacognition and global 
executive function on the BRIEF 
compared to healthy 
demographically matched 
controls. 
Children with SCD performed w, 
initiation, organization, and 
completion on the CKTA. 
Children with SCD revealed 
signiﬁcant time differences for 
the Color-Word Interference 
test for all conditions except on 
DKFS except Naming Colors and 
the Sorting test. 
Bernaudin 
et al., 2000 
X X  X X X Children with SCD performed 
more poorly than siblings overall 
on WISC III Verbal IQ 
(Similarities, Comprehension, 
Digit Span), Performance IQ 
(Coding, Symbols), Processing 
Speed, and Full IQ.  
Children with SCD and overt 
stroke evidenced significant 
impairment on WISC III 
Performance IQ and Full Scale IQ 
compared to SCD with no 
history of stroke. 
Children with SCD and silent 
stroke performed poorer than 
children with no history of silent 
stroke for WISC III Similarities, 
Vocabulary, and Verbal 
Comprehension.  
Children with severely low 
hematocrit and those with 
thrombocytosis infarcts on 
magnetic resonance imaging 
evidenced poor scores on WISC 
III Verbal IQ, Performance IQ, 
and Full Scale IQ 
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Study 
Authors 
SCD Morbidity  
 Disease 
Severity 
 
Normal 
MRI 
SCD 
Status 
Silent 
Infarcts 
Cerebral 
Vascular 
Accident 
Abnormal 
TCD 
Results 
Brandling-
Bennett et 
al., 2003 
 X  X   Children with SCD and frontal 
infarcts performed more poorly 
on learning and free recall tasks 
of the CVLT-C.  
Children with SCD and frontal 
infarcts revealed lower 
performance on Children’s 
Memory Scale Backward Digit 
Span. 
Brown et 
al., 2000 
 X  X X  Children with SCD and no 
central nervous system 
pathology evidenced greater 
general performance than the 
SCD group with Silent Infarcts.  
Children with SCD and no 
history of central nervous 
system pathology evidenced less 
omission errors and data 
suggest there is a commission 
error trend on the Cancellations 
of As task. 
Children with SCD and localized 
frontal lobe lesions made 
significantly more omission and 
commission errors on the 
Cancellations of A’s task. 
Brown et 
al., 1993 
 X     Children with SCD evidenced 
greater errors on CPT than 
siblings. 
Children with SCD performed 
more poorly on K-ABC Reading 
Decoding and Bead Memory 
subtests than siblings. 
Older children with SCD 
performed worse B-VMI and 
MMFT than younger children 
with SCD. 
Cohen et 
al., 1994 
 
    X  Children with SCD and left 
cerebral infarcts showed greater 
impairment on the Full Scale IQ, 
VIQ, and PIQ of the WISC-R than 
children with SCD and right 
cerebral infarcts. 
Children with SCD and left 
cerebral infarct showed global 
impairment on WRAT and 
GORT, Wepman, and KABC 
Number Recall when compared 
to children with SCD and right 
cerebral infarcts. 
Children with SCD and left 
cerebral infarct demonstrated 
impairment on Picture Naming 
for the Boston Naming Test. 
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Study 
Authors 
SCD Morbidity  
 Disease 
Severity 
 
Normal 
MRI 
SCD 
Status 
Silent 
Infarcts 
Cerebral 
Vascular 
Accident 
Abnormal 
TCD 
Results 
Craft et al., 
1994 
 X  X X  Children with SCD and bi-frontal 
lesions evidenced quick 
disengagement at brief cue 
intervals and slower 
disengagement for lower 
intervals on the Covert 
Orienting Task. 
Children with diffuse lesions 
showed no lateralized effects 
and greater reaction time at 
brief cue delays on the Covert 
Orienting Task. 
Craft et al., 
1993 
 X  X X  Children with SCD and diffuse 
cortical strokes performed more 
poorly on WISC-R Block Design, 
Benton Visual Retention, and 
WJR Spatial Relations than both 
children with SCD and anterior 
stroke group and siblings. 
Children with SCD and anterior 
lesions had greater intrusions 
during list recall on the CAVLT 
than both children with SCD and 
diffuse stroke and siblings. 
There were no significant 
differences between children 
with diffuse or anterior lesions 
and siblings on Finger Tapping, 
WISC- R Vocabulary, and CAVLT.   
DeBaun et 
al., 1998 
   X X  TOVA, Wisconsin Card Sorting 
Test, and the CVLT identified 
children with SCD and Silent 
Cerebral Infarct. 
TOVA (95%) evidenced greater 
sensitivity (86%) and specificity 
(81%) ratings than all other 
measures (≥ 60%).  
TOVA also demonstrated great 
sensitivity (95%) for children 
with SCD and overt stroke 
Fowler et 
al., 1988 
 X     Children with SCD and no CVA 
evidenced no group differences 
for VIQ, PIQ, and Full Scale IQ 
from healthy peers on WISC-R.  
Children with SCD and no CVA 
demonstrated significant poorer 
performance than healthy peers 
on WISC-R Coding subtest. 
Children with SCD and no CVA 
performed more poorly on 
MFFT than healthy peers. 
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Study 
Authors 
SCD Morbidity  
 Disease 
Severity 
 
Normal 
MRI 
SCD 
Status 
Silent 
Infarcts 
Cerebral 
Vascular 
Accident 
Abnormal 
TCD 
Results 
Goonan et 
al., 1994 
  X    Children’s age contributed the 
greatest significance to 
predicted variance on CPT and 
MFFT performance. 
Younger children with SCD and 
no CVA showed poorer 
sustained attention on CPT and 
greater impulsivity on MFFT 
than older children with SCD 
and siblings. 
Kral et. al., 
2004 
     X Children in the abnormal TCD 
group demonstrated greater 
deficits in the areas of inhibitory 
control, problem-solving 
ﬂexibility, and modulation of 
emotional responses when 
compared to the conditional 
group, by parent observation 
(not significant).  
Teachers rated poorer 
performance for children with 
abnormal TCD findings in their 
ability to solve problems in 
working memory, plan and 
organize, as well as self-monitor. 
Kral et. al., 
2003 
     X Children with abnormal TCD 
values evidenced lower 
performance than children with 
conditional TCD values in areas 
of verbal intelligence and 
executive function. 
Puffer et al. 
2010 
  X    Height for age in children with 
SCD was shown to partially 
account for poor cognitive 
performance on the TOLD III 
Spoken Language Quotient, B-
DTVMI, KABC Hand Movements, 
WJ-III Decision Speed,  Memory 
for Words, Letter Word 
Identification, and Applied 
Problems. 
Children with SCD and a greater 
body-mass-index performed 
significantly better on B-DTVMI 
and WJ-III Letter Word 
Identification and Applied 
Problems than children with 
SCD and smaller Body-mass-
index. This result was not 
evidenced in healthy peers. 
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Authors 
SCD Morbidity  
 Disease 
Severity 
 
Normal 
MRI 
SCD 
Status 
Silent 
Infarcts 
Cerebral 
Vascular 
Accident 
Abnormal 
TCD 
Results 
Schatz, 
2004 
X      Children with SCD had greater 
difficulties with WRAT-3 Single-
Word Reading ability and 
Written Calculations than 
healthy peers.  
DKFS Digit Span–backward, 
WRAT-3 Single-Word Reading 
ability, and Written Calculations 
were valid predictors of 
functional education outcomes 
for children with SCD.  
Overall performance on 
cognitive measures was found 
to be a strong predictor for 
WRAT-3 Single-Word Reading 
ability and Written Calculations 
for children with SCD. 
Academic attainment was 
predicted by school absences 
related to SCD; however, 
academic achievement was not 
a significant predictor for illness 
related absences. 
Schatz et 
al., 2001 
 X  X   Children with SCD and silent 
cerebral infarcts demonstrated 
a greater incidence of being 
retained a grade level in school 
or receiving special academic 
services, having cognitive 
deficits and frontal lobe injuries 
than children with SCD without 
infarcts. 
Language: Differential Abilities 
Scales Word Definitions, Word 
Fluency, WJ-R Picture 
Vocabulary, Peabody Picture 
Vocabulary Test, or Rapid 
Automatized Naming, and 
Boston Naming Test.  
Visual-spatial/visual-motor: 
Differential Abilities Scales 
Pattern Construction, Judgment 
of Line Orientation, and WJ-R 
Visual Closure, or Wechsler 
Block Design and Purdue 
Pegboard.  
Memory: CVLT-C or WRAML 
Attention and Executive 
Functioning: Test of Variables of 
Attention, Wisconsin Card 
Sorting Task, and Perseveration 
and Intrusion errors on the 
CVLT-C, or Cancellation of A’s 
and the Trail Making Test.  
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Results 
Schatz et 
al., 2007 
X      Older children with SCD showed 
poorer performance in language 
skills on the Denver-II, VABS 
Communication, CDI Vocabulary 
and on the fine motor scales of 
the Denver-II and VABS Motor.   
Working memory performance 
on the Delayed Response was 
poorer in children with higher 
risk SCD when compared to 
lower risk SCD. 
Schatz et 
al., 2006 
    X  The corpus callosum of children 
with SCD and silent infarcts or 
overt stroke was smaller than 
children with SCD and no visible 
infarct or healthy peers. 
Lesion volume was a found to 
be a predictor of WISC-III Full 
Scale IQ, Verbal Comprehension, 
Perceptual Organization, 
Freedom from Distractibility, 
Processing Speed, DKFS Verbal 
Fluency, and Self-Ordered 
Pointing Test 
The corpus callosum rostral 
body size demonstrated robust 
prediction of performance on 
measures of WISC-III Processing 
Speed factor, DKFS Verbal 
Fluency, and the SOPT. 
Schatz et 
al., 2005 
  X    Children with SCD demonstrated 
poorer performance for WJ-R 
Oral Vocabulary, Incomplete 
Words, Visual Matching and 
Digit Span-Backward on the 
WISC than healthy peers. 
Children with SCD demonstrated 
deficits in auditory processing, 
on the WJ-R Incomplete Words, 
suggesting relation to WISC Digit 
Span-Backward performance. 
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Accident 
Abnormal 
TCD 
Results 
Schatz et 
al., 2004 
X      Children with SCD and greater 
anemia severity performed 
poorer on DKEFS Category and 
Verbal Fluency, WISC III Full IQ, 
WJ-R Digit Span Backwards, 
Spatial Relations, and Visual 
Matching. 
Anemia severity was shown to 
predict overall cognitive ability, 
crystallized ability, and 
processing speed for children 
with SCD. 
A bio-psychosocial interaction of 
anemia severity and SES was 
found to predict general 
cognitive ability and short-term 
memory performance. 
Schatz et 
al. 2004 
 X   X  Children with SCD and 
independent left or right 
cerebral injury demonstrate less 
efficient visual search for the 
contra-lateral visual field.  
Deficits in global-level 
processing measured by a task 
of divided hierarchical attention 
and coordinating spatial 
judgments assessed with 
Koenig, Reiss, and Kosslyn’s Task 
were associated with right-
hemisphere injury for children 
with SCD.  
Children with SCD and bilateral 
injury showed deficits in global-
level processing and coordinate 
spatial judgments as well 
however they also evidenced a 
disruption of visual search 
across visual fields. 
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Results 
Schatz et 
al. 1999 
 X  X   Children with SCD and anterior 
cerebral infarcts, diffuse 
cerebral infarct, and siblings 
preformed significantly worse, 
respectively, on  TOVA, Tower 
of Hanoi, Wisconsin Card Sorting 
Test, DAS Position, Visual Form, 
Shape Discrimination, Pattern 
Construction; Judgment of Line 
Orientation, and WJ-R Visual 
Closure. 
Children with SCD had generally 
lower scores on the Tower of 
Hanoi and TOVA compared to 
siblings. 
Volume of cerebral lesion was 
significantly related to 
performance on TOVA, Tower of 
Hanoi, WCST, CVLT-C, PPVT-R, 
and WJ-R Picture Vocabulary for 
children with SCD and anterior 
cerebral infarct. 
Steen et al., 
2005 
 X     Children with SCD and normal 
MRI showed significant deficits 
in WISC III Full-Scale IQ, VIQ, 
PIQ, Verbal Comprehension, 
Perceptual Organization, 
Freedom from Distraction, and 
Processing Speed compared 
with healthy peers.  
The performance of children 
with SCD and normal MRI 
decreased as a function of age 
for the WISC III Full Scale IQ, 
Verbal IQ, Verbal 
Comprehension, and Perceptual 
Organization. 
Steen et al., 
2003 
 X   X  Children with SCD and MRI 
abnormalities showed greater 
cognitive impairment than 
children with SCD and normal 
MRI in VIQ and Verbal 
Comprehension on WISC III.  
 Children SCD and low 
hematocrit demonstrated 
greater impairment than 
children with SCD and higher 
hematocrit on Full Scale IQ, 
Verbal Comprehension, and 
Freedom from Distractibility. 
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Results 
Steen et al., 
1999 
 X     Children with SCD and no CVA 
were found to be at a 23 fold 
increased risk of mild mental 
deficiency. 
Hematocrit of more than 27% in 
children with SCD was positively 
correlated with Full Scale IQ, 
Verbal Comprehension, 
Perceptual Organization, 
Freedom From Distractibility, 
and Processing Speed scores on 
WISC III. 
Hemtocrit of less than 27% was 
correlated with lower WISC III 
scores as well as T1 grey matter 
reductions in the caudate, 
putamen, and cortex regions of 
the brain. 
Swift et al., 
1989 
 X     Children with SCD and no CVA 
performed significantly poorer 
on DTLA-2 Memory for Words 
and Designs, WJ Math and 
Reading, and WISC-R VIQ, PIQ, 
Full Scale IQ. 
Children with SCD and no CVA 
along with healthy peers 
demonstrated that their WJ 
Math and Reading scores were 
commiserating with their WISC-
R VIQ, PIQ, and Full Scale IQ 
performance. 
Wang et 
al., 2001 
 
 X  X X  Children with SCD and normal 
MRI had significantly higher 
scores on WISC III Full Scale IQ, 
VIQ, PIQ, Digit Span, Coding and 
WJ-R Math/Reading compared 
to children with SCD with Silent 
Infarcts or Stroke. 
Children with SCD and Silent 
Infarct performed significantly 
better than children with SCD 
and Stroke on WISC III Full Scale 
IQ, VIQ, PIQ, Digit Span, Coding 
and WJ-R Math/Reading.  
WISC III Verbal IQ, WJ-R Math 
Achievement, and WISC III 
Coding scores demonstrated 
decline with increasing age of 
the child with SCD. 
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Results 
Watkins et 
al., 1998 
 X  X X  Children with SCD and normal 
MRI demonstrated higher FSIQ, 
Digit Span, Coding, Picture 
Arrangement, and Symbol 
Search scores on WISC-III. 
A trend was evident for children 
with SCD and normal MRI 
suggesting greater performance 
on VIQ, PIQ, and FSIQ than SCD 
and CVA. 
Children with SCD and CVA 
demonstrated poorer 
performance overall on WISC-III 
compared to SCD and normal 
MRI and siblings. 
Children with SCD and CVA 
generated more perseverative 
errors on Wisconsin Card 
Sorting Test and had poorer 
performance on WMS Logical 
Memory, Visual Memory, and 
Paired Association Learning. 
White et 
al., 2006 
 X  X   CVLT-C List A recall over 5 
presentations was the most 
robust predictor for 
discriminating between children 
with SCD and silent infarct vs. no 
history of infarct. 
Block Design from the WAIS was 
the second best predictor of 
silent infarct in children with 
SCD. 
Together CVLT-C and Block 
Design from the WAIS 
demonstrated 75%, 75% 
sensitivity and 76% specificity 
for identifying children with SCD 
and silent infarct from children 
with SCD without silent infarct. 
 
Schatz J, Craft S, Koby M, et al. (2004). Asymmetries in visual-spatial processing following childhood stroke. Neuropsychology, 18, 340–352. 
 
 Schatz, J., Finke, R.L.,Roberts, C.W. (2004). Interactions among biomedical and environmental factors in cognitive development: A preliminary study of 
sickle cell disease. Journal of Developmental and Behavioral Pediatrics, 25, 303–310. 
 
 Schatz J, Craft S, Koby M, et al. (2004). Asymmetries in visual-spatial processing following childhood stroke. Neuropsychology, 18, 340–352. 
 
 Schatz, J., Finke, R.L., Kellett, J.M., & Kramer, J.H. (2002). Cognitive functioning in children with sickle cell disease: A metaanalysis. Journal of 
Pediatric Psychology, 8, 739–748. 
 
 Schatz J, Craft S, Koby M, et al. (2004). Asymmetries in visual-spatial processing following childhood stroke. Neuropsychology, 18, 340–352 
 
b Schatz, J., Finke, R.L.,& Roberts, C.W. (2004). Interactions among biomedical and environmental factors in cognitive development: A preliminary 
study of sickle cell disease. Journal of Developmental and Behavioral Pediatrics, 25, 303–310. 
 
Note: Research studies which utilize cognitive measure that evidence measurement sensitivity to 
neurologic damage associate with pediatric SCD. 
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CHAPTER II 
RESEARCH QUESTIONS AND HYPOTHESES 
 The development of the EXAMINER, a neuropsychological assessment battery 
that intended to supplant established cognitive measures such as the WJ-III and the 
BRIEF, is potentially important for more accurate EF assessment of children with SCD.  
Similar to the WJ-III, this newly developed measure includes subtests which evaluate the 
narrow domains of ability. However, these measures have been chosen to represent well 
established measures of EF, with known neural underpinnings and often used subtractive 
factors logic so that both overall performance and narrower abilities can be identified.  
Similar to the BRIEF, component tests can be combined to assess broader cognitive 
domains.  As a new battery, it is not expected that the EXAMINER can match the WJ-III 
or the BRIEF in the area of a large, representative normative sample; however, if other 
features of the battery are shown to be promising, this expensive process could be 
implemented at a later point in time. 
 Three specific research questions will be addressed in this study: (1) Will the 
psychometric qualities of the EXAMINER meet or exceed the WJ-III standards based on: 
the structure of the test, target age range, reliability (internal consistency), size of 
normative sample, and quality of normative sample for children with SCD? (2) What is 
the extent of cross-cultural validity for the EXAMINER? (3) Does the EXAMINER 
demonstrate similar criterion validity as other well-established measures, such as the WJ-
III, to detect Sickle Cell related cognitive deficits? 
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Study Hypotheses 
Goal 1: Evaluate traditional psychometric properties of the EXAMINER relative 
to the WJ-III.   
Hypothesis 1:  The reliability (internal consistency) of the EXAMINER will be 
equivalent to the WJ-III for use in pediatric SCD, including the reliability for youth tested 
across multiple sites, local demographic controls, and youth with SCD. 
The EXAMINER will be administered to a heterogeneous sample of children 
across multiple sites, a local demographic comparison group for our SCD sample, and a 
group of children with SCD in conjunction with selected measures from the WJ-III. The 
purpose of this comparison is to evaluate the reliability for the EXAMINER battery.  It is 
hypothesized that the EXAMINER will be equivalent to the WJ-III on the demonstration 
of high internal consistency.  The EXAMINER will also demonstrate better 
appropriateness for this population due to its inclusion of a special developmental sample 
of children with SCD (from this proposed study) supporting reliability within this clinical 
group.   
Goal 2: Evaluate evidence of the cultural validity of the EXAMINER for African-
Americans with SCD by comparing African-American youth relative to White youth on 
measures of convergent validity. 
Hypothesis 2A: The strength of association between EXAMINER scores and VIQ 
from the WJ-III will be similar for African American and White children. 
Hypothesis 2B: The strength of the association between the validity coefficient for 
the BRIEF Behavioral Regulation, Metacognition, and Global Executive Composite and 
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the EXAMINER executive composite, working memory factor, cognitive control factor, 
and fluency factor scores will be similar for African American and White children.  
It is plausible that the EXAMINER will demonstrate similar or greater cultural 
validity for the WJ-III and BRIEF. The developers of the EXAMINER selected, 
developed, and piloted methods of assessment including neuropsychological tests, 
computer-administered tasks, and behavioral observation techniques with an a priori goal 
to develop measures that could be applied widely to individuals across ages and 
ethnicities.  In addition, tasks were designed to minimize the need for specific cultural 
knowledge or specific linguistic knowledge that often is a source of bias in cognitive 
testing.  Furthermore, the developers of the EXAMINER appropriately field tested and 
modified forms of tests and administration procedures for test takers. These modifications 
were made as developers received feedback from the national field testing sites that 
accommodations were necessary for standardization.  
Goal 3: Establish the sensitivity (criterion validity) of the EXAMINER to SCD-
related cognitive deficits. 
Hypothesis 3A: Children with SCD at high risk for disease-related cognitive 
effects will show significantly poorer performance on the EXAMINER than 
demographically matched control children without SCD.   The effect size of these 
differences will be compared to the magnitude of group differences on selected WJ-III. 
Hypothesis 3B: The EXAMINER will show at least as high of sensitivity and 
specificity in identifying high risk children with sickle-cell disease as the selected 
measures from the WJ-III relative to the local, demographically matched comparison 
group.   
  
93 
 
 
 
  
 
  
It is believed that the degree of differences for the effect sizes of the 
EXAMINER, when compared with that found for established measures of cognitive 
functioning such as the WJ-III, will be similar or greater. With comparable criterion 
validity, the EXAMINER could be a preferred measure for clinical outcome studies 
(particularly treatment studies) given that the measures are based on well-established 
brain-behavior relationships, allows for both narrow and broad cognitive abilities to be 
measured, and specifically measures EF, a construct rooted in measuring higher-level 
cognitive skills that are essential for adaptive functioning.  
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CHAPTER III 
METHODS 
Participants 
Clinical research participants were children who voluntarily took part in the 
EXAMINER national project (Kramer, Mungas, Possin, Rankin, Boxer, Rosen, 
Widmeyer, 2014). Overall, 396 children without a known neurologic condition (8 to 18 
years of age) completed the study. One hundred and seventeen of these children, SCD 
and demographically matched controls, were recruited from a local catchment area 
surrounding Columbia, South Carolina.  The overall sample for the multisite study 
contained 279 youth identifying as White who matched the age range of the local 
African-American children without known neurologic conditions. At the University of 
South Carolina site, 32 children diagnosed with SCD participated in the investigation. 
The 85 control participants were demographically matched on race and age for children 
for the SCD sample who voluntarily participated in the study from after school, summer, 
church, and community programs in the Columbia, SC area.   
SCD subjects were a group of children diagnosed with high risk SCD (HbSS or 
HBSβ0).  Children with known neurologic histories were included given the purpose of 
the study, though participants with severe sensory or motor deficits as judged by the 
treating hematologist were not recruited.  Of the total SCD participants (n = 32), 56.3% 
were male (n = 18) and 43.8% were female (n = 14). The mean age of the SCD sample 
was 12.7 years (SD = 3.2). All local respondents self-identified as African American
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ethnicity (N = 85), mean age 12.8 years (SD = 2.53). The local control sample was also 
relatively equally balanced for gender, 46.3% were male (n = 39) and 53.7% were female 
(n = 46).  The multi-site sample (N = 279), contained participants which self-identified as 
White, mean age 11.2 years (SD = 2.9). Similar to the SCD and local control samples, the 
non-neurologic sample was comprised of 47.0% male (n = 133) and 53.0% female (n = 
146). Fisher’s Exact test indicated no differences across race/ethnicity groups for gender 
(p = .804).  Socioeconomic (determined by parent age, education, income, number of 
children and adults in the home) information was also obtained for the University of 
South Carolina site participants. Unfortunately, this data was to have been collected from 
children at other sites, but was missing as described below. 
General Inclusion/Exclusion Criteria 
For the overall EXAMINER project there were a set inclusion/exclusion criteria 
across sites.  Most of these criteria; however, were more relevant to adult neurologic 
conditions. General systemic medical conditions were exclusionary only if additional 
medical conditions were present besides the target condition, as with SCD.  Participants 
had to be between 3-90 years old and speak fluent English and/or Spanish. Subjects who 
were unable to consent for themselves required an informant to consent for them.  
General exclusion criteria were current alcohol abuse or dependence, current drug abuse, 
psychiatric disorder (apart from those specified in diagnostic groups of interest),  
B12 deficiency or other metabolic syndrome, hypothyroidism (i.e. TSH>150% of 
normal), known HIV, renal failure, respiratory failure (i.e. requiring oxygen), significant 
systemic medical illnesses (e.g. deteriorating cardiovascular disease), or current 
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medication likely to affect CNS functions (e.g. benzodiazepines, antidepressants, lithium, 
and/or neuroleptics in the phenothiazine and haloperidol families).  
Procedure 
All procedures were approved by university and hospital institutional review 
boards and by the administrations of the schools and programs involved. Informed 
consent and assent were obtained from caregivers and children. The children diagnosed 
with SCD were recruited from Palmetto Health Children’s Center for Cancer and Blood 
Disorders. Scheduling conflicts were most often cited as the reason for participation 
refusal. Children diagnosed with SCD with history of stroke or major developmental 
disabilities were excluded from analyses based on medical record review.  Children 
experiencing any acute SCD complications did not participate in the investigation and 
were rescheduled at their next routine visit.  
Neuropsychological assessment was conducted by a graduate student or trained 
undergraduate student under the psychologist’s supervision.  The data were collected via 
questionnaires with parents and one-on-one testing with the child.  Parent questionnaires 
and BRIEF-Parent Form were collected and EXAMINERs were stationed nearby to 
address any parent questions or available to help the parent if questions arose. Children 
diagnosed with SCD were typically assessed after their routine care from the 
hematologist.  Order of test administration was in a fixed order across the study. 
EXAMINERs were blind at the time of testing to disease-related measures (e.g., extent of 
SCD complications) and socioeconomic status, but not group diagnostic group (SCD vs. 
without SCD).  Each child completed the EXAMINER and WJ-II administered in a 
single, 90- to 120-minute session. Compensation for participation involved the families 
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receiving monetary compensation (both parent and child) and SCD participants’ data for 
clinically informative cognitive measures was shared with the hematologist. 
The comparison group was recruited from the same general community to match 
the sample with SCD in terms of age, gender distribution, ethnicity, and SES. Caregivers 
were asked to enroll children in the study through telecommunications, electronic 
correspondence, and face to face contact at program sites. These sites consisted of local 
schools, after-school, summer, community, and church programs providing academic 
enrichment and leisure activities for children. Children with chronic health conditions or 
developmental disabilities were excluded from participation (based on parent report on a 
demographic survey). Demographically matched children also did not participate in the 
investigation during a time when they were experiencing acute illness. 
Children without SCD were assessed at the end of their school day when the 
academic year was in session and various times of day during breaks from school. These 
participants were also assessed in a fixed order across the study. Parent report measures 
were completed by caregivers prior to study participation. Standardized procedures were 
utilized as described in the EXAMINER training manual.  
Measures 
Medical History 
Medical chart reviews were conducted for all children with SCD to collect disease 
subtype. In addition, history of SCD complication (e.g. stroke, splenic sequestration) was 
reviewed to asses’ inclusion/exclusion criteria for this study. 
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Socioeconomic Status 
At our local site, demographic information was collected pertaining to age, 
gender, ethnicity, and the presence or absence of medical/psychiatric illness, or learning 
disability from participant’s caregivers. Descriptive informative was also collected 
regarding age, gender, ethnicity, education, yearly household income, and household size 
from parents of participants. Household income data were collected in the following 
manner: less than $10,000 was recorded as Level One, $10,000 - $20,000 was recorded 
as Level Two, $20,000 - $30,000 was recorded as Level Three, $30,000 - $40,000 was 
recorded as Level Four, and more than $40,000 was recorded as Level Five. Parental 
education was recorded according to years of education and categorized: less than ninth 
grade recorded as Level One, ninth through eleventh grade recorded as Level Two, high 
school diploma/GED recorded as Level Three, Some college/Associates degree recorded 
as Level Four, and college degree/Bachelors or higher recorded as Level Five. 
Unfortunately, detailed demographic information was not collected at all sites in the 
overall study.  It was intended for each of the 11 sites to collect parent education 
information for child participants. However, due to investigator error, education was only 
collected for adult participants. Therefore, we had access to information about age, 
gender, and race for children entered at other sites  
Neuropsychological Assessment Tools 
An experimental cognitive measurement test, the EXAMINER, WJ-III, and 
BRIEF-Parent Form were selected for use in this study to best capture EF in children 
with SCD.  
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Brief-Parent Form 
The BRIEF-Parent Form is a parent questionnaire, created to measure the 
expression of the child’s behaviors related to executive function. More specifically, it was 
included in this study to assess the observed cognitive abilities for a broad range of 
children ages 5–18 in the school and home environments.  It was normed on the child 
ratings from 1,419 parents and has Eight theoretically derived clinical scales: Inhibit, 
Shift, Emotional Control, Initiate, Working Memory, Plan/Organize, Organization of 
Materials, and Monitor. These scales form two broader Indexes: Behavioral Regulation 
and Metacognition were reviewed. An overall Global Executive Composite score, which 
depicts overall executive function, was also calculated from the clinical scales to provide 
a greater understanding of cognitive abilities for this population. Two validity scales: 
Inconsistency and Negativity were evaluated for each respondent. Gioia, Isquith, Guy, 
and Kenworthy (2000) reported high internal consistency (alphas = .80-.98) and test-
retest reliability (rs = .82) for this measure. 
 Parents of participants were asked to complete an 86 items paper and pencil form. 
Each parent was asked to indicate if the behavior described in each item was never a 
problem, sometimes a problem, or often a problem for the child.  
EXAMINER 
 The EXAMINER is a newly developed neuropsychological test battery that 
purports to reliably and validly assess domains of EF, across a wide range of disorders 
which impact cognition (Kramer et al., 2014). The test was designed largely using 
Miyake’s unity and diversity model of EF with the expectation of capturing a global 
measure of executive function and more discrete component measures.  A combination if 
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Item Response Theory (IRT) and factor analytic methods were used to extract useful 
factor scores from a set of well-established EF measures used in non-clinical contexts.  
This novel neuropsychological battery has components specifically designed to measure 
narrow domains of EF (e.g., attention, set shifting, inhibition, fluency, planning, problem 
solving, and abstract reasoning). Normative data has been derived from national 
standardization, involving children and adults between the ages of 5 and 89 years of age, 
including subjects with clinical syndromes known to impact cognition. Theoretically 
derived tasks were designed to measure narrow domains of EF; which include attention, 
set shifting, inhibition, fluency, planning, problem solving, and abstract reasoning.  
Performance on the EXAMINER tasks is used to inform fluency, cognitive control, and 
working memory factor scores, as well as an overall composite score. The fluency factor 
score is constructed from the total correct responses for 2 trials of Phonemic Fluency and 
2 trials of Category Fluency tasks. The cognitive control factor score is comprised of the 
total Flanker score, total Set Shifting score, anti-saccade total, and total dysexecutive 
errors on the Continuous Performance Task. The Working Memory factor is comprised 
of total correct responses for the Dot Counting task along with the total correct and d-
prime scores for the n-back task.  Each task of EF includes aspects from multiple 
domains however for the purposes of illustrating the experimental procedures; the tasks 
are categorized accordingly below. 
Fluency Tasks 
Fluency refers to the ability to avoid response repetition while using strategies 
that maximize the formation of responses (Ruff, Allen et al. 1994).  
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Verbal Response Set 
Verbal – Phonemic: Participants were instructed to say as many words as possible 
from a category in a given time (60 seconds). This category included 2 phonemic tasks, 
such as words that begin with letter L. Number of correct responses, repetitions, and rule 
violations were recorded.   
Category – Animals: Participants were instructed to say as many words as 
possible from a category in a given time (60 seconds). This category included 2 semantic 
tasks, such as animals. Number of correct responses, repetitions, and rule violations were 
recorded. 
Attention Tasks   
Random Number: Participants were instructed to say numbers randomly from 0-9 
until they reached 100 numbers. Total number of errors, strategies utilized, and prompts 
for randomness were recorded. This task was later dropped from the final battery for 
psychometric reasons. 
Paper and Pencil Response Set 
Design – Empty Dots: Participants were instructed to draw as many designs as 
possible with 4 straight lines, connecting empty dots only. They were told to complete 
this task as fast as they could, without touching any filled dots. The given time was 60 
seconds. Rules for the second task were then modified such that participants were 
instructed to draw as many designs as possible alternating between connecting empty and 
filled dots in 60 seconds. They were also told to complete this task as fast as they could, 
without touching any filled or unfilled dots outside their designs. This task was dropped 
later from the final battery for psychometric reasons. 
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Planning, Problem Solving, and Abstract Reasoning Task  
Planning is the ability to divide an objective into the individual components 
necessary to achieve the goal (Lezak, Howieson et al. 2004). Therefore effective planning 
requires a multitude of simultaneous processes, including sustained attention, abstract 
thinking, temporal sequencing, problem solving and reasoning (Norman and Shallice, 
1986). 
Unstructured Task: Participants were given 6 minutes to earn as many points as 
possible by accurately completing puzzles. Each puzzle was worth a specific amount of 
points, which was randomly associated with difficulty levels. They were given 3 booklets 
of puzzles and each booklet contained an equal sum of points. The number of high and 
low value puzzles that were accurately completed and the total number of points earned 
was recorded.  This task was later dropped from the final battery for psychometric 
reasons. 
Computer Response Set 
Working Memory and Inhibition Tasks  
Working memory is the ability to actively hold numerous pieces of information, 
for the execution of both verbal and nonverbal tasks, and subsequently retrieve them for 
further information-processing (Becker & Morris, 1999). On the other hand, inhibition is 
the ability to deny a response or suppress irrelevant or intrusive stimuli. Inhibition has 
been shown to have both "cognitive" and "behavioral" components (Chamberlain, 
Blackwell et al. 2005). 
Flanker: Participants were shown a series of arrows, pointing to the left or right. 
They were instructed to press the left arrow key if the central arrow points to the left and 
  
103 
 
 
 
  
 
  
press the right arrow key if the central arrow pointed to the right. The target was flanked 
by arrows which correspond either to the same directional response as the target or to the 
opposite response. Response times for congruent and incongruent stimuli are recorded. 
Dot Counting: Participants were shown a series of images containing blue circles, 
green circles, and blue squares. They were instructed to count the number of blue circles 
out loud on each screen, repeat the final number out loud, and remember that number. 
After a number of displays they were presented with screen containing question marks 
and expected to repeat the final numbers counted for each screen.   
Set Shifting 
Set shifting is the ability to concurrently or alternately engage in two different 
tasks (Crossley, Hiscock et al. 2004).  
Set Shifting Task: Participants were shown a picture in the middle of the screen, 
and a word at the bottom of the screen. They were instructed to match the picture by 
shape or color with the objects in the corners of the screen. The word at the bottom of the 
screen told the subjects how to match the picture in the middle of the screen. When they 
matched the picture by color, they were instructed to push the left arrow key. When they 
matched the picture by shape they were instructed to push the right arrow key. Response 
times for accurate and inaccurate responses were recorded.     
Attention 
Attention is the ability to process selected information to the exclusion of others, 
in the service of achieving a goal. (Cohen, 2004) 
Continuous Performance Task/Go-No-Go: Participants were presented with a 
number of shapes on the screen, one at a time. If a 5 pointed star appeared, they were 
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instructed to press the left arrow key. If any other shape appeared, they were instructed to 
not press any key. Response times for accurate and inaccurate responses were recorded.     
1-Back: Participants were instructed to remember the location of the square that 
appeared on the screen, so that they could compare that location with the location of the 
next square that appeared on the screen. If the location was the same as the square before, 
they were told to push the left arrow key. If the location was different than the location of 
the square before, they were told to press the right arrow key. Response times for 
accurate and inaccurate responses were recorded.     
Saccades (Go-No-Go): Participants were instructed to look at the center of the 
computer screen. They were instructed to move only their eyes in the direction that the 
dot moves on the screen or the opposite direction that the dot moves on the screen, 
depending on the trial. The total correct initial eye movements were recorded. 
Final EXAMINER Scores  
Using a combination of IRT methods and confirmatory factor analytic methods 
the final EXAMINER structure yielded both a one-factor and a three-factor organization 
that both showed strong support from factor analysis (Kramer et al., 2014).  Eleven key 
variables from the battery (only 10 of these were used for children) were used to generate 
an overall Executive Function Composite score based on all of these variables and three 
specific factors: Fluency (based on total scores for Verbal Fluency and Category Fluency 
tests), Cognitive Control (based on four scores from the Flanker Test, Set Shifting test, 
anti-saccade test, and total dysexecutive errors), and Working Memory (based on four 
scores from N-back tests and the Dot Counting test in adults and three scores in children 
due to difficulties with 2-back version of the N-back test).  
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Given the use of IRT to measure factors with fewer items, test-retest reliability 
was chosen as the primary measure of reliability in the initial test development.  The 
more traditional approach of internal consistency, assessed with Chronbach’s alpha, is 
highly sensitive to the number of items in the scale. Therefore, test-retest reliability was 
assessed in 122 normal adult controls at an average interval of 25 days.  The Executive 
Composite factor showed a test-retest reliability of r = .93.  For the Fluency, Cognitive 
Control, and Working Memory factors the test-retest reliability was .88, .88, and .78, 
respectively. 
 The EXAMINER factor and composite scores represent the sums of weighted 
scores from the variables and are on an equal-interval scale. Each unit represents equal 
changes in ability across the scale. Scores are not age corrected.  
Woodcock Johnson Tests of Cognitive Abilities 3rd edition 
The WJ-III is designed to assess the CHC factors. It was normed on national 
sample of 4,783 children and 4,035 adults. The WJ-III was included in this investigation 
to assess verbal comprehension and knowledge, processing speed, and working memory 
as these measures have shown the most consistent and robust effects for SCD-related 
deficits. Picture Vocabulary, Synonyms, Antonyms, and Verbal Analogies are 
components within the Verbal Comprehension subtest. This subtest provides an 
assessment of comprehensive-knowledge. This subtest requires an individual to identify 
objects, provide knowledge of antonyms, and complete verbal analogies. Visual 
Matching is a subtest which provides a greater understanding of processing speed. 
Rapidly locating and circling identical numbers from a defined set of numbers, within a 
predetermined amount of time (3 min), is necessary for completion of this task. The 
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primary broad factor assessed by the Numbers Reversed subtest is Short Term Memory. 
The subject is instructed to hold a span of numbers in immediate awareness while 
verbally reversing the sequence. These subtests were given to create a greater 
understanding of the specific cognitive abilities for this population.  The processing speed 
and short-term memory subtests are components of cognitive efficiency. Reliability 
coefficients indicate adequate to high reliability (.78 to .90) with children for all 3 
subtests,  
WJ-III tasks were scored according to the test manual. WJ-III raw scores and age-
adjusted standard scores were mathematically transformed using the W scale, which is a 
data transformation used in clinical research and practice. The W scale score was created 
by converting raw scores such that they representing ability level with a center on a value 
of 500, which is set approximately at the average performance of children 10.0 years of 
age analysis (Woodcock et al., 2001). Each unit is meant to represent a similar change in 
ability level across the scale. The W metric from the WJ-III is most similar to the scaling 
of the EXAMINER factor scores and permitted the most direct comparison of both 
cognitive measures.  
 107 
 
 
  
  
CHAPTER IV 
STATISTICAL ANALYSIS PLAN 
 
Hypothesis 1:  The reliability (internal consistency) of the composite scores for 
EXAMINER will be equivalent to the WJ-III for use in pediatric SCD, including the 
reliability for youth tested across multiple sites, local demographic controls, and youth 
with SCD. 
Internal consistency scores for the EXAMINER variables will be compared to the 
WJ-III measures by assessing the magnitude of difference between the two correlation 
values (Papoulis, 1990).  WJ-III internal consistency scores will be for the 8-18 year olds 
in the normative sample who endorsed race as White or African American.  Due to the 
construction of the final EXAMINER, the Executive Composite was used as the primary 
measure to examine the internal consistency of the measure across White and African-
American participants.  Due to differences in the age distribution between these two 
groups, twenty eight- or nine-year-old children were dropped from the White sample to 
create a better match of the two age distributions.  The cases excluded were chosen at 
random using an on-line software program to select twenty cases from the total number 
of cases in this age range.   In addition, there was 3.4% missing data for children included 
in the final analyses.  I used mean substitution for missing data to allow for more cases to 
influence the reliability estimates.  Imputation procedures are preferred in most cases for 
addressing missing data; however, in this context imputation would artificially increase 
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the internal consistency scores.  All variables were centered with a mean of zero and 
standard deviation of one before computing internal consistency. 
In the comparison of the internal consistency scores, the alpha value (which is 
essentially an intraclass correlation value among items) was compared using methods that 
compare two correlation values from separate samples.  The two correlation coefficients 
are transformed with the Fisher r-to-z-transform and the probability for the magnitude of 
the difference between these two values can be computed (Lowry, 1998).   
There are potential concerns about what is an adequate sample size for computing 
a stable internal consistency score.  Many experts have recommended sample sizes of 
200-300 as a minimal requirement (Peterson, 1994; Kline, 1986; Nunnally and Bernstein, 
1994; Segall, 1994; Charter, 1999). Recent literature has indicated that the sample size 
needed for a stable measure of internal consistency is dependent on how unidimensional 
the items are in the scale (Yurdugul, 2008).  This work provides estimates of sample sizes 
needed for stable measurement of alpha based on the magnitude of the first eigen value 
from principle components analysis of the scale items.  Therefore, a principle component 
analysis was run with the healthy control sample to determine the first eigen value for the 
ten items used to compute the EXAMINER factor scores.    
Hypothesis 2A: The strength of association between EXAMINER executive 
composite, working memory factor, cognitive control factor, and fluency factor and VIQ 
from the WJ-III will be similar for African American and White children. 
Hypothesis 2B: The validity coefficient for the BRIEF Behavioral Regulation, 
Metacognition, and Global Executive Composite and the EXAMINER executive 
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composite, working memory factor, cognitive control factor, and fluency factor scores 
will be similar for African American and White children. 
These hypotheses test the similarity in convergent validity across the two samples.  
The statistical tests will be calculated by comparing the magnitude of the two correlation 
values as described with Hypothesis 1, above.   
Hypothesis 3A: Children with SCD at high risk for disease-related cognitive 
effects will show significantly poorer performance on the EXAMINER than 
demographically matched control children without SCD.   The effect size of these 
differences will be compared to the magnitude of group differences on selected WJ-III. 
Hypothesis 3B: The EXAMINER executive composite, working memory factor, 
cognitive control factor, and fluency factor will show at least as high of sensitivity and 
specificity in identifying high risk children with sickle-cell disease as the selected 
measures from the WJ-III relative to the local, demographically matched comparison 
group.   
This aim will be evaluated by comparing the area under the curve using receiver 
operating characteristic (ROC) curves for each of the EXAMINER and WJ-III variables 
using the Statistical Package for Social Sciences software, version 22 (SPS-22).  In 
previous work in SCD and other clinical conditions, sensitivity and specificity of 
measures has often been evaluated with cut-off scores that mimic the process often used 
in clinical practice, such as setting rules for the number of tests and the magnitude of 
difference (often 1.5 or 2.0 standard deviation units from age expectation) for indicating a 
positive test.  However, I decided that this type of approach would be premature in 
working with the current version of the EXAMINER. The current EXAMINER version 
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does not contain age-adjusted scores and typically a large normative database would be 
used for establishing cut-off scores. 
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CHAPTER V 
RESULTS 
Hypothesis One:  The reliability (internal consistency) of the EXAMINER will be 
equivalent to the WJ-III for use in pediatric SCD, including the reliability for youth tested 
across multiple sites, local demographic controls, and youth with SCD. 
Descriptive Statistics 
Prior to performing the statistical analyses, data were analyzed by SPSS-22 to 
detect the presence of outliers and the possible influence over variable relationships. 
Examination of histograms, independent samples t-tests, and chi-square analyses were 
performed to examine whether there were significant differences between the study 
groups.  Normality was tested using the Shapiro – Wilk test. Overall, these procedures 
revealed no significant violations of normality, however a significant statistical age 
difference was found between the SCD group with White comparison in the final sample 
used, t(362) = 4.94, p < .001. The mean age of the SCD group (M = 12.8, SD = 2.5) was 
higher than White comparison group (M = 11.2, SD= 2.9), see Table 5.1.  However, the 
overall age distribution (8-18 years), variance in age, and shapes of the distribution were 
highly similar across the two groups.  Dropping additional cases to create a closer mean 
age was viewed as throwing away data and decreasing the reliability of the internal 
consistency estimates.   
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Internal Consistency 
The reliability literature suggests that sample sizes should range from 200-500 to 
calculate a more precise estimate of coefficient alpha (Peterson, 1994; Kline, 1986; 
Nunnally and Bernstein, 1994; Segall, 1994; Charter, 1999).  However, a recent 
investigation reveals that a sample size of 100 is adequate to produce a sufficiently 
unbiased estimator of coefficient alpha if the first eigenvalue is between 3.00 and 6.00 of 
the sample data set (Yurdugul, 2008).  The principle components analysis of the 10 
EXAMINER variables yielded an eigen value of 4.1 for the one-factor model, indicating 
the sample sizes in this study were likely to yield moderately to highly stable internal 
consistency estimates for this measure in the White and African-American samples.  
Using standard eigen value and scree plot rules, the principle components analysis also 
indicated a three-factor solution is appropriate, as found in the overall development of the 
EXAMINER battery, which used both exploratory and confirmatory factor analytic 
methods. The second and third factors had eigen values above 1 (1.3 and 1.2) and the 
scree plot showed a natural break in the curve with a relatively flat (horizontal) line after 
plotting the third factor.  
Internal consistency of the EXAMINER and WJ-III were evaluated for 
Cronbach's alpha to assess the magnitude of difference between SCD and comparison 
groups. Internal consistency reliability values for 10 EXAMINER tasks were calculated 
to identify a consistent response pattern across the tasks, see Table 5.2. Although the 
EXAMINER contains 11 cognitive tests, the 2-back task was not relevant for this 
analysis. This sub-test of the N-back was only administered to the adult norming group. 
Results revealed the following Cronbach’s alpha scores for the EXAMINER: White 
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control group, α = .84 (n = 279), African American comparison group, α = .81 (n = 85), 
SCD group, α = .84 (n = 32). Reliability coefficient data for the WJ-III was obtained 
from Woodcock et al., (2001) using the mean internal consistency score: Verbal 
Comprehension, α = 0.91 (n = 3549, SEM = 4.40), Visual Matching, α = 0.88 (n = 3719, 
SEM = 5.15), and Numbers Reversed, α = 0.86 (n = 3337, SEM = 5.53).  
Significance of Difference between Cronbach’s Alpha Coefficients 
Analyses were conducted to assess the significance of the difference between 
internal consistency coefficients. Chronbach’s alpha scores for the SCD and comparison 
groups were then transformed into Fisher Z scores and the probability for the magnitude 
of the difference between the values was computed, with a two-sided test. These findings 
suggest statistically significant differences between reliability coefficients for the 
EXAMINER Composite values for White and Black youth on the WJ-III verbal 
comprehension and visual matching measures, see Table 5.3. Comparing reliability 
values from the EXAMINER to the WJ-III, for the White sample, reveal the following 
findings: verbal comprehension, (z = -4.9, p = .00), visual matching, (z = -2.48, p = .01), 
numbers reversed, (z = -1.15, p = -.25). Results for the WJ-III reliability scores compared 
to the EXAMINER composite, for the African-American sample, were as follows: verbal 
comprehension, (z = -3.59, p = .00), visual matching, (z = -2.23, p = .03), numbers 
reversed, (z = -1.49, p =.14).  In addition, analyses of the alpha reliability data between 
EXAMINER composite and WJ-III reliability coefficients for the SCD group reveal no 
significant differences between values: verbal comprehension, (z = -1.64, p = .10), visual 
matching, (z = -0.83, p =.41), numbers reversed, (z = -0.39, p =.70).  
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 For descriptive purposes, internal consistency scores were also computed for the 
specific EXAMINER factors, which indicated a generally similar pattern.  There were not 
significant differences evident across race/ethnicity groups, as a test of potential cultural 
differences in the validity of the measures. However, the internal consistency values were 
lower than found for the WJ-III.  The EXAMINER Fluency factor is based on the two 
fluency scores found in the EXAMINER composite variable.  The alpha coefficient was 
.61 for the White sample, .65 for the African-American sample, and .68 for the SCD 
sample.  The Working Memory factor was based on the variables from the Dot Counting 
and N-back tests (n = 3 variables) and showed an alpha of .76 for the White -sample, .72 
for the African-American sample, and .63 for the SCD sample.  Finally, the remaining 
variables are part of the EXAMINER Cognitive Control factor (n = 5 variables) and 
showed an alpha of .80 for the White sample, .78 for the African-American sample, and 
.71 for the SCD sample.   
Hypothesis 2A: The strength of association between EXAMINER executive 
composite, working memory factor, cognitive control factor, and fluency factor and VIQ 
from the WJ-III will be similar for African American and White children. 
Correlation Analysis 
Partial correlations, controlling for age, were conducted to examine construct 
validity for EXAMINER in relation to verbal ability. Data were computed with pairwise 
exclusion for missing values to maximize the sample size for each validity coefficient 
The verbal ability construct is represented by both the WRAT-IV reading T score 
and WJ-III verbal comprehension standard score.  As mentioned above, the WJ-III was 
not administered to the White comparison group. For that reason, reading performance on 
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the WRAT-IV was included in these analyses. Inclusion of this sub-test is 
psychometrically suitable because the WRAT-IV reading score and WJ-III verbal 
comprehension have been shown to demonstrate a moderate-to-large (r = .48) Pearson 
correlation, at the p > .05 significance level (Woodcock et al., 2001).  
Partial correlations were computed among the four scores of the EXAMINER and 
verbal ability, holding age constant.  The results of these correlational analyses indicated 
that the EXAMINER executive composite, fluency factor, cognitive control factor, and 
working memory scores were positively correlated with verbal ability standard scores, 
see Table 5.4. These partial correlation values also revealed generally similar associations 
across the two groups, with a trend toward higher convergent validity for the African-
American control sample as compared to the White control sample. The relationship 
between the EXAMINER composite scores and verbal ability for the White comparison 
group were small-to-medium in size (r = .29 to .42, p < .05). Similarly, the strength of the 
association between the EXAMINER and verbal ability for the African American 
comparison group were medium-to-large associations (r = .28 to .50, p < .05). 
Descriptive terms are based on those used by Cohen (1988). 
Significance of Difference between Correlation Coefficients 
Fisher r-to-z transformations were conducted, across the two samples, to assess 
the significance of the difference between partial correlation coefficients which evaluated 
construct validity for the EXAMINER. Partial correlation scores for the cognitive 
performance, controlling for age, of the African American control and White comparison 
groups were transformed into Fisher Z scores and the probability for the magnitude of the 
difference between the values was computed, with a two-sided test. The strength of 
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association between the EXAMINER executive composite (z = -.72, p < .05), fluency 
factor (z = -.44, p < .05), cognitive control (z = -.38, p < .05), and working memory (z = -
.01, p < .05) and verbal ability was not statistically significant for African American and 
White samples. 
Hypothesis 2B: The validity coefficient for the BRIEF Behavioral Regulation, 
Metacognition, and Global Executive Composite and the EXAMINER executive 
composite, working memory factor, cognitive control factor, and fluency factor scores 
will be similar for African American and White children. 
Correlation Analysis 
Partial correlations were computed to examine construct validity for EXAMINER 
compared to the BRIEF, controlling for age. To maximize sample size for each reliability 
coefficient, data were computed with pairwise exclusion for missing values. 
The degree of association between EXAMINER executive composite, fluency 
factor, cognitive control, and working memory scores and the BRIEF Metacognition, 
Behavioral Regulation, and Executive Composite scales was examined. Results of these 
correlational analyses indicated that all EXAMINER variables were correlated in the 
expected direction with each of the BRIEF indices, see Table 5.4. For the EXAMINER 
composite, fluency, and working memory factors higher scores mean better performance.  
For the EXAMINER cognitive control factor higher scores mean more difficulties with 
cognitive control tasks.  These partial correlation values also suggested a trend of higher 
validity coefficients for the African-American control sample as compared to the White 
control sample for the EXAMINER. The relationship between the EXAMINER scores 
and BRIEF Metacognitive Index, controlling for age, were small for the White 
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comparison group (r = -.14 to -.21, p < .05) and small-to-medium in size for the African 
American control group (r = -.18 to -.30, p < .05). The relationship between the 
EXAMINER scores and BRIEF Behavioral Regulation Index, holding age constant, also 
ranged from very small-to-medium range for the White comparison group (r = -.01 to -
.21, p < .06) yet the range of scores for the African American control group were small-
to-medium in size (r = -.18 to -.30, p < .05). Finally, the relationship between the 
EXAMINER scores and BRIEF Executive Composite Index, holding age constant, were 
small for the White comparison group (r = -.12 to -.17, p < .05) but medium-to-large in 
the African American control group (r = -.25 to -.32, p < .05). 
Significance of Difference between Correlation Coefficients 
Fisher r-to-z transformations were conducted to assess the significance of the 
difference between partial correlation coefficients utilized in EXAMINER construct 
validity evaluation. Partial correlation scores assessing the cognitive performance of 
African American control and White comparison groups between BRIEF and 
EXAMINER factors were transformed into Fisher Z scores.  
The probability for the magnitude of the difference between these values was 
computed across the two samples, with a two-sided test. Ten calculations for the test of 
the difference between EXAMINER and BRIEF scores were found to be statistically 
non-significant, see Table 5.4. The strength of association between EXAMINER 
executive composite (z = -.62, p < .05), fluency factor (z = .83, p < .05), cognitive control 
(z = -.02, p < .05), and working memory factor (z = .86, p < .05) and the BRIEF 
Metacognition Index was not statistically significant between the African American and 
White samples. The strength of association between EXAMINER fluency factor (z = 
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1.57, p < .05) and working memory factor (z = 1.27, p < .05) and the BRIEF Behavioral 
Regulation Index was not statistically significant between the African American and 
White samples. Conversely, the strength of association between EXAMINER executive 
composite (z = 2.36, p < .05) and cognitive control factor (z = 2.61, p < .01) in relation to 
the BRIEF Metacognition were significantly larger for the African American than the 
White sample. The strength of association between EXAMINER executive composite (z 
= 1.16, p < .05), fluency factor (z = 1.11, p < .05), cognitive control (z = -.89, p < .05), 
and working memory factor (z = .86, p < .05) and the BRIEF Executive Composite Index 
was not statistically significant between the African American and White samples.  
Hypothesis 3A: Children with SCD at high risk for disease-related cognitive 
effects will show significantly poorer performance on the EXAMINER than 
demographically matched control children without SCD.   The effect size of these 
differences will be compared to the magnitude of group differences on selected WJ-III. 
Descriptive Statistics 
Prior to performing the statistical analyses, data were analyzed by SPSS-22 for 
the presence of outliers and the possible influence over variable relationships. 
Examination of histograms and a series of independent sample t-tests were performed to 
examine whether there were significant differences between the age ranges of SCD and 
comparison study group.  Normality was tested using the Shapiro – Wilk test. Overall, 
these procedures revealed no significant violations of normality. These procedures 
revealed no significant statistical difference in age between the SCD group (M = 12.72, 
SD = 3.16) and the African American comparison group (M = 12.87, SD= 2.53), see 
Table 5.1.  
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Analysis of Variance Analyses 
An ANOVA analysis revealed a statistically significant difference between the 
parental income levels of the SCD group and the African American comparison group, at 
the p<.05 level [F (21.110) = 20.33, p = .00, η² = .01]. The mean level of parental income 
for the African American sample was (M = 2.92, SD= 1.22) was higher than the mean 
level of parental income for the SCD group (M = 1.74, SD= 1.40). Therefore income was 
added to the statistical models to control for this variance.  
A series of two-way analysis of variance analyses were conducted to examine 
whether there were statistically significant differences among children with SCD and the 
non-neurologic control group, in relation to performance on the EXAMINER.  
ANOVA results revealed a main effect between the SCD group and African 
American comparison group on the executive composite score, at the p<.05 level [F (1, 
111) = 12.86, p = .00, η² = .13]. The main effect of income was non-significant at the 
p<.05 level [F (4, 111) = 1.37, p = .25, η² = .05]. The average executive composite score 
was significantly higher for African American control children (M = -.18, SE = .08) than 
the SCD group (M = -.72, SE = .10) composite scores, see Figure 5.1. This evidence 
suggests that children diagnosed with SCD have poorer performance on the EXAMINER 
when compared to demographically matched peers.  
ANOVA results also reveal that the main effect of the SCD group and the African 
American comparison group, in relation to the cognitive control factor, was statistically 
significant, controlling for family income levels, at the p < .05 level [F (1, 111) = 12.66, 
p = .00, η² = .11]. The main effect of income was non-significant at the p<.05 level [F (4, 
107) = 1.26, p = .29, η² = .04]. The mean composite cognitive control scores for the SCD 
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group (M = -.60, SE = .14) were significantly lower than the Black comparison group (M 
= .06, SE = .11) cognitive control scores, see Figure 5.2. Results suggest that children 
with SCD exhibit poorer cognitive control than Black peers.  
ANOVA analysis also examined the presence of statistically significant 
differences among children, controlling for family income levels, diagnosed with SCD 
and a demographically matched comparison group related to their performance on the 
EXAMINER fluency factor score. Results revealed statistically significant differences 
among the groups, at the p < .05 level [F (2, 393) =8.08, p = .00, η² = .04]. The main 
effect of income was non-significant at the p<.05 level [F (4, 105) = .47, p = .76, η² = 
.02]. The mean fluency scores of the SCD group (M = -.68, SE = .10) were statistically 
lower than those of the demographically matched control group (M = -.20, SE = .08), see 
Figure 5.3. Findings indicate that African American children with no neurologic 
condition performed significantly higher compared to children diagnosed with SCD on 
the mean fluency composite score. 
ANOVA findings also demonstrate a significant main effect between SCD group 
status and the African American comparison group on the EXAMINER working memory 
composite score, at the p<.05 level [F (1, 92) = 7.18, p = .01, η²  = .17]. The main effect 
of income was non-significant at the p < .05 level [F (4, 92) = 1.28, p = .28, η² = .05].The 
mean score for the African American comparison group (M = -.21, SE = .09) was 
significantly different than the SCD group (M = -.64, SD = .13), see Figure 5.4. Results 
suggest that African American children with no neurologic condition performed better 
than children diagnosed with SCD on the working memory factor score, η²  = .17].   
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 Similarly, ANOVA results revealed statistically significant differences between 
the SCD group and the demographically matched control group, across income levels, on 
the W scores calculated from the WJ-III.  Results revealed that the verbal comprehension 
scores for the SCD group and the African American comparison group were statistically 
different, at the p<.05 level [F (1, 111) = 7.12, p = .01, η² = .07]. The main effect of 
income was non-significant at the p<.05 level [F (4, 111) = .84, p = .50, η² = .03].Verbal 
comprehension scores for the SCD group (M = 495.60, SE = 2.59) was significantly 
lower than the Black comparison group (M = 504.94, SE = 2.01) verbal comprehension 
scores, see Figure 5.5. This evidence suggests that children diagnosed with SCD have 
poorer verbal comprehension on the WJ-III when compared to demographically matched 
peers. 
In addition, ANOVA analysis examined the presence of statistically significant 
differences among children with SCD and a demographically matched comparison group 
in relation to their performance on WJ-III visual matching score, across all income levels. 
Results revealed a statistically significant main effect among the groups, at the p<.05 
level [F (1, 111) = 14.35, p = .00, η² = .12]. The main effect of income was non-
significant at the p<.05 level [F (4, 111) = .89, p = .47, η² = .03]. There were statistically 
significant differences between the SCD group (M = 495.88, SE = 2.75), and those of the 
demographically matched control group (M = 509.38, SE = 2.13), see Figure 5.6. 
Findings indicate that African American children with no neurologic condition performed 
significantly higher compared to children diagnosed with SCD for visual matching on the 
WJ-III. 
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ANOVA results also revealed a significant main effect of SCD group status on 
WJ-III numbers reversed W score across income levels, at the p<.05 level [F (1, 111) = 
7.21, p = .00, η²  = .06]. The main effect of income was non-significant at the p<.05 level 
[F (4, 111) = 1.09, p = .37, η² = .04]. The mean score for the African American 
comparison group (M = 504.49, SE = 3.67) was significantly different than the SCD 
group (M = 487.99, SD = 4.73), see Figure 5.7. Results suggest that African American 
children with no neurologic condition performed better than children diagnosed with 
SCD, on the WJ-III numbers reversed task. 
The eta-squared values for the EXAMINER scores ranged from small-to-large, 
.04 to .17 with a median of .12, whereas for the WJ-III the effect sizes were medium, .06 
to .12 with a median of .07. Comparison of the magnitude of the observed effects across 
the EXAMINER and WJ-III W scale measures might suggest a slight trend toward larger 
effects for the EXAMINER, though overall the values were comparable (Cohen, 1988). 
Overall, children with SCD showed significantly poorer performance on the 
EXAMINER than demographically matched control children without SCD, Table 5.5. 
Therefore, hypothesis 3A was supported. These results further support the conclusion that 
children with SCD evidence disease-related cognitive effects.  
 
Hypothesis 3B: The EXAMINER executive composite, working memory factor, cognitive 
control factor, and fluency factor will show at least as high of sensitivity and specificity 
in identifying high risk children with sickle-cell disease as the selected measures from the 
WJ-III relative to the local, demographically matched comparison group.   
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Descriptive Statistics 
Prior to performing the statistical analyses, SPSS-22 was utilized to conduct a 
subgroup analysis of African American comparison group. This procedure was 
performed to provide balance in parental income between groups. A targeted selection of 
cases was performed from the African American comparison group, with the intent of 
exclude cases more than 1 SD away from mean income level of the SCD group (M = 
1.73, SD = 1.74). A random sub-group (n = 51) was then generated with a lower mean 
parental income level (M = 1.39, SD = .73).  Normality was tested using the Shapiro–
Wilk test. Analyses revealed no significant violations of normality or significant 
statistical difference between the SCD group (M = 12.72, SD = 3.16) with skewness of 
0.8 (SE = 0.41) and kurtosis of -1.2 (SE = 0.8) and the African American comparison 
group (M = 12.64, SD= 2.77) with skewness of 0.01 (SE = .44) and kurtosis of -0.88 (SE 
= 0.86). An independent samples t-test revealed no statistical significance between the 
income range of the SCD and African American comparison groups (t = 9.99, df = 27, p 
< .73). ROC Curves were constructed based upon the sensitivity and specificity of the 
EXAMINER and WJ-III scores. 
Receiver Operating Characteristic Curve Analysis 
ROC Curve analyses were conducted to evaluate the performance of multiple 
curves in order to compare the EXAMINER and WJ-II neuropsychological measures. 
Results indicated that the EXAMINER scores were statistically significance (p = .05) in 
differentiating between the SCD and demographically matched comparison groups. The 
balance between sensitivity and false positive rate is shown in Figure 5.8. The WJ-III 
  
124 
 
 
 
  
 
  
scores were also statistically significance (p = .05) for differentiating between study 
groups.  The balance between sensitivity and false positive rate is shown in Figure 5.9.  
ROC Curves in Figure 5.8 and Figure 5.9 can be expressed numerically as area 
under the curve values, which indicate the likelihood that a randomly selected case will 
perform more poorly than a randomly selected control.  The area under the curves for the 
EXAMINER scores were: executive composite (.79), fluency factor (.74), cognitive 
control factor (.77), working memory factor (.74) and these values appear to be similar to 
the WJ-III: verbal comprehension, (.72), visual matching (.76), numbers reversed (.70). 
More specifically, for discriminating no SCD status from SCD diagnosis among all 
subjects, the areas under the ROC curves for the EXAMINER and WJ-III evidence 
moderate accuracy by Swets’s (1988) criteria, see Table 5.6.  
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Table 5.1. 
Descriptive Information for Study Groups 
Variable 
High Risk 
SCD 
(n-32) 
AA 
Comparison 
Group Without 
SCD (n-85) 
White 
Comparison 
Group 
Without 
SCD (n-279) Statistic 
Age (M ± SD; range) 12.7 ± 3.2 12.8 ± 2.5 11.2 ± 2.9 t(362) = 4.94, p < .001 
Gender (n) 
    
 Males 14 (43.8%) 39 (46.3%) 133 (47.0%)  
 
 Females 18 (56.3%) 46 (59.7%) 146 (53.0%) 
 
Race/Ethnicity 
    
 African-American 32 80 (94.5) n/a 
 
 Hispanic and African American 0 5 (0.6%) n/a 
 
Parent Education 
    
 9-11 years 3 (3.2%) 4 (3.0%) n/a 
 
 High School 4 (13.3%) 19 (16.2%) n/a 
 
 Some College 9 (28.8%) 20 (17.0%) n/a 
 
 College Degree 16 (51.2%) 42 (35.7%) n/a 
 
Family Income (n) 
   
F(21.110) = 20.33, p = 
.001 
 < $10,000/year 9 (28.8%) 3 (3.5%) n/a 
 
 $10-20,000/year 5 (15.6%) 9 (10.6% n/a 
 
 $20-30,000/year 8 (25.0%) 15 (17.6%) n/a 
 
 $30-40,000/year 5 (15.6%) 18 (21.2%) n/a 
 
 > $40.000/year 5 (15.6%) 40 (47.1%) n/a 
 
Adults in the home (M ± SD)  1.6 ± 0.5 1.8 ± 0.6 n/a 
 
Age of Primary Caregiver (M ± 
SD) 
37.4 ± 9.0 37.0 ± 9.0 n/a 
 
Current Therapy (n) 
    
 Hydroxyurea 2 n/a n/a 
 
 Chronic therapy 1 n/a n/a 
 
 Bone Marrow therapy 0 n/a n/a 
 
Routine CBC Values 
    
 White cells (K/ul) 13.1 ± 3.1 n/a n/a 
 
 Hemoglobin (g/dL) 8.6 ± 1.3 n/a n/a 
 
 Platelets (K/uL) 466 ± 129 n/a n/a 
 
SCD=sickle cell disease 
*p<0.05; **p<0.01 
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Table 5.2. 
 
Overview of Internal Consistency for EXAMINER and WJ-III 
 
 Study Groups  
 
 
 
Test 
African 
American 
Comparison 
Group 
White    
Comparison 
Group 
SCD Group 
 
WJ-III 
Normative 
Sample 
Examiner Battery     
     Composite Score .81 (n = 85) .84 (n = 279) .84 (n = 32)  
     
Woodcock-Johnson III     
     Verbal      
     Comprehension 
- - - .91 (n = 3549) 
     Visual Matching - - - .88 (n = 3719) 
     Numbers Reversed - - - .86 (n = 3337) 
Note: Internal consistency reliability values, Chronbach’s alpha, for 10 EXAMINER tasks and Woodcock-Johnson 
Tests of Cognitive Abilities, 3rd edition mean internal consistency scores for children 8-18 of age; *p<.05; **p<.01,2-
tailed test. 
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Table 5.3. 
 
Fisher r-to-z transformation scores used to assess the significance of the difference 
between EXAMINER composite scores and WJ-III tests.  
 
WJ-III Subscales African 
American  
Sickle Cell 
Disease 
White  
Verbal 
Comprehension 
-3.59** -1.64 -4.9** 
Visual Matching -2.23* -0.83 -2.48** 
Numbers Reversed -1.49 -0.39 -1.15 
Notes: Z-scores test the difference in the magnitude of the correlation between the Woodcock-Johnson Tests of 
Cognitive Abilites, 3rd edition Verbal Comprehension, Visual Matching, and Numbers Reversed scales and the 
EXAMINER Composite scores for the African-American, SCD, and White samples; *p<.05; p<.01, 2-tailed test. 
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Table 5.4. 
 
Partial correlations (controlling for age) assessing construct validity for EXAMINER 
Battery factor scores.  Twelve of sixteen coefficients were in the direction of higher 
convergent validity for the African-American sample as compared to the White sample. 
 
 
Measure Group Executive 
Composite 
Fluency Cognitive 
Control 
Working 
Memory 
Verbal Ability – 
Age Adjusted 
Score 
W .421 
(n = 231) 
.293 
(n = 232) 
-.380 
(n = 231) 
.279 
(n = 218) 
A-A .495 
(n = 82) 
.345 
(n = 82) 
-.339 
(n = 79) 
.280 
(n = 73) 
 z = -0.72 z = -0.44 z = 0.36 z = -0.01 
BRIEF - Meta-
cognitive Index 
W -.212 
(n = 246) 
-.142 
(n = 246) 
.187 
(n = 246) 
-.180 
(n = 231) 
A-A -.291 
(n = 72) 
-.250 
(n = 73) 
-.184 
(n = 70) 
-.297 
(n = 64) 
 z = 0.62 z = 0.83 z = -0.02 z = 0.86 
BRIEF - 
Behavioral 
Regulation Index 
W -.054 
(n = 246) 
-.059 
(n = 246) 
.006 
(n = 246) 
-0.153 
(n = 231) 
A-A -.352 
(n = 77) 
-.261 
(n = 77) 
.344 
(n = 74) 
-.228 
(n = 68) 
 z = 2.36* z = 1.57 z = 2.61** z = 1.27 
BRIEF – 
Executive 
Composite Index 
W -.170 
(n = 244) 
-.123 
(n = 244) 
.130 
(n = 244) 
-.145 
(n = 229) 
A-A -.318 
(n = 72) 
-.269 
(n = 72) 
.249 
(n = 69) 
-.273 
(n = 63) 
 z = 1.16 z = 1.11 z = 0.89 z = 0.92 
Notes: Verbal Ability was estimated from either the Woodcock-Johnson Tests of Cognitive Abilities, 3rd edition Verbal 
Comprehension scale or the Wide Range Achievement Test, 4th edition Reading Score; BRIEF=Behavioral Rating 
Inventory of Executive Function; Z-scores test the difference in magnitude of the correlation between the White and 
African-American samples; *p<.05; **p<.01; data were computed with pairwise exclusion for missing values to 
maximize the sample size for each validity coefficient. 
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Table 5.5. 
 
Mean Score for African American and SCD study groups on EXAMINER Z scores and  
WJ-III W Scores  
 
 Study Groups 
 
 
 
Test 
African American 
Comparison Group 
SCD Group 
Examiner Battery   
     Composite Factor Score -0.18 (SE = .08) -0.72 (SE = .10) 
     Cognitive Control  Factor Score -0.60 (SE = .14) 0.06 (SE = .11) 
     Fluency Factor Score -0.20 (SE = .08) -0.68 (SE = .10) 
     Working Memory Factor Score -0.21 (SE = .09) -0.64 (SE = .13) 
   
Woodcock-Johnson III   
     Verbal Comprehension 504.94 (SE = 2.01) 495.60 (SE = 2.59) 
     Visual Matching 509.38 (SE = 2.13) 495.88 (SE = 2.75) 
     Numbers Reversed 504.49 (SE = 3.67) 487.99 (SE = 4.73) 
Note: Internal consistency reliability values, Chronbach’s alpha, for 10 EXAMINER tasks and Wookcock-Johnson 
Tests of Cognitive Abilities, 3rd edition mean internal consistency scores and standard error scores for children 8-18, 
*p<.05; **p<.01, 2-tailed test. 
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Table 5.6 
 
Area under ROC curve for EXAMINER and WJ-III 
 
 Area Under the 
Curve (95% CI) 
Standard 
Error 
EXAMINER   
     Composite Factor Score .79* (.67-.90) .06 
     Cognitive Control  Factor Score .77* (.66-.88) .06 
     Fluency Factor Score .74* (.62-.86) .06 
     Working Memory Factor Score .74* (.63-.86) .06 
   
Woodcock-Johnson III   
     Verbal Comprehension W Score .72* (.61-.82) .06 
     Visual Matching W Score .76* (.65-.87) .06 
     Numbers Reversed W Score .70* (.59-.80)- .05 
Note: Null hypothesis: true area = 0.5 
*. Significant at the 0.05 level (2-tailed). 
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Figure 5.1. Mean EXAMINER Composite Scores for SCD and AA Comparison Group 
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Figure 5.2. Mean EXAMINER Cognitive Control Scores for SCD and AA Comparison 
Group 
 
  
133 
 
 
 
  
 
  
 
 
 
 
Table 5.3. Mean EXAMINER Fluency Scores for SCD and AA Comparison Group 
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Figure 5.4. Mean EXAMINER Working Memory Scores for SCD and AA Comparison 
Group 
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Figure 5.5. Mean WJ-III Verbal Comprehension Scores for SCD and AA Comparison 
Group 
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Figure 6.6. Mean WJ-III Visual Matching Scores for SCD and AA Comparison Group
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Figure 5.7. Mean WJ-III Numbers Reversed Scores for SCD and AA Comparison Group 
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Figure 5.8. Hypothesis 3B - Receiver-Operating Characteristic Curves for EXAMINER 
Factor and Composite Scores 
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Figure 5.9. Hypothesis 3B - Receiver-Operating Characteristic Curves for WJ-III Verbal 
Comprehension, Visual Matching, and Numbers Reversed tests 
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CHAPTER VI 
DISCUSSION 
 This study aimed to investigate the psychometric properties of a new executive 
function measure, the EXAMINER, to determine its utility with the pediatric SCD 
population.  The psychometric properties of the EXAMINER were evaluated, relative to 
the WJ-III. The WJ-III was chosen as a gold standard because this literature review 
revealed that it has strong psychometric properties and cultural validity with African-
American children. Thus, the WJ-III appears to be the most appropriate measure for use 
with the pediatric SCD population, in the US. In this investigation, the cultural validity of 
the EXAMINER was investigated for African-Americans with SCD, by comparing the 
internal consistency and convergent validity for African-American youth relative to 
White youth. In addition, criterion validity was assessed for the EXAMINER to SCD-
related cognitive deficits. Overall, this study revealed three novel findings. First, the 
EXAMINER demonstrated adequate reliability (internal consistency) for the Executive 
Composite score. This assessment of internal consistency was based on traditional 
standards. Reliability values were found to be similar across White and African-
American children.  However, reliability was found to be lower for the EXAMINER, 
compared to the normative sample of children in the WJ-III manual.  Second, the 
EXAMINER displayed acceptable cultural validity for African-Americans with SCD. 
Convergent validity was evaluated by the degree to which the EXAMINER and well 
established measures were related across Black the White samples. Finally, the 
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children with and without neurologic morbidity and performed at least as well as an 
established measure, the WJ-III.  
 Hypothesis 1:  The reliability (internal consistency) of the EXAMINER will be 
equivalent to the WJ-III for use in pediatric SCD, including the reliability for youth tested 
across multiple sites, local demographic controls, and youth with SCD. 
 Results suggested that hypothesis one was partially supported by the findings in 
this investigation. Findings revealed that the internal consistency of the EXAMINER 
composite score appeared to function adequately across SCD and comparison pediatric 
groups. Similar to the WJ-III, the EXAMINER composite score evidenced good internal 
consistency for each study group when employing commonly accepted descriptive labels 
(Cohen, 1988). More specifically, the internal consistency of the EXAMINER for each of 
the study groups reached the generally accepted 0.8 Chronbach’s alpha threshold for 
making interpretations and clinical predictions.  There were also no significant 
differences for internal reliability found between the pediatric SCD, African American, 
and White comparison groups on the EXAMINER, relative to the WJ-III. Likewise, there 
were no differences found within the pattern of responses between the EXAMINER and 
WJ-III for children diagnosed with pediatric SCD and youth in the comparison groups for 
the WJ-III working memory task.  Divergent to Hypothesis 1, the magnitude of 
difference between the internal consistency of the EXAMINER composite score and WJ-
III verbal comprehension and visual matching tests were significant for White and Black 
youth, indicating higher reliability for these WJ-III measures than for the EXAMINER.  
 Contrary to what we originally expected, the EXAMINER showed lower 
reliability than found in the WJ-III manual for the measure’s normative sample. It is 
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possible that comparison between a larger and more diverse sample, matched to the U.S. 
census, improved the alpha value by increasing the range of scores with greater 
variability.  However, the EXAMINER appeared to perform nearly as well as the WJ-III 
with one-third the items. This suggests the EXAMINER items were well chosen. The 
WJ-III measures typically have 30 or more items per scale, whereas the EXAMINER 
composite score used 10 items derived from different tasks.  Given that sensitivity of the 
alpha coefficient to the number of items in the scale, it is somewhat impressive that the 
EXAMINER composite score was able to achieve acceptable reliability as a clinical tool 
with so few items.   
 These results contribute to the emerging empirical literature which suggests that 
the EXAMINER may assess EF reliably across a variety of ages, ethnicities, and 
disorders (Kramer, 2014; Kramer, et al., 2013). The developers of the EXAMINER 
utilized IRT methods to measure factors with fewer variables. IRT is focused on 
individual items; the reliability of a scale is enhanced by containing a small number of 
non-redundant items that measure a very specific level of the latent variable. Therefore, it 
would have been more suitable for this study to utilize the IRT method of analysis, 
thereby comparing similar results with the EXAMINER manual. Future studies may 
consider using more sophisticated methods of scale development, such as IRT, to 
investigate the appropriateness of the EXAMINER for use with pediatric SCD. Future 
researchers should also consider examining test-retest reliability, in children, with other 
well established measures of EF.  These values should then be used to assess cross-
cultural examinations for the reliability of the EXAMINER across different cultural 
groups. 
  
143 
 
 
 
  
 
  
 Hypothesis 2A: The strength of association between EXAMINER scores and VIQ 
from the WJ-III will be similar for African American and White children. 
 The psychometric literature reveals that there is an association between VIQ and 
EF measures for pediatric populations (McCarthy, 1972; Ardila et al., 1998; Ardila et al. 
2000). Findings suggest that hypothesis 2A was supported in this study. The 
EXAMINER shows comparable validity across African American youth, compared to 
established measures of VIQ. Results from this study reveal that the strength of 
association between the EXAMINER and VIQ on WRAT and WJ-III was similar for 
African American and White children, when age was held constant. In addition, three of 
four partial correlation coefficients for the EXAMINER, relative to VIQ on the WRAT 
and WJ-III were in the direction of higher convergent validity for the African American 
sample, as compared to the White sample.  This suggests that increasing sample size and 
power would be unlikely to change the outcome of these analyses. Despite the fact that 
the EXAMINER appeared to demonstrate higher convergent validity for the African 
American group, there was also greater variability across partial correlation values for the 
African American sample. However, the similar convergent validity shown between the 
EXAMINER with the WJ-III and the WRAT between African American and White 
samples, demonstrates acceptable cultural validity for African American children. These 
findings are consistent in the multicultural assessment literature. Reynolds & Suzuki 
(2012) suggest that when psychological test are developed through culturally fair 
methods, they are more likely to demonstrate relatively equivalent ability levels across 
ethnic groups and are also more likely correctly identify patterns of performance between 
different ethnic groups.   
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 Hypothesis 2B: The strength of the association between the validity coefficient for 
the BRIEF Behavioral Regulation, Metacognition, and Global Executive Composite and 
the EXAMINER executive composite, working memory factor, cognitive control factor, 
and fluency factor scores will be similar for African American and White children. 
 Convergent validity for the EXAMINER was also assessed with the BRIEF. The 
BRIEF is a cognitive measure that was developed to examine the functional expression of 
EF through parent or teacher report of day-to-day behavior (Gioia, Isquith, Guy, 
Kenworthy, 2000). Findings from hypothesis 2B were supported in this study. Overall, 
the EXAMINER shows similar validity across the African American and White youth, 
relative to the BRIEF. Results reveal no significant differences for 10 of 12 analyses to 
compare the strength of the association between the BRIEF and the EXAMINER for the 
African American and White comparison groups, controlling for age. In general, these 
findings suggest that partial correlation values were more variable, but in the direction of 
higher convergent validity for the African American sample, as compared to the White 
sample. Again, this suggests that increasing sample size and statistical power would be 
unlikely to reveal a pattern of poorer convergent validity for African-American children.  
The standard deviation was slightly larger for the African American comparison group on 
the BRIEF. Differences in variability may have led to slightly lower coefficients for the 
White sample. However, the increased variability in validity values does not appear to 
detract from the moderate correlations found in the African American sample, which 
support validity for this cultural group 
 It was reasonable to expect that results of hypothesis 2A and 2B would reveal that 
the EXAMINER demonstrates similar cultural validity to well-established measures, for 
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African American children. The mission of the EXAMINER test development was to 
promote methods of measurement that could be useful across diverse ages and ethnicities 
(Kramer, et al., 2014).  Thereby, this study contributes to the emerging empirical 
literature which suggests that the EXAMINER may have appropriate detection 
capabilities for EF in the pediatric SCD population (Kramer, 2014; Kramer, et al., 2013).  
These results are also a noteworthy first-step to understanding how the EXAMINER 
performs for African Americans children when compared to White youth. Traditional 
factor analysis allows for insights into the nature of multiple latent variables, however 
this typically requires larger sample sizes than our study could efficiently recruit 
(DeVellis, 2003). An important next step is to explore the construct validity of the 
EXAMINER with confirmatory factor analysis to test whether the data fit the 
hypothesized measurement model. The sample size in this study was too small to conduct 
this analysis. Therefore, future investigations should consider concentrating on further 
enhancing our understanding of cultural and convergent validity for the EXAMINER, by 
utilizing larger sample sizes of African American children and other cultural groups.  
 Hypothesis 3A: Children with SCD at high risk for disease-related cognitive 
effects will show significantly poorer performance on the EXAMINER than 
demographically matched control children without SCD.   The effect size of these 
differences will be compared to the magnitude of group differences on selected WJ-III. 
 Overall, findings from this study suggest that Hypotheses 3A were supported. The 
EXAMINER appears to evidence comparable sensitivity in detecting neurologic 
decrements in the pediatric SCD population as compared to the WJ-III. Children with 
SCD revealed poorer performance on the Examiner Battery compared to the African 
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American comparison group, providing support for hypothesis 3A. Across all 
EXAMINER scores, statistically significant findings showed that poorer executive 
performance occurred for children diagnosed with SCD relative to the African American 
comparison group. Similarly, results revealed statistically significant differences between 
the SCD group and the demographically matched control group on each of the variables 
from the WJ-III. Comparison of the magnitude of the observed effects across the 
EXAMINER and WJ-III W scale measures suggest a slight trend toward larger effects for 
the EXAMINER, though overall the values were comparable.  
 Hypothesis 3B: The EXAMINER will show at least as high of sensitivity and 
specificity in identifying high risk children with sickle-cell disease as the selected 
measures from the WJ-III relative to the local, demographically matched comparison 
group.   
 The ROC sensitivity-specificity analyses showed that the EXAMINER predicted 
neurologic risk/status at a comparable rate as WJ-III. These findings provide support for 
hypothesis 3B. Results of the sensitivity-specificity analyses showed statistical 
significance for the EXAMINER scores and WJ-III variables in the prediction of 
neurologic status. The areas under the ROC curves for the EXAMINER and WJ-III 
evidenced moderate accuracy utilizing Swets’s (1988) criteria. Both measures 
demonstrated classification accuracy rates that were slightly lower than 80%.  Given that 
80% sensitivity and specificity are often used as common standards for accuracy of 
psychological tools in decision making, the measures fell slightly below this standard.  
However, the EXAMINER tool at this point in development does not use age-adjusted 
scores, which would likely improve its ability to differentiate between groups.  Likewise, 
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non-age adjusted scores were used with the WJ-III to provide a more direct comparison 
between measures.  Thus, the EXAMINER appears to have the potential to provide 
excellent criterion validity, but needs additional work, primarily in the area of collecting 
of a larger sample for normative purposes. 
 Taken together, these results highlight the acceptable levels of criterion validity 
for both the EXAMINER and WJ-III in terms of sensitivity to SCD-related cognitive 
deficits though for individual-level decision making the EXAMINER is still lacking in 
age-specific norms. As the WJ-III is a well-established measure for the detection of 
neurologic deficits with the pediatric SCD population, these findings provide evidence 
for the EXAMINER’s ability to effectively discriminate between children with and 
without neurologic morbidity. Therefore, this study contributes to the developing 
literature which supports the use of the EXAMINER with diverse clinical populations, 
including pediatric SCD (Kramer, 2014; Kramer et al., 2013). In addition, these results 
further support the assertion that cognitive testing is an efficacious and cost effective 
method for identifying neurologic deficits in pediatric SCD. Future investigations should 
focus efforts on further examining the EXAMINER’s ability to detect neurologic deficits 
within pediatric SCD and its use in clinical trials can be justified. 
Limitations 
 Although the EXAMINER appeared to function as well as traditional cognitive 
measures for each of these analyses, there are some limitations of this study that must be 
acknowledged. First, the sample sizes were relatively small for the SCD group and 
African-American controls, which may account for some of the variation in findings 
regarding internal consistency. Most notably, the magnitude of difference between the 
  
148 
 
 
 
  
 
  
internal consistency of the EXAMINER and WJ-III verbal comprehension and visual 
matching was significant for African American and White youth.  One reason for higher 
reliability in the WJ-III may the more limited variability of the EXAMINER sample 
groups compared to the large normative sample for the WJ-III. Data collection for the 
multi-site study was performed largely by psychologists, focused on collecting clinical 
samples. It is likely that the neurologic study samples were in some cases collected as 
samples of convenience, more so than large well-designed normative data sets. 
Consequently, decreased variability within the study sample may have translated into 
lower internal consistency observed for the EXAMINER, relative to the WJ-III normative 
sample.  
 The Yurdugul, (2008) article suggests that our sample sizes were large enough to 
adequately produce a sufficiently unbiased estimator of coefficient alpha for the 
EXAMINER composite score, given the first eigenvalue of greater than four.  However, 
in detecting differences in alpha across groups one must decide what degree of 
differences is likely to be meaningful.  With a large enough sample, it is likely that group 
differences in reliability could have been shown. Therefore the critical number of 
participants may not have been large enough to detect internal consistency. Despite the 
small sample sizes, results suggest that the overall internal consistency and convergent 
validity for the EXAMINER evidenced acceptable levels across study groups. 
 Another limitation of this study concerns the lack of detailed demographics 
provided for children from other sites. Due to investigator error at these sites, the level of 
parent education was not provided for the children that participated at 10 sites of the 
multi-site investigation. It was intended that parent education data would be included in 
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the analyses, as a proxy variable to represent SES. In 2000, the US Census Bureau 
reported that African Americans experience disproportionate poverty rates, compared to 
White non-Latino youth. Schatz and colleagues (2004) found results which suggest that 
children with SCD experience a combination of biopsychosocial risk factors related to the 
neurologic factors and socioeconomic disadvantage. Failure to include a variable to 
account for SES limited the ability to examine cultural differences.  SES differences may 
have influenced some of the comparisons of White and African American youth. It is not 
clear whether the inclusion of measures for SES would have changed the results found in 
these samples; future investigations should try to obtain information on these variables to 
improve our understanding of the performance of African American children on the 
EXAMINER.  
Conclusion 
 As revealed in the literature review, the great variability related to 
neuropsychological measures used to assess neurologic morbidity has, in part, negatively 
impacted treatment outcomes for pediatric SCD. The newly developed EXAMINER was 
developed with the central goal of reliably and validly assessing EF across a wide range 
of ages and disorders (Kramer et al., 2012). Therefore it was important to evaluate the 
psychometric properties of the EXAMINER to help determine the suitability of this tool 
with children diagnosed with SCD relative to an alternate measure. In sum, this study 
demonstrated the feasibility of using the EXAMINER for children with SCD as a reliable 
and valid tool in clinical research and intervention trials. In conclusion, findings in this 
study suggested that the internal consistency, convergent validity, cultural validity, and 
sensitivity of the EXAMINER demonstrated that it is a useful neuropsychological test for 
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the pediatric SCD population. It is important to note that as test development continues 
for the EXAMINER, consistent evaluation of its psychometric properties should be 
continued with this clinical population; due to an increased risk of subtle problems with 
learning and cognition, even in the absence of an identifiable insult to the brain.(Schatz et 
al., 2002).   
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